Plant-derived aerogels, hydrogels, and foams, and methods and uses thereof

JP2023549693A5Pending Publication Date: 2024-11-19SPIDERWORT BIOTECHNOLOGIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023526204
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-10-29
Filing Date
2021-10-29
Publication Date
2024-11-19
Patent Text Reader

Abstract

Provided herein are aerogels and foams comprising single structural cells and / or groups of structural cells derived from plant or fungal tissue, wherein the single structural cells have a decellularized 3D structure lacking cellular material and nucleic acids from the plant or fungal tissue, and the single structural cells and / or groups of structural cells are dispersed within a carrier derived from a dehydrated, lyophilized, or freeze-dried hydrogel. Also provided herein are methods for preparing the aerogels or foams, including providing decellularized plant or fungal tissue; obtaining single structural cells and / or groups of structural cells from the decellularized plant or fungal tissue by mercerization; mixing or dispersing the single structural cells and / or groups of structural cells in a hydrogel to provide a mixture; and dehydrating, lyophilizing, or freeze-drying the mixture to provide the aerogel or foam. Related methods and uses are also provided.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates generally to aerogels, hydrogels and foams, and more particularly to aerogels, hydrogels and foams derived from and / or comprising decellularized plant or fungal tissues or their structural cells. [Background technology]

[0002] Scaffold materials, especially those that provide homogeneous and / or reproducible three-dimensional structures, are highly sought after in several different fields. In the pharmaceutical, medical device, therapeutic, and food spaces, biocompatible and / or edible scaffold materials are particularly sought after, and those that can support cell growth are highly desirable.

[0003] A variety of scaffolding materials have been developed, many of which are based on synthetic polymers or other such materials. Although some of these are known to be biocompatible and / or bioinert, additional scaffolding materials remain of great interest for various applications.

[0004] Scaffold biomaterials comprising decellularized plant or fungal tissue have been developed and are described in PCT Patent Publication No. 2017 / 136950, entitled "Decellularized Cell Wall Structures From Plants and Fungus and Use Thereof as Scaffold Materials." Remarkable biocompatibility and uses in a variety of therapeutic applications have been described. These scaffold biomaterials are of great interest for a variety of different applications.

[0005] Nevertheless, additional scaffolding materials are desirable in various fields, particularly those that provide aerogels, hydrogels, and / or foams that offer tunable or customizable physical / mechanical properties and / or micro / macro-scale architectures.

[0006] Alternative, additional, and / or improved aerogels, hydrogels, and / or foams and methods and / or uses thereof are desirable. [Prior art documents] [Patent documents]

[0007] [Patent Document 1] International Publication No. 2017 / 136950 Brochure Summary of the Invention [Problem to be solved by the invention]

[0008] Aerogels, hydrogels, and foams derived from and / or containing decellularized plant or fungal tissues or their structural cells are provided herein. As described below, aerogels, hydrogels, and foams have been developed that may be derived from and / or contain decellularized plant or fungal tissues or their structural cells; may contain desired plant or fungal microstructures and / or architectures; may be produced by readily scalable production methods; may offer a wide range of scaffold microstructures and / or macrostructures and / or biochemistries; may offer tunable mechanical properties; may offer tunable porosity; may be biocompatible in vitro and / or in vivo; may be stable under various conditions (such as cooking conditions in the case of food); or any combination thereof. Various aerogels, hydrogels, and foams with desirable properties have been developed and prepared by using single structural cells, groups of structural cells, or both derived from plant or fungal tissue (single structural cells or groups of structural cells having a decellularized three-dimensional structure lacking the cellular material and nucleic acids of the plant or fungal tissue) dispersed within one or more dehydrated, lyophilized, or freeze-dried hydrogel-derived carriers. In certain embodiments, the single structural cells, groups of structural cells, or both may be derived from plant or fungal tissue (typically decellularized plant or fungal tissue) using a mercerization process as described herein, allowing for reproducible and scalable production. Related methods and uses, as well as production methods, are also described in detail herein. [Means for solving the problem]

[0009] In one embodiment, provided herein is the following aerogel or foam: a single structural cell, a group of structural cells, or both, derived from plant or fungal tissue, wherein the single structural cell or the group of structural cells has a decellularized three-dimensional structure that is devoid of cellular material and nucleic acids of the plant or fungal tissue; An aerogel or foam in which single structural cells, groups of structural cells, or both are dispersed within a carrier derived from a dehydrated, lyophilized, or freeze-dried hydrogel.

[0010] In another embodiment of the above aerogel or foam, the aerogel or foam is rehydrated.

[0011] In yet another embodiment of any of the aerogel(s) or foam(s) described above, the plant or fungal tissue from which the single structural cell or group of structural cells is derived may comprise decellularized plant or fungal tissue.

[0012] In yet another embodiment of any of the above aerogel(s) or foam(s), plant or fungal tissue can be decellularized using SDS and optionally CaCl2.

[0013] In another embodiment of any of the above aerogel(s) or foam(s), single structural cells, groups of structural cells, or both can be obtained from plant or fungal tissue by mercerization. In certain embodiments, the plant or fungal tissue can be decellularized plant or fungal tissue.

[0014] In yet another embodiment of any of the above aerogel(s) or foam(s), mercerization may include treatment of plant or fungal tissue using sodium hydroxide and hydrogen peroxide in conjunction with heat.

[0015] In yet another embodiment of any of the aerogel(s) or foam(s) described above, the aerogel or foam can comprise a particle size distribution of monostructural cells having an average Feret diameter in the range of about 1 μm to about 1000 μm, e.g., about 100 to about 500 μm, e.g., about 100 to about 300 μm.

[0016] In another embodiment of any of the above aerogel(s) or foam(s), the hydrogel is selected from the group consisting of alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, extracellular matrix. The hydrogel may comprise a protein (e.g., collagen, gelatin, or fibronectin, or any combination thereof), monoacrylated poly(ethylene glycol), poly(ethylene glycol) diacrylate, poly(ethylene glycol) diacrylate (PEGDA)-co-PEGMA, poly(vinyl alcohol), poly(vinylpyrrolidone), poly(lactic-co-glycolic acid), chitosan, chitin, xanthan gum, elastin, fibrin, fibrinogen, cellulose derivatives, carrageenan, or microcrystalline cellulose, or any combination thereof, and the hydrogel is optionally crosslinked.

[0017] In yet another embodiment of any of the above aerogel(s) or foam(s), the aerogel or foam may include templated or aligned microchannels created by directional freezing, or by molding with microscale features, by punching, pressing, stamping, or otherwise forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface, or any combination thereof.

[0018] In yet another embodiment of any of the above aerogel(s) or foam(s), the plant tissue may include apple tissue or pear tissue.

[0019] In another embodiment of any of the aerogel(s) or foam(s) described above, the aerogel or foam may comprise from about 5% to about 95% m / m of single structural cells, groups of structural cells, or both when the aerogel or foam is in a hydrated form.

[0020] In yet another embodiment of any of the aerogel(s) or foam(s) above, the hydrogel may include alginate, pectin, or both, and the aerogel or foam may be rehydrated with a CaCl solution to provide cross-linking.

[0021] In yet another embodiment of any of the above aerogel(s) or foam(s), the aerogel or foam can have a bulk modulus in the range of about 0.1 to about 500 kPa, e.g., about 1 to about 200 kPa.

[0022] In another embodiment of any of the aerogel(s) or foam(s) above, the aerogel or foam may be rehydrated and may further comprise one or more animal cells.

[0023] In yet another embodiment of any of the aerogel(s) or foam(s) described above, at least a portion of the cellulose and / or cellulose derivative(s) of the aerogel or foam may be crosslinked by physical crosslinking (e.g., using glycine) and / or chemical crosslinking (e.g., using citric acid in the presence of heat), at least a portion of the cellulose and / or cellulose derivative(s) of the aerogel or foam is functionalized with a linker (e.g., succinic acid) optionally having one or more functional moieties attached thereto (e.g., amine-containing groups to which crosslinking may further optionally be achieved using one or more protein crosslinking agents, e.g., formalin, formaldehyde, glutaraldehyde, and / or transglutaminase), or any combination thereof.

[0024] In yet another embodiment, provided herein is a single structural cell, a group of structural cells, or both, obtained from decellularized plant or fungal tissue by mercerization of the decellularized plant or fungal tissue, wherein the single structural cell or group of structural cells has a decellularized three-dimensional structure that is devoid of cellular material and nucleic acids of the plant or fungal tissue and is devoid of one or more base-soluble lignin components of the plant or fungal tissue.

[0025] In yet another embodiment, there is provided a method of preparing an aerogel or foam, comprising: providing a decellularized plant or fungal tissue; obtaining single structural cells, groups of structural cells, or both from the decellularized plant or fungal tissue by performing mercerization of the decellularized plant or fungal tissue, and recovering the resulting single structural cells or groups of structural cells having a decellularized three-dimensional structure; mixing or dispersing single structural cells, groups of structural cells, or both in a hydrogel to provide a mixture; and Dehydrating, lyophilizing, or freeze-drying the mixture to provide an aerogel or foam. Provided herein is a method comprising:

[0026] In yet another embodiment of the above method, mercerization may involve treatment of the decellularized plant or fungal tissue with a base and a peroxide, preferably with sodium hydroxide or another hydroxide base as the base and hydrogen peroxide as the peroxide.

[0027] In yet another embodiment of any of the above method(s), mercerization may involve treatment of the decellularized plant or fungal tissue with aqueous sodium hydroxide and hydrogen peroxide in the presence of heat.

[0028] In yet another embodiment of any of the above method(s), the decellularized plant or fungal tissue may be treated with aqueous sodium hydroxide for a first period of time, after which hydrogen peroxide is added to the reaction.

[0029] In another embodiment of any of the above method(s), the hydrogen peroxide may be added as a 30% aqueous hydrogen peroxide solution.

[0030] In yet another embodiment of any of the above method(s), hydrogen peroxide for mercerization may be used in the following ratios: About 20 mL to about 5 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, for example, Approximately 20 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution, about 10 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, or Approximately 5 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution.

[0031] In yet another embodiment of any of the above method(s), the method may further comprise neutralizing the pH using one or more neutralizing treatments.

[0032] In another embodiment of any of the above method(s), the neutralization treatment may include treatment with an acidic solution, preferably aqueous HCl.

[0033] In yet another embodiment of any of the above method(s), mercerization may be carried out by heating to about 80°C.

[0034] In yet another embodiment of any of the above method(s), mercerization may be carried out using a ratio of decellularized plant or fungal tissue:aqueous sodium hydroxide (m:v in g:L) of about 1:5 for 1 M aqueous sodium hydroxide, or an equivalent ratio for another aqueous sodium hydroxide concentration.

[0035] In another embodiment of any of the above method(s), mercerization may be carried out for at least about 30 minutes, preferably about 1 hour.

[0036] In yet another embodiment of any of the above method(s), the resulting single structural cell or group of structural cells having a decellularized three-dimensional structure may be collected by centrifugation.

[0037] In yet another embodiment of any of the above method(s), the single structural cell, the group of structural cells, or both, are made from alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, extracellular matrix proteins (e.g., cellulose acetate, cellulose acetate-based hydrogels), cellulose acetate-based hydrogels, ... For example, the hydrogel may be mixed or dispersed in a hydrogel comprising a polysaccharide, such as collagen, gelatin, or fibronectin, or any combination thereof, monoacrylated poly(ethylene glycol), poly(ethylene glycol) diacrylate, poly(ethylene glycol) diacrylate (PEGDA)-co-PEGMA, poly(vinyl alcohol), poly(vinylpyrrolidone), poly(lactic acid-co-glycolic acid), chitosan, chitin, xanthan gum, elastin, fibrin, fibrinogen, cellulose derivatives, carrageenan, or microcrystalline cellulose, or any combination thereof, and the hydrogel may be optionally crosslinked.

[0038] In another embodiment of any of the above method(s), the method may further include: performing directional freezing of the mixture to introduce templated or aligned microchannels on a surface of the mixture, within the mixture, or both; molding the mixture using a mold having microscale features that contact one or more surfaces of the mixture and / or the aerogel or foam resulting from dehydrating, lyophilizing, or freeze-drying the mixture to introduce templated or aligned microchannels; punching, pressing, stamping, or otherwise forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface of the mixture and / or the aerogel or foam before, during, or after dehydrating, lyophilizing, or freeze-drying the mixture; or any combination thereof.

[0039] In yet another embodiment of any of the above method(s), directional freezing may be performed by creating a thermal gradient throughout the mixture from one or more directions to form aligned ice crystals starting from the cold side(s) of the thermal gradient.

[0040] In yet another embodiment of any of the above method(s), the microarchitecture of the microchannels produced from directional freezing can be controlled by creating mixtures that include solvents containing varying amounts of one or more other dissolved compounds, such as sucrose, dextrose, trehalose, corn starch, glycerol, ethanol, mannitol, sodium chloride, CaCl, gelatin, citric acid, PVA, PEG, dextran, NaF, NaBr, NaI, phosphate buffer, or other such agents that alter the structural properties of aligned ice crystals growing from the cold side of a thermal gradient.

[0041] In yet another embodiment of any of the above method(s), the mixture may be directionally frozen for a period of at least about 30 minutes, preferably for a period of about 2 hours.

[0042] In another embodiment of any of the above method(s), the mixture can be directionally frozen by cooling to a temperature between about -190°C and about 0°C, for example, at least about -15°C, preferably about -25°C.

[0043] In yet another embodiment of any of the above method or methods, the step of dehydrating, lyophilizing, or freeze-drying the mixture to provide an aerogel or foam may include freezing the mixture and subsequently lyophilizing or freeze-drying the mixture.

[0044] In yet another embodiment of any of the above method(s), the method may include the further steps of crosslinking the hydrogel (e.g., crosslinking the hydrogel before or after freezing / lyophilization), rehydrating the aerogel, the foam, or both; and optionally, using a CaCl solution to provide crosslinking when an alginate, pectin, or agar hydrogel is present.

[0045] In another embodiment of any of the above method(s), the method may include the further step of culturing animal cells on or in the aerogel or foam.

[0046] In another embodiment, provided herein is an aerogel or foam produced by any of the method(s) as described herein.

[0047] In yet another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein for bone tissue engineering.

[0048] In yet another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein to template or align the growth of cells.

[0049] In another embodiment of the above use, the cells may comprise muscle cells.

[0050] In yet another embodiment of the above use, the cells may comprise nerve cells.

[0051] In yet another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein for the repair of spinal cord injuries.

[0052] In another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein as an insulation or packaging foam.

[0053] In yet another embodiment, there is provided a method for bone tissue engineering or repair in a subject in need thereof, comprising: implanting either the aerogel(s) or foam(s) as described herein into the affected area in a subject in need thereof; As a result, methods are provided herein in which the aerogel or foam promotes bone tissue generation or repair.

[0054] In yet another embodiment, there is provided a method for templating or aligning the growth of cells, comprising: Culturing cells on either aerogel(s) or foam(s) as described herein, wherein the aerogel or foam comprises templated or aligned microchannels formed on at least one surface of the aerogel or foam, within the aerogel or foam, or both, optionally by directional freezing, by molding using a mold having microscale features, by punching, pressing, stamping, or by forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface, or by any combination thereof; As a result, methods are provided herein in which cultured cells align along microchannels.

[0055] In another embodiment of the above method, the cells may comprise muscle cells or nerve cells.

[0056] In yet another embodiment, there is provided a method of repairing spinal cord injury in a subject in need thereof, comprising: implanting either an aerogel(s) or foam(s) as defined herein into the affected site in a subject in need thereof, wherein the aerogel or foam optionally comprises templated or aligned microchannels formed by directional freezing; As a result, methods are provided herein in which aerogels or foams promote spinal cord repair by aligning neural cell growth along templated or aligned microchannels.

[0057] In another embodiment, provided herein is a food product comprising any of the aerogel(s) or foam(s) as described herein.

[0058] In yet another embodiment of the above food products, the food products can be produced for the cell-based or plant-based meat industry, and cellular agriculture techniques can be utilized to create cultivated or plant-based meat products that include or use aerogels and / or foams as described herein, e.g., those containing materials derived from decellularized plant or fungal tissue. Examples included herein below support that aerogels and / or foams as described herein can be cooked, can support mammalian cell growth, and can be colored and formed into plant-based and / or cell-based meat products. Examples provided herein below include a detailed example of a plant-based tuna meat imitation as an illustrative example.

[0059] In yet another embodiment of the above food product, the food product may include a dye or colorant.

[0060] In yet another embodiment of any of the above food product(s), the food product may include two or more aerogel or foam subunits bonded together.

[0061] In another embodiment of any of the above food product(s), the adhesive may comprise agar.

[0062] In yet another embodiment of any of the above food product(s), the aerogel or foam may optionally comprise templated or aligned microchannels formed by directional freezing, wherein the aerogel or foam comprises muscle cells, fibroblasts, myofibroblasts, neurons, dorsal root ganglion cells, neuronal structures such as axons, neural progenitor cells, neural stem cells, glial cells, endogenous stem cells, neutrophils, mesenchymal stem cells, satellite cells, myoblasts, myotubes, muscle progenitor cells, adipocytes, preadipocytes, chondrocytes, osteoblasts, osteoclasts, preosteoblasts, tendon progenitor cells, tenocytes, periodontal ligament stem cells, or endothelial cells, or any combination thereof, aligned along the templated or aligned microchannels; preferably, the aerogel or foam comprises templated or aligned microchannels formed by directional freezing, wherein the aerogel or foam comprises muscle cells, adipocytes, connective tissue cells (e.g., fibroblasts), cartilage, bone, epithelial, or endothelial cells, or any combination thereof, aligned along the templated or aligned microchannels.

[0063] In another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein in a food product.

[0064] In yet another embodiment, there is provided a method for preparing single structural cells, groups of structural cells, or both, from decellularized plant or fungal tissue, comprising: providing a decellularized plant or fungal tissue; obtaining single structural cells, groups of structural cells, or both from the decellularized plant or fungal tissue by performing mercerization of the decellularized plant or fungal tissue, and recovering the resulting single structural cells or groups of structural cells having a decellularized three-dimensional structure. Provided herein is a method comprising:

[0065] In yet another embodiment of the above method, mercerization may involve treatment of the decellularized plant or fungal tissue with a base and a peroxide, preferably with sodium hydroxide or another hydroxide base as the base and hydrogen peroxide as the peroxide.

[0066] In another embodiment of any of the above method(s), mercerization may involve treatment of the decellularized plant or fungal tissue with aqueous sodium hydroxide and hydrogen peroxide in the presence of heat.

[0067] In yet another embodiment of any of the above method(s), the decellularized plant or fungal tissue may be treated with aqueous sodium hydroxide for a first period of time, after which hydrogen peroxide is added to the reaction.

[0068] In yet another embodiment of any of the above method(s), the hydrogen peroxide may be added as a 30% aqueous hydrogen peroxide solution.

[0069] In yet another embodiment of any of the above method(s), hydrogen peroxide for mercerization may be used in the following ratios: About 20 mL to about 5 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, for example, Approximately 20 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution; about 10 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, or Approximately 5 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution.

[0070] In yet another embodiment of any of the above method(s), the method may further comprise neutralizing the pH using one or more neutralizing treatments.

[0071] In another embodiment of any of the above method(s), the neutralization treatment may include treatment with an acidic solution, preferably aqueous HCl.

[0072] In yet another embodiment of any of the above method(s), mercerization may be carried out by heating to about 80°C.

[0073] In yet another embodiment of any of the above method(s), mercerization may be carried out using a ratio of decellularized plant or fungal tissue:aqueous sodium hydroxide (m:v in g:L) of about 1:5 for 1 M aqueous sodium hydroxide, or an equivalent ratio for another aqueous sodium hydroxide concentration.

[0074] In yet another embodiment of any of the above method(s), mercerization may be carried out for at least about 30 minutes, preferably about 1 hour.

[0075] In yet another embodiment of any of the above method(s), the resulting single structural cell or group of structural cells having a decellularized three-dimensional structure may be collected by centrifugation.

[0076] In yet another embodiment, provided herein is a single structural cell, a group of structural cells, or both, prepared by any of the method(s) as described herein.

[0077] In yet another embodiment, provided herein is a cellulose-based hydrogel comprising cellulose derived from plant or fungal tissue that has been decellularized by dissolution with dimethylacetamide and lithium chloride, followed by regeneration with ethanol.

[0078] In yet another embodiment, there is provided a method for preparing a cellulose-based hydrogel, comprising: providing a decellularized plant or fungal tissue; dissolving the cellulose of the decellularized plant or fungal tissue by treatment with dimethylacetamide (DMAc) and lithium chloride (LiCl); and Cellulose-based hydrogels were regenerated from the dissolved cellulose by solvent exchange with ethanol. Thereby providing a cellulose-based hydrogel. Provided herein is a method comprising:

[0079] In another embodiment of the above method, solvent exchange with ethanol can be performed using a dialysis membrane or by adding ethanol on top of the dissolved cellulose to facilitate solvent exchange.

[0080] In yet another embodiment of any of the above method(s), the method may further comprise bleaching the cellulose-based hydrogel with hydrogen peroxide.

[0081] In yet another embodiment, provided herein is a cellulose-based hydrogel comprising cellulose derived from plant or fungal tissue that has been decellularized by dissolution with dimethylacetamide and lithium chloride, LiClO, xanthogenic acid, EDA / KSCN, HPO, NaOH / urea, ZnCl, TBAF / DMSO, NMMO, an ionic liquid (IL) (e.g., 1-butylpyridinium chloride and aluminum chloride, alkylimidazolium with nitrate salts, preferably room temperature ionic liquids), or any combination thereof.

[0082] In yet another embodiment, there is provided a method for preparing a cellulose-based hydrogel, comprising: providing a decellularized plant or fungal tissue; dissolving the cellulose of the decellularized plant or fungal tissue by treatment with dimethylacetamide and lithium chloride, LiClO, xanthic acid, EDA / KSCN, HPO, NaOH / urea, ZnCl, TBAF / DMSO, NMMO, ionic liquids (ILs) (e.g., 1-butylpyridinium chloride and aluminum chloride, alkylimidazolium with nitrates, preferably room temperature ionic liquids), or any combination thereof; Obtaining dissolved cellulose and using the dissolved cellulose to prepare a cellulose-based hydrogel Provided herein is a method comprising:

[0083] In another embodiment, provided herein is a cellulose-based hydrogel prepared by any of the method(s) as described herein.

[0084] In another embodiment of any of the aerogel(s) or foam(s) as described herein, the hydrogel may comprise any of the cellulose-based hydrogel(s) as described herein.

[0085] In yet another embodiment, provided herein is a food product comprising any of the aerogel(s) or foam(s) or structural cell(s) as described herein, wherein the food product is a meat imitation and comprises a plurality of lines that provide the appearance of fatty white lines found in tuna, salmon, or another fish meat.

[0086] In yet another embodiment of the above food product, the food product may be a tuna, salmon, or other fish imitation.

[0087] In another embodiment of any of the above food products or foods, the food product may contain one or more dyes or colorants that provide the color of the tuna, salmon, or other fish meat.

[0088] In yet another embodiment of any of the above food product(s), a plurality of lines may be formed in the cuts or channels formed in the aerogel or foam.

[0089] In yet another embodiment of any of the above food product(s), the plurality of lines may optionally comprise titanium dioxide in combination with an agar binder or another such binder.

[0090] In another embodiment of any of the above food product(s), titanium dioxide, optionally in combination with an agar binder, can be applied in the cuts or channels formed in the aerogel or foam to provide the appearance of fatty white lines found in tuna, salmon, or other fish meat.

[0091] In another embodiment, there is provided a method for preparing a food product that is a tuna, salmon, or other fish imitation, comprising: Providing either an aerogel(s) or foam(s) as described herein; Optionally, dyeing or coloring the aerogel to the color of tuna, salmon, or other fish meat; cutting or processing the aerogel to form cuts or channels along the surface of the aerogel; and applying a dye or colorant to the cuts or channels to provide the appearance of fatty white lines characteristic of tuna, salmon, or other fish meat; Provided herein is a method comprising:

[0092] In another embodiment of the above method, the dye or colorant applied in the cuts or channels may include titanium dioxide.

[0093] In yet another embodiment of any of the above method(s), the dye or colorant applied in the cuts or channels may be combined with a binder.

[0094] In yet another embodiment of any of the above method(s), the binder may comprise agar.

[0095] In another embodiment, provided herein is a food product prepared by any of the method(s) described herein.

[0096] In another embodiment, provided herein is a non-absorbable dermal filler comprising an aerogel, a foam, a structural cell, or a cellulose-based hydrogel as described herein, or any combination thereof.

[0097] In yet another embodiment, provided herein is a dermal filler comprising a single structural cell, a group of structural cells, or both, derived from plant or fungal tissue, wherein the single structural cell or the group of structural cells has a decellularized three-dimensional structure devoid of cellular material and nucleic acids of the plant or fungal tissue, and wherein the single structural cell, the group of structural cells, or both are obtained from said plant or fungal tissue by mercerization.

[0098] In another embodiment of any of the above dermal filler(s), the dermal filler may further comprise a carrier fluid or gel.

[0099] In yet another embodiment of any of the above dermal filler(s), the carrier fluid or gel may comprise water, an aqueous solution, or a hydrogel.

[0100] In yet another embodiment of any of the above dermal filler(s), the carrier fluid or gel may comprise a saline solution, or a collagen-, hyaluronic acid-, methylcellulose-, and / or dissolved plant-derived decellularized cellulose-based hydrogel.

[0101] In another embodiment of any of the above dermal filler(s), the dermal filler may further comprise an anesthetic.

[0102] In yet another embodiment of any of the above dermal filler(s), the anesthetic agent may include lidocaine, benzocaine, tetracaine, polocaine, epinephrine, or any combination thereof.

[0103] In another embodiment of any of the above dermal filler(s), the dermal filler may include PBS (physiological saline), hyaluronic acid (crosslinked or non-crosslinked), alginate, collagen, pluronic acid (e.g., Pluronic® F127), agar, agarose or fibrin, calcium hydroxylapatite, poly-L-lactic acid, autologous fat, silicone, dextran, methylcellulose, or any combination thereof.

[0104] In another embodiment of any of the above dermal filler(s), the dermal filler may comprise at least one of 2% lidocaine gel, triple anesthetic gel comprising 20% ​​benzocaine, 6% lidocaine, and 4% tetracaine (BLTgel), 3% benzocaine, or a mixture of 2% lidocaine with epinephrine.

[0105] In another embodiment of any of the above dermal filler(s), the structural cells may have a size, diameter, or minimum Feret's diameter of at least about 20 μm.

[0106] In another embodiment of any of the above dermal filler(s), the structural cells may have a size, diameter, or maximum Feret's diameter of less than about 1000 μm.

[0107] In yet another embodiment of any of the above dermal filler(s), the structural cells may have a size, diameter or Feret's diameter distribution within the range of about 20 μm to about 1000 μm.

[0108] In yet another embodiment of any of the above dermal filler(s), the structural cells may have a particle size, diameter, or Feret's size distribution with a peak of about 200-300 μm.

[0109] In another embodiment of any of the above dermal filler(s), the structural cells may have an average particle size, diameter or Feret's diameter, within the range of about 200 μm to about 300 μm.

[0110] In another embodiment of any of the above dermal filler(s), the structural cells are between about 30,000 and about 75,000 μm 2 The grains may have an average projected grain area in the range of

[0111] In yet another embodiment of any of the above dermal filler(s), the dermal filler can be sterilized.

[0112] In yet another embodiment of any of the above dermal filler(s), sterilization may be by gamma sterilization.

[0113] In yet another embodiment of any of the above dermal filler(s), the dermal filler may be formulated for subdermal injection, deep dermal injection, subcutaneous injection (e.g., subcutaneous fat injection), or any combination thereof.

[0114] In another embodiment of any of the above dermal filler(s), the dermal filler may be provided in a syringe or injection device.

[0115] In another embodiment, provided herein is the use of any of the dermal filler(s) as described herein as a soft tissue filler, for reconstructive surgery, or both.

[0116] In another embodiment, provided herein is a use of any of the dermal filler(s) as described herein for improving the cosmetic appearance of a subject in need thereof.

[0117] In another embodiment, provided herein is the use of any of the dermal filler(s) as described herein for increasing tissue volume, smoothing wrinkles, or both, in a subject in need thereof.

[0118] In another embodiment, a method for improving cosmetic appearance, increasing tissue volume, smoothing wrinkles, or any combination thereof in a subject in need thereof, comprising: administering or injecting any of the dermal filler(s) as described herein into the area in need thereof; thereby improving the cosmetic appearance of the subject, increasing tissue volume, smoothing wrinkles, or any combination thereof. A method is provided herein.

[0119] In another embodiment of the above use(s) or method(s), the subject's native cells may infiltrate the dermal filler.

[0120] In yet another embodiment of the above use(s) or method(s), the dermal filler may be non-absorbable such that the decellularized plant or fungal tissue remains substantially intact within the subject. [Brief explanation of the drawings]

[0121] These and other features will be better understood in view of the following description and accompanying drawings. [Figure 1]Figure 1 shows the results of AA (apple) mercerization and discoloration of a smaller sample of AA (100 g in the image), as described in Example 1. 100 g of decellularized AA (apple) material was mercerized in 500 mL of 1 M NaOH at 80°C for 1 hour. A total of 75 mL of HO was added throughout the mercerization process to discolor the sample (the reaction formed NaO (sodium peroxide), a strong oxidizing agent). Figure 1(A) shows the AA sample in NaOH (T=0 min). Figure 1(B) shows the AA sample in NaOH immediately after the addition of 25 mL of HO. The discoloration process began immediately after the addition (T=2 min). In Figure 1(C), the sample appears yellowish (T=10 min). In Figure 1(D), the AA sample appears off-white 60 min after mercerization in NaOH and HO addition. [Figure 2] Figure 2(A) shows the decellularized AA tissue used as the starting material for the mercerization process, and Figure 2(B) shows the product obtained after mercerization as described in Example 1. The product is shown after follow-up neutralization and centrifugation. The resulting product material shown in Figure 2(B) is extremely thick and viscous, resembling a type of apple "paste." [Figure 3] Figure 3 shows images of decellularized single structural cells (and some groups of structural cells containing a few single structural cells linked together) from apples obtained / isolated after mercerization as described in Example 1. In Figure 3, dilution and fluorescent staining of the structural cells with Congo Red dye showed that the cellular microarchitecture was intact. [Figure 4] Figure 4 shows the particle size distribution (N=10 analyzed images) of mercerized (1 M NaOH) decellularized AA with added HO as described in Example 1. The average size confirms the presence of intact, single-structure cells that maintain their microarchitectural features. [Figure 5]FIG. 5 shows the color change of AA-NaOH solutions through 60 minutes of mercerization for all three ratio conditions (i.e., 20 g, 50 g, and 100 g of AA in 100 mL of 1 M NaOH), as described in Example 1. [Figure 6] Figure 6 shows that after mercerization in various solutions, isolated single AA cells were imaged and their Ferret diameters were measured as described in Example 1. The results show that there were no significant differences in the average size, number, and distribution of mercerized cells isolated under each condition. [Figure 7] Figure 7 shows a 5% alginate aerogel as described in Example 1. The scaffold is 6 cm in diameter and 0.7 cm thick. [Figure 8] FIG. 8 shows a microscopic image of a 50% alginate aerogel as described in Example 1 (scale bar = 500 μm). [Figure 9] FIG. 9 shows a cross-linked 50% alginate aerogel that has been rehydrated as described in Example 1 (the aerogel is approximately 1 cm in diameter and 4 mm thick). [Figure 10] FIG. 10 shows an example of hydrated aerogel (in this example, alginate-based) on a frying pan with butter at the beginning of cooking, as described in Example 1. [Figure 11] FIG. 11 shows the same aerogel depicted in FIG. 10, but after a few minutes of cooking, it is observed that the aerogel maintains its shape and integrity and a crust forms. [Figure 12] FIG. 12 shows a comparison of "raw" (left) and cooked (right) aerogels, as described in Example 1. [Figure 13] FIG. 13 shows the custom-made directional freezing device used in Example 1. [Figure 14] FIG. 14 shows a schematic diagram of the directional freezing apparatus depicted in FIG. [Figure 15]FIG. 15 shows a syringe mixing device used to mix alginate hydrogel with a gel containing structural cells obtained from mercerization of decellularized apple tissue, as described in Example 1. [Figure 16] FIG. 16 shows a top view of the aerogel still in the Falcon tube, as described in Example 1, where the porous structure is observable. [Figure 17] FIG. 17 shows the aerogel after removal from the Falcon tube, as described in Example 1. [Figure 18] 18 shows aerogel foam prepared without additional freezing time in a −20° C. freezer (left) and aerogel foam placed in a freezer (−20° C.) overnight before freeze-drying (right), which collapsed during freeze-drying, as described in Example 1. Each scaffold is approximately 3 cm tall. [Figure 19] FIG. 19 shows a reflected light image (1× condenser, 0.75× magnification) of a cross section of a whole aerogel, as described in Example 1. [Figure 20] FIG. 20 shows a bright field cross section (stereomicroscope 2X condenser, 1.25 zoom) perpendicular to the axis of an aerogel cylinder, as described in Example 1. [Figure 21] FIG. 21 shows a bright field cross section (stereomicroscope 2X condenser, 1.25 zoom) parallel to the axis of an aerogel cylinder, as described in Example 1. [Figure 22] FIG. 22 shows a dark-field cross section (stereomicroscope 2X condenser, 1.25 zoom) perpendicular to the axis of an aerogel cylinder, as described in Example 1. [Figure 23] FIG. 23 shows a dark-field cross section (stereomicroscope 2X condenser, 1.25 zoom) parallel to the axis of an aerogel cylinder, as described in Example 1. [Figure 24] FIG. 24 shows an SEM cross section perpendicular to the axis of an aerogel cylinder, as described in Example 1, showing the microchannels. [Figure 25] FIG. 25 shows an SEM cross section perpendicular to the axis of an aerogel cylinder showing the microchannels, as described in Example 1. [Figure 26] FIG. 26 shows an SEM cross section perpendicular to the axis of the cylinder as described in Example 1. [Figure 27] FIG. 27 shows an SEM cross section perpendicular to the axis of an aerogel cylinder. [Figure 28] FIG. 28 shows an SEM cross section parallel to the axis of an aerogel cylinder, as described in Example 1, showing long-range alignment. [Figure 29] FIG. 29 shows an SEM cross section parallel to the axis of an aerogel cylinder, as described in Example 1. [Figure 30] FIG. 30 shows an SEM cross section parallel to the axis of an aerogel cylinder, as described in Example 1. [Figure 31] FIG. 31 shows an SEM cross section parallel to the axis of an aerogel cylinder, as described in Example 1. [Figure 32] Figure 32 shows images of a dried aerogel section (left) and a rehydrated aerogel section treated with 0.1 M CaCl (right), as described in Example 1. The images were taken at approximately the same height and magnification. The aerogel section remained intact, maintained its microstructure, and could be picked and manipulated. In this case, rehydration with CaCl solution crosslinked and stabilized the alginate in the rehydrated aerogel (right). [Figure 33] FIG. 33 is a diagram of the freezing apparatus in a Styrofoam box, as described in Example 1, where LN2 was just added just before the picture was taken and boiling at the bottom can be seen. [Figure 34]Figure 34 shows three formulations of hydrogel mixtures prepared in either A) PBS, B) 0.9% saline, or C) water as the solvent to assess whether salt alters ice crystal formation and channel alignment / architecture during directional freezing (scale bar = 2 mm, applies to all). In all cases, aligned channels were not observed because the material froze rapidly and without significant ice crystal formation. This process resulted in a very dense, soft foam, as described in Example 1. [Figure 35] Figure 35 shows (A) a water-based alginate mixture directionally frozen in the LN2 system of Figure 33 (scale bar = 2 mm). The scaffolds were very dense, soft, and appeared homogeneous to the naked eye. This was in stark contrast to scaffolds produced with a Peltier-based directional freezing platform, where the channeled architecture was clearly visible to the naked eye. However, as shown in (B) at higher resolution (scale bar = 200 μm), the small pore size of the scaffolds becomes visible, creating opportunities for cell infiltration as well as several other potential applications in, for example, tissue engineering and food science, as described in Example 1. [Figure 36] FIG. 36 shows a 5% alginate and pectin stock solution, as described in Example 2. [Figure 37] FIG. 37 is a diagram illustrating the preparation of pluronic stock solutions, as described in Example 2. [Figure 38] FIG. 38 illustrates the preparation of gelatin-AA aerogels, as described in Example 2. [Figure 39] FIG. 39 shows a syringe-based mixing device for mixing hydrogels with mercerized structural cells as described in Example 2. [Figure 40] FIG. 40 depicts a representation of various aerogel formulations prepared as described in Example 2 before and after freeze-drying the samples. [Figure 41]Figure 41 shows the results of GFP 3T3 cells (green) seeded onto certain aerogels (as indicated) stained with Congo red (red) as described in Example 2. Agar, alginate, pectin, and gelatin hydrogels were used in combination with 1.5 g of decellularized, mercerized apple (10%) or 7.5 g of decellularized, mercerized apple (50%) (scale = 200 μm). Images were acquired at 10X on a BX53 upright microscope using a GFP filter for the cells and a TXRED filter for the scaffold. [Figure 42] FIG. 42 shows the stress-strain curve of a dry agar-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 43] FIG. 43 shows the stress-strain curve of a dry agar-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 44] FIG. 44 shows the stress-strain curve of a dried alginate-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 45] FIG. 45 shows the stress-strain curve of a dried alginate-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 46] FIG. 46 shows the stress-strain curve of a dried pectin-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 47] FIG. 47 shows the stress-strain curve of a dried pectin-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 48] FIG. 48 shows the stress-strain curve of a dried gelatin-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 49] FIG. 49 shows the stress-strain curve of a dried gelatin-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 50] FIG. 50 shows the stress-strain curve of a dried methylcellulose-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 51] FIG. 51 shows the stress-strain curve of a dried methylcellulose-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 52] FIG. 52 shows the stress-strain curve of a dried Pluronic-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 53] FIG. 53 shows stress-strain curves of dried Pluronic and alginate-based gels containing 7.5 g of mercerized AA, as described in Example 2. [Figure 54] Figure 54 shows the Young's modulus of the dry samples with their hydrated counterparts. The volumes of mercerized AA are indicated by 1.5 and 7.5, both in grams, corresponding to 10% and 50% solutions, respectively. A 1% agar, alginate, and pectin base hydrogel was used. Gelatin was in a 5% final solution, as described in Example 2. [Figure 55] FIG. 55 shows the stress-strain curve of a hydrated agar-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 56] FIG. 56 shows the stress-strain curve of a hydrated agar-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 57] FIG. 57 shows the stress-strain curve of a hydrated alginate-based gel containing 1.5 g of mercerized AA as described in Example 2. [Figure 58] FIG. 58 shows the stress-strain curve of a hydrated alginate-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 59]FIG. 59 shows the stress-strain curve of a hydrated pectin-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 60] FIG. 60 shows the stress-strain curve of a hydrated pectin-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 61] FIG. 61 shows the stress-strain curve of a hydrated gelatin-based gel containing 1.5 g of mercerized AA, as described in Example 2. [Figure 62] FIG. 62 shows the stress-strain curve of a hydrated gelatin-based gel containing 7.5 g of mercerized AA, as described in Example 2. [Figure 63] FIG. 63 shows stress-strain curves of hydrated pluronic and alginate-based gels containing 7.5 g of mercerized AA, as described in Example 2. [Figure 64] Figure 64 shows the Young's modulus of the hydrated samples. The volumes of mercerized AA are indicated by 1.5 and 7.5, both in grams, corresponding to 10% and 50% solutions, respectively. A 1% agar, alginate, and pectin base hydrogel was used. Gelatin was at a 5% final solution, as described in Example 2. [Figure 65] FIG. 65 shows SEMs of alginate-based aerogels containing 1.5 g (10%) and 7.5 g (50%) of decellularized, mercerized AA, as described in Example 2. [Figure 66] FIG. 66 shows SEMs of pectin-based aerogels containing 1.5 g (10%) and 7.5 g (50%) of decellularized, mercerized AA, as described in Example 2. [Figure 67]Figure 67 shows a maximum intensity z-projection of a confocal image of alginate foam containing 7.5 g of mercerized AA (50%) as described in Example 2. Red is the scaffold stained with Congo red. Green is GFP from stably transfected 3T3 cells, and blue are nuclei of GFP 3T3 cells. [Figure 68] FIG. 68 shows a dissolution solution of decellularized apple with DMAc and LiCl after 72 hours of reaction, as described in Example 3. [Figure 69] FIG. 69 shows a dissolution solution of DMAc and LiCl containing decellularized apple after centrifugation to remove undissolved material, as described in Example 3. [Figure 70] Figure 70 shows the regeneration of cellulose films. Dissolved cellulose was poured into a 60 mm Petri dish to cover the bottom surface. 95% ethanol was poured on top of the dissolution solution to facilitate solution exchange and regenerate the cellulose. As described in Example 3, wrinkles are observed as the film forms. [Figure 71] FIG. 71 shows that within 5 minutes of adding ethanol, the films could be pressed with a spatula and bound together, as described in Example 3. [Figure 72] FIG. 72 shows the recovered regenerated cellulose gel as described in Example 3. [Figure 73] FIG. 73 shows a regenerated cellulose film when left undisturbed, as described in Example 3. [Figure 74] FIG. 74 shows a regenerated cellulose file titled Showing Wafer Slides in Petri Dish, as described in Example 3. [Figure 75]Figure 75 shows regenerated cellulose with a density gradient. Solvent exchange was achieved using a dialysis membrane. Regeneration occurred in a 50 mL Falcon tube. The ends of the cylinder were in contact with the membrane and had the greatest amount of solution exchange. They were more rigid and held their shape compared to the less rigid, less dense tail region as described in Example 3. [Figure 76] FIG. 76 shows a regenerated cellulose film setup using a dialysis membrane secured by a lid with a hole cut in the center, as described in Example 3. [Figure 77] Figure 77 shows a freeze-dried section of the dense region from Figure 76. As described in Example 3, freeze-drying led to scaffold collapse. [Figure 78] Figure 78 shows regenerated cellulose 5 mm punches from recycled film bleached with HO (30%). The materials were light brown before treatment and were transparent after treatment with peroxide. In fact, as described in Example 3, they were difficult to see due to their transparency. [Figure 79] FIG. 79 shows a regenerated cellulose 5 mm punch from recycled film bleached with H 2 O 2 (30%) imaged by dark field imaging, as described in Example 3. [Figure 80] Figure 80 shows a regenerated cellulose 5 mm punch from regenerated film bleached with HO (30%) stained with Congo red to visualize the microstructure. The surface was very flat with small pores. This is a fluorescent image using TRITC, as described in Example 3. [Figure 81] FIG. 81 shows DMAc LiCl dissolved cellulose mixed with mercerized AA as described in Example 3 (color comes from DMAc LiCl dissolved cellulose solution; mercerized material was white). [Figure 82]Figure 82 shows dissolved cellulose mixed with mercerized AA. The membrane was regenerated by covering it with a layer of 95% ethanol overnight. A composite film was obtained as described in Example 3. [Figure 83] Figure 83 shows a fluorescence microscope image of regenerated cellulose mixed with mercerized material. The apple structure cells from the mercerized material can be seen packed together. This topography is different from the smooth material obtained from pure regenerated cellulose, as described in Example 3. [Figure 84] Figure 84 shows the reaction set-up as described in Example 3. Reactions were carried out in small beakers containing magnetic stir bars. These beakers were covered with parafilm and placed in a larger beaker containing an ice bath. [Figure 85] Figure 85 shows methylcellulose and mercerized AA. Methylcellulose mixed with glycine (top in a weighing boat) and mercerized AA (bottom in a Petri dish). As described in Example 3, 1 g of methylcellulose was more viscous (right two images) compared to 0.5 g (left two images). [Figure 86] Figure 86 shows methylcellulose gels containing mercerized AA (apple) and glycine (AA introduced after glycine addition) after overnight incubation at room temperature for cross-linking. The gels were removed from the Petri dish and were able to maintain their shape. As described in Example 3, the 1 g methylcellulose gel was more rigid. [Figure 87] Figure 87 shows a methylcellulose and mercerized AA gel. 1 g of methylcellulose, 1 g of AA mixed in 10 mL of 2 M NaOH, was mixed with magnetic stirring in an ice bath for 1 hour, then 5 mL of 30% glycine in 2 M NaOH was added and stirred on ice for an additional hour. Crosslinking was performed overnight at room temperature in a 60 mm Petri dish. The gel was able to be handled and maintain its shape as described in Example 3. [Figure 88] Figure 88 shows the same gel from Figure 87 cut into two halves with a scalpel blade. One half was kept and the other half was used to test neutralization, as described in Example 3. Neutralization consisted of 1 hour with 5% acetic acid, followed by 10 washes with water. This was also done to test whether there would be a slow release of NaOH, which would result in a pH increase. This occurred. As a result, half the aerogel was washed 70 times and also neutralized with 30% acetic acid. [Figure 89] Figure 89 shows that the excess washed "half aerogel" from Figure 88 was frozen at -20°C and then freeze-dried at -46°C and 0.050 mbar (top). The dried material appeared brittle but was actually quite rigid to the touch. Directional freezing was also observed. Sections were then pulled off and immersed in dH2O (bottom image). They remained intact and had a soft, sticky texture, as described in Example 3. [Figure 90] Figure 90 shows that the second half of the cut aerogel from Figure 88 was neutralized. Neutralization was performed immediately with 30% acetic acid. This had a similar but opposite result: the pH drifted toward acidic values, and the slow release of acetic acid caused the pH to drift to lower values ​​over time. This was corrected with a slow titration with 1 M NaOH. Nevertheless, this indicates that an optimal neutralization step of approximately between 5% and 30% acetic acid is likely a faster, more efficient approach. Neutral samples were kept for future dye testing, as described in Example 3. [Figure 91] Figure 91 shows methylcellulose with mercerized AA (1:1) half aerogels neutralized with 15% acetic acid. It was also found that the methylcellulose gels (with or without AA) swelled significantly. This can also occur during freezing and freeze-drying, as described in Example 3. [Figure 92]Figure 92 shows methylcellulose with mercerized AA (1:1) half aerogels neutralized with 15% acetic acid. The aerogels shown in Figure 92 were neutralized as half aerogels (Figure 91). They expanded to fill a 60 mm Petri dish upon freezing. Once freeze-dried, they produce a white foam that is easily handled and relatively rigid. As described in Example 3, once hydrated, they expand, and if they continue to expand, they turn into a loose material with a sticky consistency. [Figure 93] Figure 93 shows the swelling of methylcellulose with mercerized AA (1:1). For comparison, half the aerogel was placed on top of its original 60 mm dish, as described in Example 3. [Figure 94] FIG. 94 shows that methylcellulose with mercerized AA (1:1) continued to swell to a loose material as described in Example 3. [Figure 95] FIG. 95 shows the crystallization of glycine at low temperature (about 4° C.) from a 40% solution, as described in Example 3. [Figure 96] FIG. 96 shows that carboxymethyl cellulose gels in the absence of glycine result in similar physically cross-linked materials. [Figure 97] FIG. 97 shows alginate (left) and pectin (right) aerogel scaffolds prior to implantation into a drilled defect, as described in Example 4. [Figure 98] FIG. 98 shows alginate (left) and pectin (right) aerogel biomaterials implanted into a burr hole defect in the parietal bone, as described in Example 4. [Figure 99] FIG. 99 shows an alginate aerogel implant in a rat calvaria prior to extraction, as described in Example 4. [Figure 100] FIG. 100 shows an excised rat calvaria as described in Example 4. [Figure 101]Figure 101 shows rat calvaria with a burr hole defect, removed after 8 weeks and scanned by computed tomography (CT). Alginate biomaterial (left) and pectin biomaterial (right). The results show that the aerogel biomaterial supports cell infiltration and regeneration in vivo, as described in Example 4. [Figure 102] FIG. 102 shows bleaching during mercerization over the course of 1 hour using 20 mL of hydrogen peroxide, as described in Example 5. [Figure 103] FIG. 103 shows bleaching during mercerization over the course of 1 hour using 10 mL of hydrogen peroxide, as described in Example 5. [Figure 104] FIG. 104 shows bleaching during mercerization over the course of 1 hour using 5 mL of hydrogen peroxide, as described in Example 5. [Figure 105] FIG. 105 shows, as described in Example 5, that (A) after 1 hour of mercerization with different amounts of peroxide, the color was slightly clearer for the higher peroxide concentrations, (B) after neutralization, the slight color variation disappeared and all three had a clear / off-white color, and (C) the final concentrated products were comparable for the three hydrogen peroxide ratios. [Figure 106] Figure 106 shows fluorescence microscopy images of three different AA:NaOH ratio conditions (i.e., mercerization conditions), as described in Example 6: (A) -1:5, (B) -1:2, and (C) -1:1. Images were acquired at 2.5x magnification with an Olympus SZX16 microscope using a BV filter and Congo red staining. [Figure 107] FIG. 107 shows histograms of particle size distribution from mercerization of different ratios of decellularized AA with 1 M NaOH, as described in Example 6. [Figure 108] FIG. 108 shows an example of alginate aerogel biomaterial cut from a 60 mm dish after freeze-drying, as described in Example 7. [Figure 109]FIG. 109 shows 10 mm biopsy punches of dry (left) and cross-linked / wet (right) alginate biomaterials being measured in compression-axial fashion, as described in Example 7. [Figure 110] Figure 110 shows the results where CMC cross-linked with citric acid is shown. As described in Example 8, the CMC control was a clear gel, while the CMC with mercerized material (structural cells) was a translucent white gel. [Figure 111] Figure 111 shows the results of CMC crosslinking with citric acid films. As described in Example 8, the CMC control (left) was a clear film, while the CMC with mercerized material (structural cells) was a more rigid—translucent white film with the texture of a shrimp shell. [Figure 112] FIG. 112 shows the cellulose after the reaction is completed, as described in Example 8. [Figure 113] FIG. 113 shows the cellulose after extensive washing with water has been completed, as described in Example 8. [Figure 114] FIG. 114 shows the FTIR spectrum of a chemically bonded composite of decellularized scaffold (2AP-DECEL) and succinylated plant-derived cellulose (5AP-AS), as described in Example 8. [Figure 115] FIG. 115 shows freeze-dried aerogels produced using formulations as described in Example 3 (samples P1, P2, P3, P4, P5, P6), approximately 1 cm in diameter. [Figure 116] FIG. 116 shows larger scale freeze-dried (3 cm diameter) aerogels produced using the formulation as described in Example 3 (P2 (left), P7 (center), P3 (right) images). [Figure 117]Figure 117 shows a "tuna" sushi imitation (colored red) created by layering and gluing small pieces of aerogel (cross-linked 50% alginate) scaffold together with more alginate. The construct was then cut into 3 x 2 cm pieces (approximately) and stained with red food dye to mimic real tuna. Small diagonal sections were cut along its length to mimic the boundaries between muscle layers, as described in Example 9. [Figure 118] Figure 118 shows a "tuna" sushi imitation (colored red) created by layering and adhering small pieces of pre-dyed aerogel (cross-linked 50% alginate) with an agar "glue" that was colored with titanium dioxide (TiO), a common white food coloring. As described in Example 9, this construct allowed for a more reliable mimicry of the fascia that exists between the distinct layers of muscle tissue in real tuna. [Figure 119] Figure 119 shows "tuna" (dyed red) created by layering and adhering small pieces of pre-dyed aerogel (cross-linked 50% alginate) with agar "glue" that has been colored with titanium dioxide (TiO), a common white food coloring. As described in Example 9, the agar glue can be placed between layers or in thin grooves cut along the surface of the aerogel to create the linear pattern of fascia present between muscle layers. [Figure 120] Figure 120 shows a needle occlusion test using mercerized AA, as described in Example 10. In (A), a 27G needle and syringe are shown. (B) Extrusion of mercerized AA is shown. (C) An example of, e.g., 3D printing or controlled injection / extrusion is shown. [Figure 121] FIG. 121 shows the force-displacement curves for N=10 extrusions of water from 1 cc syringes, as described in Example 10. [Figure 122]FIG. 122 shows the force-displacement curves for N=10 extrusions of 20% mercerized AA in saline mixture from 1 cc syringes, as described in Example 10. [Figure 123] FIG. 123 shows the force-displacement curves for N=10 extrusions of undiluted mercerized AA from 1 cc syringes, as described in Example 10. [Figure 124] FIG. 124 shows the maximum extrusion force of water only, a 20% mercerized AA solution diluted with 0.9% saline, and undiluted mercerized material, as described in Example 10. [Figure 125] Figure 125 shows generation II dermal fillers. (A) shows MER, (B) shows MER20SAL80, (C) shows MER20COL80, and (D) shows MER20REG80. The injections contained 0.3% lidocaine and were prepared as 600 μL injections in 1 cc syringes, as described in Example 10. [Figure 126] Figure 126 shows the results of a generation II dermal filler used as a dermal filler in a rat model. (A) shows pre-injection and (B) shows post-injection, as described in Example 10. The implantation site was tracked weekly using a black outline. The subcutaneous bump was measured. The bump size was measured using a caliper. The area and volume of the injection were estimated using an ellipsoid estimate. [Figure 127] Figure 127 shows the results of dermal filler size measurement for a rat model injection, as described in Example 10. (A) shows the normalized height, (B) shows the normalized ellipse area, and (C) shows the normalized ellipse volume. [Figure 128] FIG. 128 shows a flow chart depicting an illustrative example of an aerogel / foam preparation using crosslinking before and after freeze drying. [Figure 129] FIG. 129 shows an aerogel scaffold being cut using a 5 mm biopsy punch (A) and then removed using a fine wire (B) to yield the final scaffold (C and D). [Figure 130]FIG. 130 shows aerogels produced using cross-linked regenerated cellulose (D1) and succinylated cellulose. [Figure 131] FIG. 131 shows aerogels produced using cross-linked mercerized cellulose (AS4) and succinylated cellulose. [Figure 132] Figure 132 shows a bright field microscope image of the circled bottom surface of the bottom layer of an aerogel prepared from cross-linked regenerated cellulose (AD1CLS). [Figure 133] FIG. 133 shows a bright field microscope image of the circled top surface of the bottom layer of the aerogel in FIG. [Figure 134] Figure 134 shows a bright field microscope image of the circled bottom surface of the top layer of an aerogel prepared from cross-linked mercerized cellulose (AS4). [Figure 135] FIG. 135 shows a bright field microscope image of the circled top surface of the bottom layer of the aerogel in FIG. [Figure 136] FIG. 136 shows aerogels AS6, AS9, and AS10 prepared from crosslinked mercerized cellulose mixed with succinylated mercerized cellulose (samples S6, S9, and S10). [Figure 137] FIG. 137 shows a microscope image of the bottom surface of the lowest layer of each of the aerogels AS6, AS9, and AS10. [Figure 138] FIG. 138 shows the stability of each aerogel AS6, AS9 and AS10 after 45 minutes in PBS compared to the aerogel at t=0. [Figure 139] FIG. 139 shows hydrogels mixed in two 50 mL syringes connected with f / f luer lock connectors (A) and inserted into steel tubes (B and C) prior to directional freezing. [Figure 140] FIG. 140 shows aerogels Merc.AA, D1A, and Merc.AA+D1A after directional freezing and before crosslinking. [Figure 141]FIG. 141 shows the aerogels Merc.AA, D1A and Merc.AA+D1A after crosslinking. [Figure 142] FIG. 142 shows a microscope image of the Merc.AA aerogel of FIG. [Figure 143] FIG. 143 shows a microscope image of the D1A aerogel of FIG. [Figure 144] FIG. 144 shows a microscope image of the Merc.AA+D1A aerogel of FIG. [Figure 145] FIG. 145 shows a microscope image of the Merc.AA+ succinylated cellulose aerogel of FIG. [Figure 146] FIG. 146 shows aerogels prepared with cross-linked Merc.AA after 5 minutes (A and B) and 6 hours (C) of incubation in PBS after lyophilization. [Figure 147] FIG. 147 shows aerogels prepared with cross-linked D1A after lyophilization and incubation in PBS for 5 minutes (A and B) and 6 hours (C). [Figure 148] FIG. 148 shows aerogels prepared with crosslinked Merc.AA+D1A after 5 minutes (A and B) and 6 hours (C) of incubation in PBS after lyophilization. [Figure 149] FIG. 149 shows aerogels prepared with cross-linked Merc.AA+ succinylated cellulose after 24 hours of incubation in PBS after lyophilization. [Figure 150] FIG. 150 shows a microscope image of an aerogel prepared using Merc.AA crosslinked with citric acid for 2 hours. [Figure 151] FIG. 151 shows a microscope image of an aerogel prepared using regenerated cellulose (D1A) cross-linked with citric acid for 2 hours. [Figure 152] FIG. 152 shows a microscope image of an aerogel prepared using Merc. AA+ regenerated cellulose (D1A) cross-linked with citric acid for 2 hours. [Figure 153] Figure 153 shows the silicon mold and needle (30G) used to optimize pore formation in the aerogels prepared as described above. [Fig. 154] FIG. 154 shows aerogels prepared from Merc. AA using a silicon-type needle before cross-linking (A, B) and after cross-linking with citric acid (C, D). [Figure 155] FIG. 155 shows aerogels prepared from Merc. AA+ regenerated cellulose using a silicon-type needle before cross-linking (A, B, C) and after cross-linking with citric acid (D). [Figure 156] FIG. 156 shows aerogels prepared from Merc. AA+ succinylated cellulose using silicone mold needles after freeze-drying (left) and after removal from the needle mold (right). [Figure 157] Figure 157 shows the crosslinked aerogel (left) of Figure 156 cut into thin sections (right) for subsequent imaging. [Figure 158] Figure 158 shows microscopic images of aerogels prepared from Merc.AA cross-linked with citric acid, scale bars = 2000 μm (A), 1000 μm (B), and 500 μm (C, D, E). [Figure 159] Figure 159 shows a scanning electron microscope (SEM) image of the top view (A) of the aerogel of Figure 158, showing cross sections perpendicular (B) and parallel (C) to the axis of the aerogel. [Figure 160] Figure 160 shows microscopic images of aerogels prepared from Merc.AA + regenerated cellulose (D1A) cross-linked with citric acid, scale bars = 2000 μm (A), 1000 μm (B), and 500 μm (C). [Figure 161] Figure 161 shows a scanning electron microscope (SEM) image of the top view (A) of the aerogel of Figure 160, showing cross sections perpendicular (B) and parallel (C) to the axis of the aerogel. [Figure 162]FIG. 162 shows microscopic images of aerogels prepared from Merc.AA+ succinylated cellulose cross-linked with citric acid, scale bar = 1000 μm (A) and 500 μm (B). [Figure 163] Figure 163 shows a scanning electron microscope (SEM) image of the top view (A) of the aerogel of Figure 162, showing cross sections perpendicular (B) and parallel (C) to the axis of the aerogel. [Fig. 164] Figure 164 shows the Fourier transform infrared spectra (FTIR) of mercerized succinylated cellulose crosslinked with various concentrations of citric acid. [Figure 165] Figure 165 shows Fourier transform infrared spectra (FTIR) of aerogels prepared from Merc. AA, Merc. AA + regenerated cellulose, and Merc. AA + succinylated cellulose crosslinked with 10% citric acid compared to mercerized cellulose (Merc. AA151). [Figure 166] Figure 166 shows aerogels prepared from Merc.AA, Merc.AA + succinylated cellulose and Merc.AA + regenerated cellulose in a 60 mm TC dish and then crosslinked at 110°C for 1.5 hours. [Figure 167] FIG. 167 shows the 5 mm wet aerogel sample of FIG. 166 immersed in saline for 30 minutes prior to mechanical testing. [Figure 168] FIG. 168 shows dry Merc.AA+regenerated cellulose (A) and wet Merc.AA+regenerated cellulose (B) scaffolds before (left) and after (right) compression testing. [Figure 169] FIG. 169 shows the mechanical properties of dried aerogels calculated using the slope of the linear portion of the strain-stress curve obtained in uniaxial compression tests. [Figure 170] FIG. 170 shows the mechanical properties of wet aerogels calculated using the slope of the linear portion of the strain-stress curve obtained in uniaxial compression tests. [Figure 171]FIG. 171 shows each aerogel formulation (n=6) plated along one row of a 24-well TC dish. [Fig. 172] Figure 172 shows the freeze-dried aerogel before cross-linking. [Figure 173] FIG. 173 shows the freeze-dried aerogel after cross-linking. [Fig. 174] Figure 174 shows the color change of the growth medium from red to yellow within 10 minutes of incubation with aerogel. [Figure 175] Figure 175 shows that after neutralization and subsequent washing with water, aerogels were incubated in MEM alpha (left) for 24 hours, and no color change was observed compared to the tube of stock medium (right). [Figure 176] FIG. 176 shows the resulting aerogels prepared from Merc. AA, Merc. AA + succinylated cellulose, and Merc. AA + regenerated cellulose. [Figure 177] Figure 177 shows the aerogels of Figure 176 on which 100 μL of the final cell suspension was plated, incubated for 2.5 hours, and then replenished with 1.5 mL of growth medium per well. [Figure 178] Figure 178 shows GFP-NIH3T3 cells stained with Hoechst on (A) MercAA aerogel, (B) MercAA + succinylated cellulose aerogel, and (C) MercAA + regenerated cellulose aerogel. Scale bar = 100 μm. Purple = scaffold, yellow dots = cell nuclei. [Figure 179] Figure 179 shows mercerization using 10% bicarbonate solution at 80°C for 1 hour. [Figure 180] Figure 180 shows bicarbonate mercerized apples (bottom) compared to NaOH mercerized apples (top). [Figure 181] Figure 181 shows a 5 day mercerization reaction using 10% bicarbonate solution at room temperature. [Figure 182] Figure 182 shows bicarbonate mercerized apple mercerized apple (mer AA) product. [Figure 183] FIG. 183 shows AA mercerized with bicarbonate at room temperature for 5 days (A), with bicarbonate at 80° C. for 1 hour (B), and with NaOH at 80° C. for 1 hour (control). [Figure 184] Figure 184 shows 1% alginate packs of AA mercerized with bicarbonate at room temperature for 5 days (A), with bicarbonate at 80°C for 1 hour (B), and with NaOH at 80°C for 1 hour (control). [Figure 185] FIG. 185 shows dark field microscopy images (6.3×) of AA lyophilized and then mercerized with bicarbonate at room temperature for 5 days (A), with bicarbonate at 80° C. for 1 hour (B), and with NaOH at 80° C. for 1 hour (control). [Figure 186] Figure 186 shows the FTIR of AA mercerized with bicarbonate at room temperature for 5 days (red), with bicarbonate at 80°C for 1 hour (yellow), and with NaOH at 80°C for 1 hour (blue). [Figure 187] Figure 187 shows fluorescence microscopy images of single particles of AA mercerized with bicarbonate at room temperature for 5 days (A), with bicarbonate at 80°C for 1 hour (B), and with NaOH at 80°C for 1 hour (control). [Figure 188] FIG. 188 shows a histogram of particle size distribution of AA mercerized with bicarbonate at room temperature for 5 days. [Figure 189] FIG. 189 shows a histogram of particle size distribution of AA mercerized with bicarbonate at 80° C. for 1 hour. [Figure 191] FIG. 191 shows a McIntosh apple processed in a kitchen food processor prior to decellularization. [Figure 192] FIG. 192 shows the mercerization of AA136 at 80° C. using a 10% bicarbonate and 15% H 2 O 2 stock solution for 60 minutes at 15 minute intervals. [Figure 193] FIG. 193 shows a histogram of particle size distribution of mercerized AA bleached with bicarbonate and a 30% H2O2 stock solution. [Figure 194] FIG. 194 shows a histogram of particle size distribution of mercerized AA bleached with a 30% H2O2 stock solution using NaOH. [Figure 195] FIG. 195 shows a histogram of particle size distribution of mercerized AA bleached with bicarbonate and a 15% H2O2 stock solution. [Figure 196] Figure 196 shows fluorescence microscopy images of single cells of AA mercerized with bicarbonate stained with Congo red (A) and bleached with 15% HO (B) stock solutions under 10x magnification. [Figure 197] Figure 197 shows the FTIR of mercerized AA using bicarbonate bleached with either 15% HO or 30% HO compared to mercerized AA bleached with NaOH and 30% HO. [Figure 198] Figure 198 shows the FTIR of AA mercerized with bicarbonate or NaOH bleached with 15% H2O2 using decellularized or raw apples. [Figure 199] FIG. 199 shows the processing of fresh apples in a large Hobart stand mixer bowl. [Figure 200] Figure 200 shows a processed apple in 0.1% SDS during the decellularization process. [Figure 201] Figure 201 shows treated apples in 0.1M CaCl2 solution. [Figure 202] FIG. 202 shows the mercerization of a decellularized apple on the stove. [Figure 203] FIG. 203 shows the sieving of decellularized apple using a 25 μl stainless steel sieve. [Figure 204] Figure 204 shows a 2% alginate solution being prepared on the stove. [Figure 205] Figure 205 shows a stand mixer mix of mercerized apples and 2% alginate. [Figure 206] Figure 206 shows the deposition of biomaterial into a silicon mold. [Figure 207] Figure 207 shows a silicon mold containing frozen biomaterial in a freeze dryer. [Figure 208] FIG. 208 shows cooked biomaterial. [Figure 209] Figure 209 shows a 60 mm alginate / merAA pack cooked by sous vide (A), pan-frying (b) and baking (C). [Figure 210] Figure 210 shows the apple (AA138) treatment. [Figure 211] Figure 211 shows the decellularization and mercerization of processed apples (Mer 138). [Figure 212] Figure 212 shows the fabrication of the scaffold. [Figure 213] Figure 213 shows fried biological material (A) and squid (B). [Figure 214] Figure 214 shows a diagram of sous vide cooking, seared biomaterial (A) and cod (B). [Figure 215] Figure 215 shows a colour test of raw biomaterial (RB), cooked biomaterial (CB), raw cod (RC), cooked cod (CC), raw calamari squid (RS) and cooked calamari squid (CS). [Figure 216] FIG. 216 shows the odor station for six samples and ground coffee. [Figure 217] FIG. 217 shows a texture comparison station of raw and cooked biomaterials compared to cod and squid. [Figure 218] Figure 218 shows the chopping of apples and decellularization of AA139. [Figure 219] Figure 219 shows mercerization of decellularized AA139. [Figure 220] Figure 220 shows scaffold fabrication. [Figure 221] Figure 221 shows bleached MerAA139 (left) and unbleached (right) 1% alginate / AA139 biomaterials before freezing. [Figure 222] Figure 222 shows the sensory results of flavor-word frequency. [Figure 223] Figure 223 shows the texture / mouthfeel-word frequency sensory results. [Figure 224] Figure 224 shows directional freezing of 1% alginate treatment. [Figure 225] Figure 225 shows microscopic images of the top side of a 1% alginate biomaterial after unidirectional freezing at 0.7x (left) and 1.6x (right) magnification. [Figure 226] Figure 226 shows microscopic images of the bottom side of a 1% alginate biomaterial after unidirectional freezing at 0.7x (left) and 1.25x (right) magnification. [Figure 227] Figure 227 shows directional freezing of Mer AA:2% sodium alginate (1:1) in a Petri dish. [Figure 228] Figure 228 shows microscopic images of the edge (left) and center (right) of the "Mer AA:2% sodium alginate (1:1) in a Petri dish" biomaterial after unidirectional freezing. [Figure 229] Figure 229 shows microscopic images of the edge (left) and center (right) of the "Mer AA:2% sodium alginate (1:1)-Petri dish" biomaterial after unidirectional freezing at 0.7x magnification. [Figure 230] FIG. 230 shows biomaterial preparation for Treatment A (left), UF treatment (center) and freeze-dried biomaterial (right). [Figure 231]FIG. 231 shows a microscopic image of a longitudinal section from Treatment A using 1×. [Figure 232] FIG. 232 shows biomaterial preparation for Treatment B. [Figure 233] FIG. 233 shows Treatment B, directional freezing. [Figure 234] FIG. 234 shows the freeze-dried biomaterial of Treatment B. [Figure 235] Figure 235 shows microscopic images of freeze-dried Treatment B at 1.6x (left) and 0.7x (right) magnification. [Figure 236] Figure 236 shows microscopic images of crosslinked Treatment B at 0.7x (left) and 1.6x (right) magnification. [Figure 237] Figure 237 shows a mercerized / decellularized palm heart blend in a metal mold. [Figure 238] Figure 238 shows the freeze-dried biomaterial of decellularized mercerized palm heart before cross-linking. [Figure 239] Figure 239 shows decellularized mercerized palm heart raw crosslinked biomaterials "fish stick" (left) and "scallop" (right). [Figure 240] Figure 240 shows decellularized mercerized palm heart cooked crosslinked biomaterials "fish stick" (left) and "scallop" (right). [Figure 241] FIG. 241 shows the peeled backing of cooked palm heart biomaterial. [Figure 242] FIG. 242 shows the preparation of layers of biomaterial and treatment C. [Figure 243] FIG. 243 illustrates the bonding process and fabrication of two different pieces from Treatment B. [Figure 244] FIG. 244 illustrates the bonding process and fabrication of two different pieces from Treatment C. [Figure 245]Figure 245 shows the cross-linking step with 1% CaCl2 for 1 hour at room temperature or 24 hours under refrigeration. [Figure 246] Figure 246 shows Treatment B crosslinked for 1 hour at room temperature. [Figure 247] Figure 247 shows cross-linked (left) and pan-cooked treatment C. [Figure 248] FIG. 248 illustrates the bread cooking process and treatment B cooked in the pan. [Figure 249] Figure 249 shows Treatment B crosslinked for 24 hours under refrigeration. [Figure 250] FIG. 250 shows the boiling process and boiled treatment B. [Figure 251] FIG. 251 shows ingredient mixing and product creation - Fish A and Fish B. [Figure 252] Figure 252 shows Fish A after the sous vide cooking process. [Figure 253] Figure 253 shows pan-cooked and cooked fish A. [Figure 254] Figure 254 shows a cross section of pan-cooked fish A. [Figure 255] Figure 255 shows fish B placed in an inox mold. [Figure 256] Figure 256 shows freeze-dried fish B. [Figure 257] Figure 257 shows cross-linked fish B. [Figure 258] Figure 258 shows vacuum sealed fish B before (left) and during (right) sous vide cooking. [Figure 259] Figure 259 shows a cross section of pan-cooked and pan-cooked fish B. [Figure 260]Figure 260 shows high-throughput sequential crosslinking from an injectable composite material. A: Injectable pectin and MerAA mixture. B: Hydrogel material loaded into a platen extruded through a perforated plate. C: Extrusion into a crosslinking bath. D: Resulting crosslinked hydrogel with a predetermined shape. E: Physical properties can be tuned, allowing for easy material handling. F: Recovery and preparation for lyophilization, if desired. [Figure 261] Figure 261 shows a schematic diagram of a continuous feed bridge. [Figure 262] Figure 262 shows directionally frozen scaffolds - HE (A, B) and MT (C, D) 4x and 10x excised after 4 weeks of subcutaneous implantation. [Figure 263] Figure 263 shows directionally frozen scaffolds - HE (A, B) and MT (C, D) 4x and 10x excised after 12 weeks of subcutaneous implantation. [Figure 264] Figure 264 shows the aerogel material prior to surgical subcutaneous implantation in a 0.9% sterile saline solution. [Figure 265] FIG. 265 shows Sprague-Dawley rats each having aerogel material subcutaneously implanted at each of their sites before suturing. [Figure 266] Figure 266 shows non-orientationally frozen aerogel scaffolds - HE (A, B) and MT (C, D) 4x and 10x excised after 4 weeks of subcutaneous implantation. [Figure 267] Figure 267 shows non-orientationally frozen aerogel scaffolds - HE (A, B) and MT (C, D) 4x and 10x excised after 12 weeks of subcutaneous implantation. [Figure 268] Figure 268 shows a scaffold directionally frozen prior to implantation in sterile 0.9% saline solution. [Figure 269] FIG. 269 shows a directionally frozen scaffold implanted into the spinal cord of a Sprague-Dawley rat. [Figure 270] FIG. 270 shows the aerogel biomaterial prior to surgical implantation into the calvarial defect. [Fig. 271] FIG. 271 shows a Sprague-Dawley rat implanted with aerogel material cross-linked with alginate and calcium chloride. [Fig. 272] FIG. 272 ​​shows a CT scan of an excised skull with a calvarial defect in a Sprague-Dawley rat that was excised after implantation of an aerogel material 8 weeks prior. DETAILED DESCRIPTION OF THE INVENTION

[0122] Described herein are aerogels, hydrogels, and foams derived from and / or comprising decellularized plant or fungal tissue or their structural cells. It will be appreciated that the embodiments and examples are provided for illustrative purposes intended for those skilled in the art and are not meant to be limiting in any way.

[0123] Provided herein are aerogels, hydrogels and foams derived from and / or comprising decellularized plant or fungal tissue or their structural cells. As described in detail herein below, aerogels, hydrogels, and foams have been developed herein that may be derived from and / or comprise decellularized plant or fungal tissues or their structural cells; may comprise desired plant or fungal microstructure and / or architecture; may be produced by readily scalable production methods; may provide a wide range of scaffold microstructures and / or macrostructures and / or biochemistry; may provide tunable mechanical properties; may provide tunable porosity, density, architecture (amorphous, aligned, channeled, etc.), and / or alignment; may be biocompatible in vitro and / or in vivo; may be stable to a variety of conditions (such as cooking conditions in the case of foods); may be produced on a large scale with control over micro- and / or macrostructural properties; may allow control over density, long-range architecture, and / or mass production; may be scalable in terms of the quantity of material produced and the size and / or shape of the product; may be produced using GRAS components to maintain edibility; may be freeze-dried to provide shelf stability and / or shippability; or any combination thereof. Various aerogels, hydrogels, and foams with desirable properties have been developed and prepared herein by using single structural cells, groups of structural cells, or both derived from plant or fungal tissue (single structural cells or groups of structural cells having a decellularized three-dimensional structure lacking the cellular material and nucleic acids of the plant or fungal tissue) dispersed within one or more dehydrated, lyophilized, or freeze-dried hydrogel-derived carriers. In certain embodiments, the single structural cells, groups of structural cells, or both can be obtained from plant or fungal tissue (typically decellularized plant or fungal tissue) using a mercerization process as described herein, allowing for reproducible and scalable production. Related methods and uses, as well as production methods (which can be partially or fully automated), are also described in detail herein.

[0124] In one embodiment, provided herein is the following aerogel or foam: a single structural cell, a group of structural cells, or both, derived from plant or fungal tissue, wherein the single structural cell or the group of structural cells has a decellularized three-dimensional structure that is devoid of cellular material and nucleic acids of the plant or fungal tissue; An aerogel or foam in which single structural cells, groups of structural cells, or both are dispersed within a carrier derived from a dehydrated, lyophilized, or freeze-dried hydrogel.

[0125] As will be appreciated, aerogels or foams generally can comprise any three-dimensional scaffold or matrix. Typically, aerogels and foams as described herein are highly porous and lightweight (low density), although the porosity and density can be adjusted as desired, as described herein. Aerogels and foams are typically hydrophilic and can be provided as either dry aerogels or foams, or rehydrated or wetted aerogels or foams that further comprise water, an aqueous solution (e.g., cell culture buffer, salt solution, buffer, or another aqueous solution), or another liquid (e.g., an alcohol, e.g., ethanol, or a non-aqueous liquid) (sometimes referred to herein as hydrogels).

[0126] As will be appreciated, plant or fungal tissue may comprise a plurality of connected plant cells formed as an expanded 3D structure. Such plant or fungal tissue may be decellularized (e.g., using decellularization methods such as those described in International Publication No. WO 2017 / 136950, entitled "Decellularized Cell Wall Structures From Plants and Fungus and Use Thereof as Scaffold Materials," the entirety of which is incorporated herein by reference) to provide decellularized plant or fungal tissue that lacks the cellular material and nucleic acids of the plant or fungal cells but maintains a substantially intact 3D structure. Such decellularized plant or fungal tissue (e.g., decellularized thixosa or pulp tissue or any other suitable plant or fungal tissue / structure / component desired) may comprise an expanded 3D structure (which may be composed of any one or more of cellulose, hemicellulose, pectin, lignin, etc.; typically, the expanded 3D structure may comprise a lignocellulosic structure / material). As described herein, a single structural cell, a group of structural cells (including a plurality of connected single structural cells), or both may be derived from the expanded 3D structure, where the single structural cell or group of structural cells has a decellularized 3D structure lacking cellular material and nucleic acids of the plant or fungal tissue. In certain embodiments, the single structural cell or group of structural cells may comprise an isolated structural cell or a small group of clustered structural cells, where the structural cells have a substantially intact 3D structure, typically resembling a hollow cell or pocket, as shown in FIG. 3. As will be appreciated, such structures may generally comprise lignocellulosic materials, e.g., cellulose and / or lignin-based structures, although it will be understood that in certain embodiments, such structures may also comprise other building blocks, such as chitin and / or pectin.

[0127] In certain embodiments of the aerogel(s) or foam(s), the plant or fungal tissue from which the single structural cell or group of structural cells is derived may include decellularized plant or fungal tissue.

[0128] As described herein, the single structural cell, the group of structural cells, or both can preferably be obtained from decellularized plant or fungal tissue, and even more preferably from plant or fungal tissue that has been decellularized using a mercerization process as described in detail herein. However, it will be understood that in certain embodiments, the single structural cell, the group of structural cells, or both can instead be obtained from plant or fungal tissue and then subsequently decellularized, or, for example, can be obtained from plant or fungal tissue in a manner that simultaneously provides decellularization. In certain embodiments, the structural cell can comprise a decellularized structural cell that includes a cell wall that previously contained one or more plant cells prior to decellularization.

[0129] In certain embodiments, aerogels, foams, hydrogels, and other such materials as described herein may include cell wall architecture and / or vascular structures found in the plant and / or fungal kingdoms to create 3D scaffolds that may promote cell infiltration, cell proliferation, bone tissue repair, bone remodeling, tissue engineering, spinal cord repair, and the like. As will be appreciated, biomaterials as described herein may be produced from any suitable part of a plant or fungus. Biomaterials may include, for example, one or more substances, such as cellulose, chitin, lignin, lignans, hemicellulose, pectin, lignocellulose, and / or any other suitable biochemicals / biopolymers naturally found in these organisms.

[0130] It will be understood that unless otherwise stated, the meanings / definitions of the kingdoms Plantae and Fungi used herein are based on the Cavalier-Smith classification (1998).

[0131] In certain embodiments, the plant or fungal tissue may generally include any suitable plant or fungal tissue or part suitable for a particular application. In certain embodiments, the plant or fungal tissue is selected from the group consisting of apple thixosa (Malus pumila) tissue, fern (Monilophytes) tissue, turnip (Brassica rapa) root tissue, ginkgo biloba branch tissue, horsetail (Equisetum) tissue, hermocallis hybrid leaf tissue, kale (Brassica oleracea) stem tissue, conifer Douglas-fir (Pseudotsuga menziesii) tissue, cactus fruit (pitaya) flesh tissue, Maculata Vinca tissue, water lotus (Nelumbo nucifera) tissue, tulip (Tulipa gesneriana) tissue, and the like. gesneriana) petal tissue, plantain (Musa paradisiaca) tissue, broccoli (Brassica oleracea) stem tissue, maple leaf (Acer psuedoplatanus) stem tissue, beet (Beta vulgaris) primary root tissue, green onion (Allium cepa) tissue, orchid (Orchidaceae) tissue, turnip (Brassica rapa) stem tissue, leek (Allium ampeloprasum) tissue, maple (Acer) tree branch tissue, celery (Apium graveolens) graveolens) tissue, green onion (Allium cepa) stem tissue, pine tissue, aloe vera tissue, watermelon (Citrullus lanatus var. lanatus) tissue, eggplant (Lysimachia nummularia) tissue, cactus (cactae) tissue, Lychnis alpina tissue, rhubarb (Rheum labarbarum) tissue,The tissue may include cucumber (Cucurbita pepo) tissue, pumpkin flesh (Cucurbita pepo) tissue, dracaena (Asparagaceae) stem tissue, tradescantia (Tradescantia virginiana) stem tissue, asparagus (Asparagus officinalis) stem tissue, mushroom (fungus) tissue, fennel (Foeniculum vulgare) tissue, rose (Rosa) tissue, carrot (Daucus carota) tissue, or pear (Pomaceous) tissue. Further examples of plant and fungal tissues are described in Example 18 of WO 2017 / 136950, entitled "Decellularized Cell Wall Structures from Plants and Fungus and Use Thereof as Scaffold Materials," which is incorporated herein by reference in its entirety.

[0132] In certain embodiments, the decellularized plant or fungal tissue can be cellulose-based, chitin-based, chitosan-based, lignin-based, lignan-based, hemicellulose-based, or pectin-based, or any combination thereof. In certain embodiments, the plant or fungal tissue is selected from the group consisting of apple stipule (Malus pumila) tissue, fern (Monilophytes) tissue, turnip (Brassica rapa) root tissue, ginkgo biloba branch tissue, horsetail (Equisetum aestivum) tissue, forget-me-not hybrid leaf tissue, kale (Brassica oleracea) stem tissue, conifer Douglas-fir (Douglas-fir) tissue, cactus fruit (Pitaya) flesh tissue, Maculata vinca tissue, water lotus (Nelumbo nucifera) tissue, and the like. nucifera) tissue, tulip (Tulipa gesneriana) petal tissue, plantain (Musa paradisiaca) tissue, broccoli (Brassica oleracea) stem tissue, maple leaf (Acer pseudoplatanus) stem tissue, beet (Beta vulgaris) primary root tissue, green onion (Allium cepa) tissue, orchid (Orchidaceae) tissue, turnip (Brassica rapa) stem tissue, leek (Allium ampeloprasum) tissue , maple (Acer spp.) tree branch tissue, celery (Apium graveolens) tissue, green onion (Allium cepa) stem tissue, pine tissue, aloe vera tissue, watermelon (Citrullus lanatus var. lanatus) tissue, nightshade (Lysimachia nummularia) tissue, cactus tissue, Lychnis alpina tissue, rhubarb (Rheum labarum) tissue, pumpkin pulp (Cucurbita pepo) tissue, Dracaena (Asparagus The tissue may include tissue from (Triticum aestivum) stem tissue, tradescantia (Tradescantia recutita) stem tissue, asparagus (Asparagus officinalis) stem tissue, mushroom (fungus) tissue, fennel (Fennel) tissue, rose (Rosa) tissue, carrot (Ninolandia) tissue, or pear (Pome fruit) tissue, or tissue that has been genetically modified via direct genomic modification or by selective breeding, or any combination thereof.

[0133] As will be understood, the cellular material and nucleic acids of plant or fungal tissue may include intracellular contents, such as organelles (e.g., chloroplasts, mitochondria), nuclei, cellular nucleic acids, and / or cellular proteins. These may be substantially removed, partially removed, or completely removed from the plant or fungal tissue and / or from the structural cells. It will be recognized that trace amounts of such components may still be present in decellularized plant or fungal tissue and / or structural cells as described herein. As will also be understood, reference herein to decellularized plant or fungal tissue is intended to reflect that such cellular material found in the plant or fungal source of the tissue has been substantially removed—this does not preclude the possibility that the decellularized plant or fungal tissue or structural cells may, in certain embodiments, contain or may comprise subsequently introduced or reintroduced cells, cellular material, and / or nucleic acids of generally any type, e.g., animal or human cells, e.g., bone or bone precursor cells / tissue.

[0134] Various methods can be used to generate decellularized plant or fungal tissue as described herein. By way of example, in certain embodiments, decellularized plant or fungal tissue can include plant or fungal tissue(s) that have been decellularized by heat shock, treatment with detergents (e.g., SDS, Triton X, EDA, alkaline treatment, acidic ionic detergents, non-ionic detergents, and zwitterionic detergents), osmotic shock, freeze-drying, physical lysis (e.g., hydrostatic pressure), electrical disruption (e.g., non-thermal irreversible electroporation), or enzymatic digestion, or any combination thereof. In certain embodiments, biomaterials as described herein can be obtained from plants and / or fungi by using a decellularization process that can include any of several approaches (individually or in combination), including, but not limited to, heat shock (e.g., rapid freeze-thawing), chemical treatment (e.g., detergents), osmotic shock (e.g., distilled water), freeze-drying, physical lysis (e.g., pressure treatment), electrical disruption, and / or enzymatic digestion.

[0135] In certain embodiments, decellularized plant or fungal tissue may include plant or fungal tissue that has been decellularized by treatment with a detergent or surfactant. Examples of detergents include, but are not limited to, sodium dodecyl sulfate (SDS), Triton X, EDA, alkaline treatment, acidic ionic detergents, nonionic detergents, and zwitterionic detergents. In a preferred embodiment, plant or fungal tissue may be decellularized using SDS and CaCl2.

[0136] In yet further embodiments, the decellularized plant or fungal tissue may include plant or fungal tissue that has been decellularized by treatment with SDS. In yet another embodiment, residual SDS can be removed from the plant or fungal tissue by washing with an aqueous divalent salt solution. The aqueous divalent salt solution can be used to precipitate / disintegrate salt residues containing SDS micelles from the solution / scaffold, and dH2O, acetic acid, or dimethyl sulfoxide (DMSO) treatment or sonication may also be used to remove salt residues or SDS micelles. In certain embodiments, the divalent salt of the aqueous divalent salt solution can include, for example, MgCl2 or CaCl2.

[0137] In another embodiment, plant or fungal tissue can be decellularized by treatment with an SDS solution of 0.01-10%, e.g., between about 0.1% and about 1%, or, e.g., about 0.1% SDS or about 1% SDS, in a solvent such as water, ethanol, or another suitable organic solvent, and residual SDS may be removed using an aqueous CaCl solution at a concentration of about 100 mM followed by incubation in dH2O. In certain embodiments, the SDS solution may be at a concentration greater than 0.1%, which may facilitate decellularization and may involve increased washing to remove residual SDS. In certain embodiments, plant or fungal tissue can be decellularized by treatment with an SDS solution of about 0.1% SDS in water, and residual SDS may be removed using an aqueous CaCl solution at a concentration of about 100 mM followed by incubation in dH2O.

[0138] Further examples of applicable decellularization protocols for producing decellularized materials as described herein can be found in WO 2017 / 136950, entitled "Decellularized Cell Wall Structures from Plants and Fungus and Use Thereof as Scaffold Materials," the entire text of which is incorporated herein by reference.

[0139] In certain embodiments, aerogels, foams, and / or hydrogels as described herein may include single structural cells, groups of structural cells, or both dispersed within a carrier. In certain embodiments, the carrier may be derived from a dehydrated, lyophilized, or freeze-dried hydrogel. As will be appreciated, the carrier may generally include any suitable carrier material, structure, or matrix for providing support and / or structure to the aerogel, foam, and / or hydrogel, and may be used to support, support, attach, or retain the single structural cells, groups of structural cells, or both of the aerogel, foam, and / or hydrogel. Those skilled in the art, in light of the teachings herein, will recognize a variety of different carriers that can be used and selected to suit the particular application(s) desired. In certain embodiments, the carrier may include a hydrogel in which single structural cells, groups of structural cells, or both are intermixed, or the carrier may be derived from a dehydrated, lyophilized, or freeze-dried hydrogel in which single structural cells, groups of structural cells, or both are intermixed.A variety of different hydrogels can be used to provide the carrier, including, but not limited to, alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, extracellular matrix proteins, etc. Hydrogel(s) comprising one or more of the following: a protein (e.g., collagen, gelatin, or fibronectin, or any combination thereof), monoacrylated poly(ethylene glycol), poly(ethylene glycol) diacrylate, poly(ethylene glycol) diacrylate (PEGDA)-co-PEGMA, poly(vinyl alcohol), poly(vinylpyrrolidone), poly(lactic acid-co-glycolic acid), chitosan, chitin, xanthan gum, elastin, fibrin, fibrinogen, cellulose derivatives, carrageenan, or microcrystalline cellulose, or any combination thereof. In certain embodiments, the hydrogel / carrier is optionally crosslinked.

[0140] In certain embodiments of any of the aerogel(s) or foam(s) described herein, the hydrogel may be made from any of a variety of materials, including but not limited to alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, extracellular matrix materials, and the like. The hydrogel may comprise a matrix protein (e.g., collagen, gelatin, or fibronectin, or any combination thereof), monoacrylated poly(ethylene glycol), poly(ethylene glycol) diacrylate, poly(ethylene glycol) diacrylate (PEGDA)-co-PEGMA, poly(vinyl alcohol), poly(vinylpyrrolidone), poly(lactic acid-co-glycolic acid), chitosan, chitin, xanthan gum, elastin, fibrin, fibrinogen, cellulose derivatives, carrageenan, or microcrystalline cellulose, or any combination thereof, and the hydrogel is optionally crosslinked.

[0141] In certain embodiments of the aerogels or foams described herein, the aerogels or foams can optionally be rehydrated with water, an aqueous solution, a buffer, a cell buffer, an alcohol (e.g., ethanol), or another aqueous or non-aqueous liquid or solution appropriate for the desired application(s). Alternatively, the aerogels or foams can be provided in dry form.

[0142] In preferred embodiments of the aerogel(s) or foam(s) described herein, single structural cells, groups of structural cells, or both can be obtained from plant or fungal tissue, preferably decellularized plant or fungal tissue, by mercerization. Other approaches to obtaining single structural cells, groups of structural cells, or both, such as maceration or other liquid extraction, are also contemplated, but mercerization as described herein is preferred.

[0143] As will be appreciated, mercerization can include any suitable process for treating plant or fungal tissue (preferably, decellularized plant or fungal tissue) to obtain single structural cells, groups of structural cells, or both, typically using a liquid extraction solution that utilizes a base, preferably further utilizing peroxide. Typically, mercerization of plant or fungal tissue (preferably, decellularized plant or fungal tissue) breaks down the plant or fungal tissue into tissue / cellular components (including single structural cells, groups of structural cells, or both). In certain embodiments, mercerization may utilize an alkaline / base solution and peroxide. In certain embodiments, more than one treatment or solution can be used, either simultaneously or sequentially.

[0144] In certain embodiments, mercerization may include at least one treatment with a base solution. As will be appreciated, the base solution may generally include any suitable base, such as any suitable base capable of osmotic shock to extract intact tissue structures and / or disrupting hydrogen bonds and / or polymer crystalline structures. As will be appreciated, particularly for food and / or medical applications, the base may be selected to be appropriate for the particular application, such as physiologically occurring, easily washed away, non-toxic, and / or selected according to various factors related to the particular application, as needed. In certain embodiments, the base may include NaOH, KOH, or a combination thereof. In one embodiment, the base may be dissolved / mixed in a suitable solvent to form a base solution. Typically, the solvent may include water, although other solvents or solvent combinations (e.g., a mixture of water and ethanol) are also contemplated. The concentration of the base in the base solution may be adjusted to suit the particular application desired. Typically, the base solution can comprise a base concentration of about 0.1 to 10 M, or any concentration therebetween (which may be rounded to the nearest 0.1), or any subrange extending between any two of these concentrations. In certain embodiments, the base concentration can be about 0.5 M to 3 M, or any value therebetween (which may be rounded to the nearest 0.1), or any subrange extending between any two of these concentrations. By way of example, in certain embodiments, the base solution can comprise an aqueous solution of NaOH having a concentration of about 0.5 M to 3 M. As will be appreciated, the base solution as well as the treatment conditions (i.e., heating, agitation) can be adjusted as needed to suit the particular application, the desired structure to be extracted, the plant or fungal tissue being used, etc.

[0145] In certain embodiments, the base may comprise a base selected from the group consisting of carbonate, nitrate, phosphate, sulfate, ammonia, sodium hydroxide, calcium hydroxide, magnesium hydroxide, potassium hydroxide, lithium hydroxide, zinc hydroxide, sodium carbonate, sodium bicarbonate, butyllithium, sodium azide, sodium aminde, sodium hydride, sodium borohydride, or lithium diisopropylamine. Neutralization and / or washing can be performed to remove residual base and other reagents, depending on the intended use of the base and / or product, for example, to prevent undesired contamination.

[0146] In a preferred embodiment, mercerization may involve treatment of plant or fungal tissue (preferably decellularized plant or fungal tissue) using sodium hydroxide and hydrogen peroxide in conjunction with heat.

[0147] In yet another embodiment of any of the aerogel(s) or foam(s) described herein, the aerogel or foam can comprise a particle size distribution of monostructural cells having an average Feret's diameter in the range of about 1 μm to about 1000 μm, e.g., about 100 to about 500 μm, e.g., about 100 to about 300 μm.

[0148] In yet another embodiment of any of the aerogel(s) or foam(s) described herein, the plant tissue may include apple tissue or pear tissue.

[0149] In another embodiment of any of the aerogel(s) or foam(s) described herein, the aerogel or foam can comprise from about 5% to about 95% m / m, e.g., from about 10 to 50% m / m (or more), of single structural cells, groups of structural cells, or both, when the aerogel or foam is in a hydrated form.

[0150] In yet another embodiment of any of the aerogel(s) or foam(s) described herein, the hydrogel may include alginate, pectin, or both, and the aerogel or foam may be rehydrated with a CaCl solution to provide cross-linking.

[0151] In yet another embodiment of any of the aerogel(s) or foam(s) described herein, the aerogel or foam can have a bulk modulus in the range of about 0.1 to about 500 kPa, e.g., about 1 to about 200 kPa.

[0152] In another embodiment of any of the aerogel(s) or foam(s) described herein, the aerogel or foam may be rehydrated and may further comprise one or more animal cells.

[0153] In another embodiment of any of the aerogel(s) or foam(s) described herein, the aerogel or foam may be rehydrated and may contain any one or more cells selected from fibroblasts, myofibroblasts, neurons, dorsal root ganglion cells, neuronal structures such as axons, neural progenitor cells, neural stem cells, glial cells, endogenous stem cells, neutrophils, mesenchymal stem cells, satellite cells, myoblasts, myotubes, muscle progenitor cells, adipocytes, preadipocytes, chondrocytes, osteoblasts, osteoclasts, preosteoblasts, tendon progenitor cells, tenocytes, periodontal ligament stem cells, endothelial cells, or any combination thereof. Cells may be selected to suit the particular application(s) desired. In certain embodiments, when a food application is desired, the one or more cells may include, for example, muscle cells, adipocytes, connective tissue cells (i.e., fibroblasts), cartilage, bone, epithelial, or endothelial cells, or any combination thereof.

[0154] In yet other embodiments of any of the aerogel(s) or foam(s) described herein, at least a portion of the cellulose and / or cellulose derivative(s) of the aerogel or foam may be crosslinked by physical crosslinking (e.g., using glycine) and / or chemical crosslinking (e.g., using citric acid in the presence of heat), or at least a portion of the cellulose and / or cellulose derivative(s) of the aerogel or foam may be functionalized with a linker (e.g., succinic acid) optionally having one or more functional moieties attached thereto (e.g., amine-containing groups to which crosslinking may further optionally be achieved using one or more protein crosslinking agents, e.g., formalin, formaldehyde, glutaraldehyde, and / or transglutaminase), or any combination thereof. In certain embodiments, crosslinking can impart additional structural integrity to the aerogels, foams, and / or hydrogels described herein, and it is contemplated that the degree of crosslinking can be controlled to tailor the physical properties of the resulting product. In certain embodiments, the cellulose or cellulose derivative or other material of the structural cells of the aerogel or foam may be crosslinked; the material of the carrier (usually derived from a hydrogel) may be crosslinked; or a combination thereof. Example 8 below provides illustrative examples of physical and chemical crosslinking approaches, including those utilizing linkers. Those skilled in the art, having the benefit of the teachings herein and considering the structural cells and carrier / hydrogel used in a particular aerogel / foam, will recognize appropriate approaches for achieving crosslinking.

[0155] In certain embodiments, the carrier of the aerogel(s) or foam(s) as described herein may or may not be crosslinked. In certain embodiments, the carrier may be crosslinked before dehydration, lyophilization, or freeze-drying; after dehydration, lyophilization, or freeze-drying, or both. In embodiments in which the carrier is crosslinked, the carrier may be crosslinked before or after dehydration, lyophilization, or freeze-drying of the mixture, typically after mixing or dispersing single structural cells, groups of structural cells, or both therein. Figure 128 shows a flow chart depicting an illustrative example of aerogel / foam preparation using crosslinking before or after freezing and lyophilization.

[0156] In yet another embodiment of any of the aerogel(s) or foam(s) as described herein, the aerogel or foam may include templated or aligned microchannels created by directional freezing, by molding using a mold having microscale and / or macroscale features, by punching, pressing, stamping, or forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface, or any combination thereof.

[0157] Approaches for directional freezing are described in detail in the Examples below. Briefly, by creating a larger thermal gradient on one side of the hydrogel, linear, highly aligned ice crystals can be formed from the colder side. This can cause surrounding hydrogel polymer to form around the ice crystals, creating aligned microscale channels. After freeze-drying the resulting material, a scaffold with numerous microchannels can be created. As will be appreciated, directional freezing can be used to template or form channels and / or other structural features within the aerogel and / or foam, on the surface of the aerogel and / or foam, or both.

[0158] In yet another embodiment of any of the above method(s), the microarchitecture of the microchannels produced from directional freezing can be controlled by creating mixtures that include solvents containing varying amounts of one or more other dissolved compounds, such as sucrose, dextrose, trehalose, corn starch, glycerol, ethanol, mannitol, sodium chloride, CaCl, gelatin, citric acid, PVA, PEG, dextran, NaF, NaBr, NaI, phosphate buffer, another sugar or salt, or another such agent that can alter the structural properties of aligned ice crystals growing from the cold side of the thermal gradient.

[0159] In certain embodiments, directional freezing (also known as freeze-casting or ice templating) can involve a process that can create well-controlled microscale features (e.g., channels, pores, etc.) in aerogels, including hydrogels, polymers, biopolymers, etc. In certain embodiments, the process can involve controlled freezing of a solution, typically an aqueous solution, suspension, or sol-gel, followed by sublimation in a freeze-dryer. Typically, a solution undergoing controlled freezing can be placed on a cold plate, which creates a non-uniform thermal gradient, typically starting on one side. Ice crystals form from the cold side and grow linearly away from the cold surface. As the ice crystals grow, solution components (e.g., polymers, hydrogels, colloids, monolayer cells, etc.) migrate and collect among the growing ice crystals. After freezing is complete, sublimation can be performed, typically in a freeze-dryer, which can remove the ice crystals and leave anisotropically templated nano- to microscale features, e.g., aerogels or foams with aligned channels. Thus, the final structural properties of the features can vary depending on the structure of the ice crystals formed in the solution. Therefore, other solutes that affect ice crystallization may allow for control of the final architecture of the aerogel. In such a scenario, it is contemplated that dissolving other salts, lipids, sugars, and / or other additives in the aqueous solution may affect ice crystal formation. In certain embodiments, such compounds may include any of the following, alone or in combination: sucrose, dextrose, trehalose, corn starch, glycerol, ethanol, mannitol, sodium chloride, CaCl2, gelatin, citric acid, PVA, PEG, dextran, NaF, NaBr, NaI, phosphate buffer, and the like. In addition to additives to the solution, it is contemplated that temperature and freezing rate may also affect ice crystal shape in certain embodiments. In certain embodiments, temperatures between -195°C and 0°C may be used, with certain embodiments utilizing operating temperatures more typically between -30°C and -10°C to create aligned, directionally frozen scaffolds.

[0160] The molding of aerogels, foams, and hydrogels as described herein is also described in detail in the Examples below. In certain embodiments, the aerogel / foam / hydrogel precursor mixture can be introduced into a container or mold and then dehydrated, lyophilized, or freeze-dried. In preferred embodiments, the aerogel / foam / hydrogel precursor mixture can be frozen in the container or mold prior to dehydration, lyophilization, or freeze-drying. In certain embodiments, the mold or container can be designed to provide an aerogel / foam / hydrogel having a desired shape and / or size. In certain embodiments, the container or mold can be designed to present microscale and / or macroscale features on the surface of the aerogel / foam / hydrogel contained therein (e.g., the mold can have structural features such as protrusions / depressions on its interior walls to form structure on and / or within the aerogel and / or foam), and / or can be designed to project microscale and / or macroscale features into the aerogel / foam / hydrogel contained therein to impart a desired structure to the aerogel / foam / hydrogel upon molding. Examples of microscale and / or macroscale features can include geometric patterns, channels, depressions, tunnels, or holes, or any other microscale and / or macroscale features desired or appropriate for the particular application(s) desired.

[0161] In certain embodiments, macroscale and / or microscale structural features can be imparted to the aerogel / foam / hydrogel by mechanical processing, such as punching, pressing, stamping, drilling, or, as needed, forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface of the aerogel / foam / hydrogel. In some embodiments, it is contemplated that such mechanical processing can be computer-guided (e.g., by numerical control), for example, using automated machinery. Mechanical processing can be performed, for example, before, during, and / or after freezing and / or lyophilization or freeze-drying.

[0162] In yet another embodiment, provided herein are single structural cells, groups of structural cells, or both, obtained from decellularized plant or fungal tissue by mercerization of the decellularized plant or fungal tissue, wherein the single structural cell or group of structural cells has a decellularized three-dimensional structure that is devoid of the cellular material and nucleic acids of the plant or fungal tissue and devoid of one or more base-soluble lignin components of the plant or fungal tissue. As will be appreciated, mercerization using a base (e.g., NaOH, optionally further in the presence of, e.g., hydrogen peroxide) may remove one or more base-soluble lignin components, but as shown in the examples below, the entire three-dimensional structure of the resulting single structural cell, group of structural cells, or both, derived from the decellularized plant or fungal tissue may remain substantially intact. The structural cells obtained from mercerization may differ from structural cells obtained in alternative methods, such as, for example, acid-based maceration approaches, which may remove lignin components that are more soluble in certain acids than base-soluble lignin components, and thus provide structural cells with different lignin contents. In certain embodiments, single structural cells, groups of structural cells, or both may be provided in dry form or suspended in an aqueous or non-aqueous liquid or solution, such as, but not limited to, water, aqueous buffer, or ethanol.

[0163] In certain embodiments, any of the aerogel(s), foam(s) described herein may further comprise one or more cells cultured or disposed thereon. In certain embodiments, the one or more cells may comprise any one or more of muscle cells, adipocytes, connective tissue cells, fibroblasts, myofibroblasts, neurons, dorsal root ganglion cells, neuronal structures such as axons, neural progenitor cells, neural stem cells, glial cells, endogenous stem cells, neutrophils, mesenchymal stem cells, satellite cells, myoblasts, myotubes, muscle progenitor cells, adipocytes, preadipocytes, chondrocytes, osteocytes, epithelial cells, endothelial cells, chondrocytes, osteoblasts, osteoclasts, preosteoblasts, tendon progenitor cells, tenocytes, periodontal ligament stem cells, or endothelial cells, or any combination thereof.

[0164] In certain embodiments, aerogels and foams as described herein may generally be biocompatible. By way of example, in certain embodiments, aerogels and foams as described herein may be compatible with a variety of different cell types relevant to tissue engineering and / or food applications, and may be biocompatible with a variety of animals, including, but not limited to, humans, rodents (e.g., mice, rats, guinea pigs), lagomorphs (e.g., rabbits, hares), carpine (goats), ovine (e.g., sheep, lamb, mutton), porcine (e.g., pigs, hogs), and the like. It is contemplated that the cells may be biocompatible with cells from many different species and kingdoms, including porcine, boar, bovine (e.g., cow, bison, buffalo), feline, canine, fish (e.g., salmon, tuna, snapper, mackerel, cod, trout, carp, catfish, and sardines), mollusks, crustaceans (e.g., crab, lobster, crayfish, shrimp, prawns), birds (e.g., chicken, turkey, duck), reptiles, amphibians, insects, and / or plant species. As will be appreciated, cells may be selected based on the particular application(s) desired, which may include, but are not limited to, therapeutic (human or veterinary), food, or other such applications.

[0165] In yet another embodiment, there is provided a method of preparing an aerogel or foam, comprising: providing a decellularized plant or fungal tissue; obtaining single structural cells, groups of structural cells, or both from the decellularized plant or fungal tissue by performing mercerization of the decellularized plant or fungal tissue, and recovering the resulting single structural cells or groups of structural cells having a decellularized three-dimensional structure; mixing or dispersing single structural cells, groups of structural cells, or both in a hydrogel to provide a mixture; and Dehydrating, lyophilizing, or freeze-drying the mixture to provide an aerogel or foam. Provided herein is a method comprising:

[0166] Aerogels, foams, plant or fungal tissue, decellularization, structural cells and groups of structural cells and hydrogels have already been described in detail herein above.

[0167] As will be appreciated, single structural cells, groups of structural cells, or both can be obtained from plant or fungal tissue (preferably, from decellularized plant or fungal tissue) by performing mercerization. Mercerization can include any suitable process for treating plant or fungal tissue (preferably, decellularized plant or fungal tissue) to obtain single structural cells, groups of structural cells, or both, typically using a liquid extraction solution utilizing a base, preferably further utilizing a peroxide. Typically, mercerization of plant or fungal tissue (preferably, decellularized plant or fungal tissue) breaks down the plant or fungal tissue into tissue / cellular components (including single structural cells, groups of structural cells, or both). In certain embodiments, mercerization may utilize an alkaline / base solution and peroxide. In certain embodiments, more than one treatment or solution can be used, either simultaneously or sequentially. It is contemplated that in certain embodiments, mercerization may be performed on plant or fungal tissue and then decellularization may be performed, or mercerization may be performed on plant or fungal tissue and mercerization conditions may be selected to provide for simultaneous decellularization, however, it is preferred that mercerization be performed on plant or fungal tissue that has already been previously decellularized, as described herein.

[0168] In certain embodiments, mercerization may include at least one treatment with a base solution. As will be appreciated, the base solution may generally include any suitable base, such as any suitable base capable of osmotic shock to extract intact tissue structures and / or disrupting hydrogen bonds and / or polymer crystalline structures. As will be appreciated, particularly for food and / or medical applications, the base may be selected to be appropriate for the particular application, such as physiologically occurring, easily washed away, non-toxic, and / or selected according to various factors related to the particular application, as needed. In certain embodiments, the base may include NaOH, KOH, or a combination thereof. In one embodiment, the base may be dissolved / mixed in a suitable solvent to form a base solution. Typically, the solvent may include water, although other solvents or solvent combinations (e.g., a mixture of water and ethanol) are also contemplated. The concentration of the base in the base solution may be adjusted to suit the particular application desired. Typically, the base solution can comprise a base concentration of about 0.1 to 10 M, or any concentration therebetween (which may be rounded to the nearest 0.1), or any subrange extending between any two of these concentrations. In certain embodiments, the base concentration can be about 0.5 M to 3 M, or any value therebetween (which may be rounded to the nearest 0.1), or any subrange extending between any two of these concentrations. By way of example, in certain embodiments, the base solution can comprise an aqueous solution of NaOH having a concentration of about 0.5 M to 3 M. As will be appreciated, the base solution as well as the treatment conditions (i.e., heating, agitation) can be adjusted as needed to suit the particular application, the desired structure to be extracted, the plant or fungal tissue being used, etc.

[0169] In certain embodiments, the base may comprise a base selected from the group consisting of carbonate, nitrate, phosphate, sulfate, ammonia, sodium hydroxide, calcium hydroxide, magnesium hydroxide, potassium hydroxide, lithium hydroxide, zinc hydroxide, sodium carbonate, sodium bicarbonate, butyllithium, sodium azide, sodium aminde, sodium hydride, sodium borohydride, or lithium diisopropylamine. Neutralization and / or washing can be performed to remove residual base and other reagents, depending on the intended use of the base and / or product, for example, to prevent undesired contamination.

[0170] In a preferred embodiment, mercerization may involve treatment of plant or fungal tissue (preferably decellularized plant or fungal tissue) using sodium hydroxide and hydrogen peroxide in conjunction with heat.

[0171] The resulting single structural cell or group of structural cells (with a decellularized three-dimensional structure) can be collected and provided in a dry form, as a paste or gel, or in another suitable form as needed.

[0172] Mercerization processes in other industries, such as the pulp and paper industry, result in degradation down to cellulose polymers / fibers (i.e., complete degradation of the plant structure). In contrast, a mercerization process such as that described herein (whether the plant or fungal tissue is decellularized before, during, or after mercerization) can provide for the preservation of intact single structural cells or groups of structural cells with three-dimensional structure. While mercerization can be performed before decellularization of plant or fungal tissue, this is not preferred because it is expected to take a long time, be less efficient, and may result in a less pure resulting material to be decellularized. Therefore, mercerization of already decellularized plant or fungal tissue is preferred. Using a mercerization process such as that described herein, decellularized but desired intact single structural cells and / or plant tissue structures (e.g., parenchyma, ground tissue, epidermal tissue, vascular bundles, phloem, petioles, veins, roots, root hairs, etc.) can be obtained as needed to suit the specific application(s) desired.

[0173] In embodiments of the methods described herein, single structural cells or groups of structural cells resulting from mercerization (having a decellularized three-dimensional structure) can be mixed or dispersed in a hydrogel to provide a mixture.

[0174] In certain embodiments, the hydrogel into which the single structural cells, groups of structural cells, or both are mixed or dispersed may be made from any of a variety of materials, including but not limited to alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, extracellular matrix proteins, and the like. The hydrogel / carrier may comprise any one or more of the following: proteins (e.g., collagen, gelatin, or fibronectin, or any combination thereof), monoacrylated poly(ethylene glycol), poly(ethylene glycol) diacrylate, poly(ethylene glycol) diacrylate (PEGDA)-co-PEGMA, poly(vinyl alcohol), poly(vinylpyrrolidone), poly(lactic-co-glycolic acid), chitosan, chitin, xanthan gum, elastin, fibrin, fibrinogen, cellulose derivatives, carrageenan, or microcrystalline cellulose hydrogel(s), or any combination thereof. In certain embodiments, the hydrogel / carrier is optionally crosslinked.

[0175] In further embodiments of the methods as described herein, the mixture of single structural cells, groups of structural cells, or both and hydrogel may be dehydrated, lyophilized, or freeze-dried to provide an aerogel or foam. Those skilled in the art, having the benefit of the teachings set forth herein, including the examples provided below, will recognize a variety of suitable techniques and devices for dehydrating, lyophilizing, or freeze-drying, or drying or removing at least a portion of the liquid / solvent from the mixture to provide an aerogel and / or foam as described herein.

[0176] In certain embodiments of the above methods, mercerization may involve treating the decellularized plant or fungal tissue with a base and a peroxide, preferably with sodium hydroxide or another hydroxide base as the base and hydrogen peroxide as the peroxide. Mercerization may chemically decompose the decellularized plant or fungal tissue into single structural cells, groups of structural cells, or both, without destroying the lignocellulosic structures that contribute to the three-dimensional structure of the single structural cells.

[0177] In yet another embodiment of any of the above method(s), mercerization may involve treatment of the decellularized plant or fungal tissue with aqueous sodium hydroxide and hydrogen peroxide in the presence of heat.

[0178] In yet another embodiment of any of the above method(s), mercerization may be carried out by heating to about 80° C. In certain embodiments, such heating may allow for a reduction in reaction time, particularly when using, for example, sodium hydroxide.

[0179] In yet another embodiment of any of the above method(s), the decellularized plant or fungal tissue may be treated with aqueous sodium hydroxide for a first period of time, after which hydrogen peroxide is added to the reaction. In certain embodiments, the first period of time can be from about 1 minute to about 24 hours, or any time point therebetween, or any subrange extending between any two such time points.

[0180] In certain embodiments, the peroxide may be added to the reaction at intervals, such as about 15 minute intervals. An illustrative, non-limiting example of such a peroxide interval approach may proceed as follows: Protocol for peroxide addition at 15 minute intervals: The volumes presented here are for a 4 L beaker reaction vessel. As will be appreciated, volumes may be adjusted for different setups. A. Clean the work station with Accel TB solution, then with 70% ethanol. B. Use a sterile sieve placed over a waste beaker to press the water out of the decellularized material. Divide into 500 g portions using a balance. All processing is performed using sterile surgical gloves and aseptic technique in a biosafety cabinet. C. Place 500 g of material into a clean, sterile 4 L beaker. D. Add 2.5 L of 1 M NaOH to the beaker. Raise the temperature to 80°C. E. Add 125 mL of 30% hydrogen peroxide. Note: This 30% hydrogen peroxide solution is the stock concentration. Add the stock to be 30%. Add hydrogen peroxide in 25 mL aliquots every 15 minutes starting at t=0 and continuing throughout the 1 hour reaction. F. Place a clean, sterile magnetic stir bar into the beaker. G. Stir for 1 hour at 80°C. Ensure the stirring is adequate to provide movement of the material but not scattering. H. Check to make sure the color is clear or off-white. If it is still yellow, allow the reaction to proceed until the color disappears. I. Turn off the heat and remove the beaker from the heat source. Allow the solution to cool to room temperature. J. Neutralize the solution using stock HCl until the pH is 6.8-7.2. Centrifuge the material at 8000 rpm for 15 minutes in an Avanti J-26XPI centrifuge. Ensure the centrifuge is properly balanced and the correct rotor is used. Use clean, sterile 1 L centrifuge vessels that correspond to the rotor, identified by the maximum speed (8000 rpm). L. Remove the supernatant by pouring the liquid into a clean waste beaker. Break up the pellet with a sterile spatula. For each centrifuge vessel (1 L vessel), resuspend the material in 0.75 L of water. Seal the centrifuge vessel lid and shake to resuspend the material. Pour back into the 4 L beaker for neutralization. M. Repeat the neutralization and centrifugation cycle until the pH remains within 6.8-7.2 for successive measurements after centrifugation and resuspension. N. Record the final pH and number of cycles. O. Centrifuge the material one last time to concentrate the mercerized material. P. Store samples refrigerated at 4°C.

[0181] In another embodiment of any of the above method(s), the hydrogen peroxide may be added as a 30% aqueous hydrogen peroxide solution.

[0182] In yet another embodiment of any of the above method(s), hydrogen peroxide for mercerization may be used in the following ratios: About 20 mL to about 5 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, for example, Approximately 20 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution; about 10 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, or Approximately 5 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution.

[0183] As will be understood, these ratios can be scaled up or down as needed to suit a particular application - the amounts listed are provided to indicate relative ratios rather than absolute amounts.

[0184] In yet another embodiment of any of the above method(s), the method may further comprise neutralizing the pH using one or more neutralization treatments. In another embodiment of any of the above method(s), the neutralization treatment may comprise treatment with an acidic solution, preferably aqueous HCl.

[0185] In yet another embodiment of any of the above method(s), mercerization may be carried out using a ratio of decellularized plant or fungal tissue:aqueous sodium hydroxide (m:v in g:L) of about 1:5 for 1 M aqueous sodium hydroxide, or an equivalent ratio for another aqueous sodium hydroxide concentration. As will be appreciated, these ratios can be scaled up or down as needed to suit a particular application—the amounts listed are provided to indicate relative ratios rather than absolute amounts.

[0186] In another embodiment of any of the above method(s), mercerization may be carried out for at least about 30 minutes, preferably about 1 hour.

[0187] In yet another embodiment of any of the above method(s), the resulting single structural cell or group of structural cells having a decellularized three-dimensional structure may be collected by centrifugation.

[0188] In yet another embodiment of any of the above method(s), the single structural cell, the group of structural cells, or both, are made from alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropyl cellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, extracellular matrix proteins (e.g., collagen), The hydrogel may be mixed or dispersed in a hydrogel comprising a cellulose derivative, a cellulose acetate hydrogel ...

[0189] In another embodiment of any of the above method(s), the method may further include: performing directional freezing of the mixture to introduce templated or aligned microchannels on a surface of the mixture, within the mixture, or both; molding the mixture using a mold having microscale features that contacts one or more surfaces of the mixture and / or the aerogel or foam resulting from dehydrating, lyophilizing, or freeze-drying the mixture to introduce templated or aligned microchannels; punching, pressing, stamping, or otherwise forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface of the mixture and / or the aerogel or foam before, during, or after dehydrating, lyophilizing, or freeze-drying the mixture; or any combination thereof.

[0190] Directional freezing, molding, and mechanical processing to impart microscale and / or macroscale structures to aerogels, foams, and / or hydrogels have already been described in detail herein above and are further described in the examples provided below.

[0191] In yet another embodiment of any of the above method(s), directional freezing may be performed by creating a thermal gradient across the mixture from one or more directions to form aligned ice crystals originating from the cold side(s) of the thermal gradient.

[0192] In yet another embodiment of any of the above method(s), the mixture may be directionally frozen for a period of at least about 30 minutes, preferably about 2 hours.

[0193] In another embodiment of any of the above method(s), the mixture can be directionally frozen by cooling to a temperature between about -190°C and about 0°C, for example, to a temperature of at least about -15°C, preferably about -25°C.

[0194] In yet another embodiment of any of the above method or methods, the step of dehydrating, lyophilizing, or freeze-drying the mixture to provide an aerogel or foam may include freezing the mixture and subsequently lyophilizing or freeze-drying the mixture.

[0195] In yet another embodiment of any of the above method(s), the method may include the further step of cross-linking the hydrogel, rehydrating the aerogel or foam, or both, optionally using a CaCl solution to provide cross-linking if an alginate or pectin or agar hydrogel is present.

[0196] As will be appreciated, a variety of techniques can be used for cross-linking, if desired, and can be selected based on the particular aerogel / foam / hydrogel and / or desired application(s). In certain embodiments, structural cells can be mixed with a single hydrogel or combination of hydrogels, with or without cross-linking. In certain embodiments, the mixture can then be frozen and subsequently lyophilized or freeze-dried to form the aerogel or foam.

[0197] In embodiments where optional crosslinking is desired, an exemplary list of hydrogels and a corresponding list of potential crosslinkers are provided below for illustrative, non-limiting purposes for those skilled in the art. While in certain embodiments, such crosslinking approaches may be used as needed, it should be understood that crosslinking may be optional, and the decision to crosslink or not may be made to suit the desired application(s) and the particular details or requirements thereof. In certain embodiments, combinations of hydrogels may be used with or without additional crosslinking. Various illustrative examples are provided in the Examples below, particularly Example 2.

[0198] [Table 1] JPEG2023549693000002.jpg162134

[0199] In another embodiment of any of the above method(s), the method may include the further step of culturing animal cells on or in the aerogel or foam. In certain embodiments, the method may include the further step of culturing muscle cells, fibroblasts, myofibroblasts, neurons, dorsal root ganglion cells, neuronal structures such as axons, neural progenitor cells, neural stem cells, glial cells, endogenous stem cells, neutrophils, mesenchymal stem cells, satellite cells, myoblasts, myotubes, muscle progenitor cells, adipocytes, preadipocytes, chondrocytes, osteoblasts, osteoclasts, preosteoblasts, tendon progenitor cells, tenocytes, periodontal ligament stem cells, or endothelial cells, or any combination thereof, on or in the aerogel or foam.

[0200] In another embodiment, provided herein is an aerogel or foam produced by any of the method(s) as described herein.

[0201] As will be appreciated, aerogels, foams, and / or hydrogels as described herein can be configured and / or used for a wide variety of different applications. By way of non-limiting example, in certain embodiments, it is contemplated that provided herein is the use of any of the aerogel(s) or foam(s) as described herein for bone tissue engineering, for templating or aligning cell growth, for regenerative medicine, for spinal cord injury repair, for food preparation, or any combination thereof.

[0202] In another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein to template or align the growth of cells. In certain embodiments, the cells may include muscle cells, nerve cells, or both.

[0203] In yet another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein for the repair of spinal cord injuries.

[0204] In another embodiment, provided herein is the use of any of the aerogel(s) or foam(s) as described herein as a thermal insulation or packaging foam.

[0205] In yet another embodiment, there is provided a method for bone tissue engineering or repair in a subject in need thereof, comprising: implanting either the aerogel(s) or foam(s) as described herein into the affected area in a subject in need thereof; As a result, methods are provided herein in which the aerogel or foam promotes bone tissue generation or repair.

[0206] In yet another embodiment, there is provided a method for templating or aligning the growth of cells, comprising: Culturing cells on either aerogel(s) or foam(s) as described herein, wherein the aerogel or foam comprises templated or aligned microchannels formed on at least one surface of the aerogel or foam, within the aerogel or foam, or both, optionally by directional freezing, by molding using a mold having microscale features, by punching, pressing, stamping, or by forming geometric patterns, depressions, holes, channels, grooves, ridges, wells, or other structural features in and / or on at least one surface, or by any combination thereof; As a result, methods are provided herein in which cultured cells align along microchannels.

[0207] In another embodiment of the above method, the cells may include muscle cells or nerve cells or both.

[0208] In yet another embodiment, there is provided a method of repairing spinal cord injury in a subject in need thereof, comprising: implanting either an aerogel(s) or foam(s) as defined herein into the affected site in a subject in need thereof, wherein the aerogel or foam optionally comprises templated or aligned microchannels formed by directional freezing; As a result, methods are provided herein in which aerogels or foams promote spinal cord repair by promoting and / or aligning neural cell growth along templated or aligned microchannels.

[0209] In another embodiment, provided herein is a food product comprising aerogel(s) or foam(s) as described herein, wherein the aerogel(s) or foam(s) are designed / selected to be food-safe and edible. In yet another embodiment, the food product may further comprise dyes or colorants, preservatives, flavorings, salt, marinades, or other food-related ingredients or agents as desired.

[0210] In yet another embodiment of any of the above food product(s), the food product may comprise two or more aerogel or foam subunits glued together. In certain embodiments, the glue may comprise agar.

[0211] In certain embodiments, food products can be designed or configured to mimic traditional meat products. By way of example, tuna, salmon, and similar fish are characterized by lines found scattered among the flakes of meat. These lines are due to the presence of fat (omega-3). Wild salmon typically have fewer, thinner white lines due to the fact that wild salmon typically consume more calories than farmed salmon. Similarly, their flesh is redder due to an increased blood supply. Thus, the presence of these white lines and their appearance and thickness will vary depending on the desired meat appearance to be achieved. An illustrative, non-limiting example of a protocol for producing these lines in an aerogel biomaterial as described herein may proceed as follows: A. Aerogel biomaterials are produced as detailed herein using a set concentration of mercerized apple material (structural cells) and a binder carrier such as alginate. B. The ingredients are mixed thoroughly and then poured into a container of the desired size and frozen overnight. C. The material is then freeze-dried to dryness. D. The material is then cross-linked (if combined with alginate or pectin or similar) with calcium chloride by adding enough calcium chloride to immerse the material and allowing it to fully hydrate for at least 30 minutes to an hour. E. The material is then cut from its container and prepared, which involves cutting the material to the desired dimensions. F. Cut the resulting material using a sharp knife, scalpel or microtome blade to achieve the appearance of tuna or salmon "lines." a. For the salmon sashimi imitation, cut the biomaterial into rectangular pieces and cut away the remainder of the material. b. Slight diagonal cuts are then made into the material at varying and scattered lengths (5mm to 1cm increments down the length of the piece) without cutting all the way through the material (approximately 3 / 4 deep). G. After cutting through the material, create white lines by combining another binder, such as 2% agar, with titanium dioxide powder. The proportions can vary depending on the desired appearance of the white color. Less than 0.1 g of titanium dioxide per 100 mL of agar is sufficient to achieve the white color. H. Premixed agar and titanium dioxide may then be spread or gently pipetted between the cuts in the wells made by the pre-cut lines made in step (F). I. Allow the material to solidify for a short time (approximately 3-5 minutes). J. If any agar overflows or is not enough, the lines may be corrected, shaped or cut after drying or during further drying. a. Be careful with the moisture content of the original scaffold material. A sample that is too wet may absorb too much of the agar or may prevent it from drying quickly. The sample is preferably hydrated, but not overly wet.

[0212] In yet another embodiment of any of the food products, the aerogel or foam may optionally include templated or aligned microchannels formed by directional freezing.

[0213] In certain embodiments, the aerogel or foam may optionally comprise muscle cells, fibroblasts, myofibroblasts, neurons, dorsal root ganglion cells, neuronal structures such as axons, neural progenitor cells, neural stem cells, glial cells, endogenous stem cells, neutrophils, mesenchymal stem cells, satellite cells, myoblasts, myotubes, muscle progenitor cells, adipocytes, preadipocytes, chondrocytes, osteoblasts, osteoclasts, preosteoblasts, tendon progenitor cells, tenocytes, periodontal ligament stem cells, or endothelial cells, or any combination thereof, aligned along the templated or aligned microchannels; preferably, the aerogel or foam optionally comprises templated or aligned microchannels formed by directional freezing, and the aerogel or foam comprises muscle cells, adipocytes, connective tissue cells (e.g., fibroblasts), cartilage, bone, epithelial, or endothelial cells, or any combination thereof, aligned along the templated or aligned microchannels.

[0214] In another embodiment, provided herein is the use of aerogel(s) or foam(s) as described herein in food products, wherein the aerogel(s) and / or foam(s) are designed / selected to be food-safe and edible.

[0215] In yet another embodiment, there is provided a method for preparing single structural cells, groups of structural cells, or both, from decellularized plant or fungal tissue, comprising: providing a decellularized plant or fungal tissue; obtaining single structural cells, groups of structural cells, or both from the decellularized plant or fungal tissue by performing mercerization of the decellularized plant or fungal tissue, and recovering the resulting single structural cells or groups of structural cells having a decellularized three-dimensional structure. Provided herein is a method comprising:

[0216] In yet another embodiment of the above method, mercerization may involve treatment of the decellularized plant or fungal tissue with a base and a peroxide, preferably with sodium hydroxide or another hydroxide base as the base and hydrogen peroxide as the peroxide.

[0217] In another embodiment of any of the above method(s), mercerization may involve treatment of the decellularized plant or fungal tissue with aqueous sodium hydroxide and hydrogen peroxide in the presence of heat.

[0218] In yet another embodiment of any of the above method(s), the decellularized plant or fungal tissue may be treated with aqueous sodium hydroxide for a first period of time, after which hydrogen peroxide is added to the reaction.

[0219] In yet another embodiment of any of the above method(s), the hydrogen peroxide may be added as a 30% aqueous hydrogen peroxide solution.

[0220] In yet another embodiment of any of the above method(s), hydrogen peroxide for mercerization may be used in the following ratios: About 20 mL to about 5 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, for example, Approximately 20 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution, about 10 mL of 30% hydrogen peroxide solution: about 100 g of decellularized plant or fungal tissue: about 500 mL of 1 M NaOH solution, or Approximately 5 mL of 30% hydrogen peroxide solution: approximately 100 g of decellularized plant or fungal tissue: approximately 500 mL of 1 M NaOH solution.

[0221] In yet another embodiment of any of the above method(s), the method may further comprise neutralizing the pH using one or more neutralizing treatments.

[0222] In another embodiment of any of the above method(s), the neutralization treatment may include treatment with an acidic solution, preferably aqueous HCl.

[0223] In yet another embodiment of any of the above method(s), mercerization may be carried out by heating to about 80°C.

[0224] In yet another embodiment of any of the above method(s), mercerization can be carried out using a ratio of decellularized plant or fungal tissue:aqueous sodium hydroxide (m:v in g:L) of about 1:5 for 1 M aqueous sodium hydroxide, or an equivalent ratio for another aqueous sodium hydroxide concentration.

[0225] In yet another embodiment of any of the above method(s), mercerization may be carried out for at least about 30 minutes, preferably about 1 hour.

[0226] In yet another embodiment of any of the above method(s), the resulting single structural cell or group of structural cells having a decellularized three-dimensional structure may be collected by centrifugation.

[0227] In yet another embodiment, provided herein is a single structural cell, a group of structural cells, or both, prepared by any of the method(s) as described herein.

[0228] Also provided herein are cellulose-based hydrogels that can have a variety of different applications. In certain embodiments, such cellulose-based hydrogels as described herein can be for use as hydrogels for preparing aerogels and / or foams as described herein, by way of non-limiting example.

[0229] In one embodiment, provided herein is a cellulose-based hydrogel comprising cellulose derived from decellularized plant or fungal tissue by dissolution with dimethylacetamide and lithium chloride, followed by regeneration with ethanol. An illustrative example of such dissolution is described in further detail in Example 3 below.

[0230] In yet another embodiment, there is provided a method for preparing a cellulose-based hydrogel, comprising: providing a decellularized plant or fungal tissue; dissolving the cellulose of the decellularized plant or fungal tissue by treatment with dimethylacetamide (DMAc) and lithium chloride (LiCl); and Cellulose-based hydrogels were regenerated from the dissolved cellulose by solvent exchange with ethanol. Thereby providing a cellulose-based hydrogel. Provided herein is a method comprising:

[0231] As will be appreciated, cellulose-based hydrogels can include hydrogels containing one or more cellulose or cellulose derivatives. Typically, the cellulose and / or cellulose derivatives can be obtained by dissolving the cellulose and / or cellulose derivatives from decellularized plant or fungal tissue. As will be appreciated, the cellulose and / or cellulose derivatives can alternatively, in certain embodiments, be obtained by dissolving non-decellularized plant or fungal tissue, although dissolving the cellulose and / or cellulose derivatives from decellularized plant or fungal tissue as described herein is preferred. The preparation of decellularized plant or fungal tissue has already been described in detail herein above and further described in the Examples below.

[0232] The cellulose and / or cellulose derivatives of decellularized plant or fungal tissue can be dissolved by treatment with DMAc and LiCl. An illustrative example of such a dissolution treatment is described in further detail in Example 3 below.

[0233] In another embodiment of the above method, solvent exchange with ethanol can be performed using a dialysis membrane or by adding ethanol on top of the dissolved cellulose to facilitate solvent exchange.

[0234] In yet another embodiment of any of the above method(s), the method may further comprise bleaching the cellulose-based hydrogel with hydrogen peroxide.

[0235] In yet another embodiment, provided herein is a cellulose-based hydrogel comprising cellulose derived from decellularized plant or fungal tissue by dissolution with dimethylacetamide and lithium chloride, LiClO, xanthogenic acid, EDA / KSCN, HPO, NaOH / urea, ZnCl, TBAF / DMSO, NMMO, ionic liquids (ILs) (e.g., 1-butylpyridinium chloride and aluminum chloride, alkylimidazolium with nitrates, preferably room temperature ionic liquids), or any combination thereof.

[0236] In yet another embodiment, there is provided a method for preparing a cellulose-based hydrogel, comprising: providing a decellularized plant or fungal tissue; Dimethylacetamide and lithium chloride, LiClO, xanthic acid, EDA / KSCN, HPO, NaOH / urea, ZnCl, TBAF / DMSO, NMMO, ionic liquids (ILs) (e.g., 1-butylpyridinium chloride and aluminum chloride, alkylimidazolium with nitrates, preferably room temperature ionic liquids; estimated 10 12 dissolving the cellulose of the decellularized plant or fungal tissue by treatment with an ionic liquid such as obtaining dissolved cellulose and using the dissolved cellulose to prepare a cellulose-based hydrogel; Provided herein is a method comprising:

[0237] Treatments for dissolving cellulose and / or cellulose derivatives in decellularized plant or fungal tissue can be designed or selected to suit the particular application(s) desired. Examples of agents that can be used to dissolve cellulose and / or cellulose derivatives in decellularized plant or fungal tissue can include, but are not limited to, dimethylacetamide and lithium chloride, LiClO, xanthic acid, EDA / KSCN, HPO, NaOH / urea, ZnCl, TBAF / DMSO, NMMO, ionic liquids (ILs) (e.g., 1-butylpyridinium chloride and aluminum chloride, alkylimidazolium with nitrates, preferably room temperature ionic liquids), or any combination thereof.

[0238] In another embodiment, provided herein is a cellulose-based hydrogel prepared by any of the method(s) as described herein.

[0239] In another embodiment of any of the aerogel(s) or foam(s) as described herein, the hydrogel may comprise any of the cellulose-based hydrogel(s) as described herein.

[0240] In yet another embodiment, provided herein is a food product comprising any of the aerogel(s) or foam(s) or structural cell(s) as described herein, wherein the food product is a meat imitation and comprises a plurality of lines that provide the appearance of fatty white lines found in tuna, salmon, or another fish-based meat.

[0241] In yet another embodiment of the above food product, the food product may be a tuna, salmon, or other fish imitation.

[0242] In yet another embodiment, provided herein is a food product comprising any of the aerogel(s) or foam(s) or structural cell(s) as described herein, wherein the food product is a meat simulant and may include a plurality of lines or other patterns that provide the appearance of fatty material or fatty deposits found in natural meat.

[0243] In yet another embodiment of the above food product, the food product may be a mimic of poultry, beef, fish, or pork, or any other suitable meat, hi certain embodiments, the food product may be, for example, a mimic of steak, chicken, pork, or another such meat.

[0244] In another embodiment of any of the above food products or foods, the food product may contain one or more dyes or colorants that provide the color of tuna, salmon, or other fish or meat.

[0245] In yet another embodiment of any of the above food product(s), a plurality of lines may be formed in the cuts or channels formed in the aerogel or foam.

[0246] In yet another embodiment of any of the above food product(s), the plurality of lines may comprise titanium dioxide, optionally in combination with an agar binder or another such binder.

[0247] In another embodiment of any of the above food product(s), titanium dioxide, optionally in combination with an agar binder, can be applied in cuts or channels formed in the aerogel or foam to provide the appearance of fatty white lines found in tuna, salmon, or other fish or meat.

[0248] In another embodiment, there is provided a method of preparing a food product that is a tuna, salmon, or other fish imitation or another meat imitation, comprising: Providing either an aerogel(s) or foam(s) as described herein; Optionally, dyeing or coloring the aerogel to the color of tuna, salmon, or other fish or meat; cutting or processing the aerogel to form cuts or channels along the surface of the aerogel; and applying a dye or colorant to the cuts or channels to provide the appearance of fatty white lines characteristic of tuna, salmon, or other fish or other meats; Provided herein is a method comprising:

[0249] In another embodiment of the above method, the dye or colorant provided in the cuts or channels may include titanium dioxide.

[0250] In yet another embodiment of any of the above method(s), the dye or colorant applied to the cuts or channels may be combined with a binder.

[0251] In yet another embodiment of any of the above method(s), the binder may comprise agar.

[0252] In another embodiment, provided herein is a food product prepared by any of the method(s) described herein.

[0253] In another embodiment, provided herein is a non-absorbable dermal filler comprising an aerogel, a foam, a structural cell, or a cellulose-based hydrogel as described herein, or any combination thereof.

[0254] In yet another embodiment, provided herein is a dermal filler comprising a single structural cell, a group of structural cells, or both, derived from plant or fungal tissue, wherein the single structural cell or the group of structural cells has a decellularized three-dimensional structure devoid of cellular material and nucleic acids of the plant or fungal tissue, and wherein the single structural cell, the group of structural cells, or both are obtained from the plant or fungal tissue by mercerization.

[0255] In another embodiment of any of the above dermal filler(s), the dermal filler may further comprise a carrier fluid or gel.

[0256] In yet another embodiment of any of the above dermal filler(s), the carrier fluid or gel may comprise water, an aqueous solution, or a hydrogel.

[0257] In yet another embodiment of any of the above dermal filler(s), the carrier fluid or gel may comprise a saline solution or a collagen-, hyaluronic acid-, methylcellulose-, and / or dissolved plant-derived decellularized cellulose-based hydrogel.

[0258] In another embodiment of any of the above dermal filler(s), the dermal filler may further comprise an anesthetic.

[0259] In yet another embodiment of any of the above dermal filler(s), the anesthetic agent may include lidocaine, benzocaine, tetracaine, porocaine, epinephrine, or any combination thereof.

[0260] In another embodiment of any of the above dermal filler(s), the dermal filler may include PBS (physiological saline), hyaluronic acid (crosslinked or non-crosslinked), alginate, collagen, pluronic acid (e.g., Pluronic F127), agar, agarose or fibrin, calcium hydroxylapatite, poly-L-lactic acid, autologous fat, silicone, dextran, methylcellulose, or any combination thereof.

[0261] In another embodiment of any of the above dermal filler(s), the dermal filler may comprise at least one of 2% lidocaine gel, triple anesthetic gel comprising 20% ​​benzocaine, 6% lidocaine, and 4% tetracaine (BLTgel), 3% benzocaine, or a mixture of 2% lidocaine with epinephrine.

[0262] In another embodiment of any of the above dermal filler(s), the structural cells may have a size, diameter, or minimum Feret's diameter of at least about 20 μm.

[0263] In another embodiment of any of the above dermal filler(s), the structural cells may have a size, diameter, or maximum Feret's diameter of less than about 1000 μm.

[0264] In yet another embodiment of any of the above dermal filler(s), the structural cells may have a size, diameter or Feret's diameter distribution within the range of about 20 μm to about 1000 μm.

[0265] In yet another embodiment of any of the above dermal filler(s), the structural cells may have a particle size, diameter, or Feret's size distribution with a peak of about 200-300 μm.

[0266] In another embodiment of any of the above dermal filler(s), the structural cells may have an average particle size, diameter or Feret's diameter, within the range of about 200 μm to about 300 μm.

[0267] In another embodiment of any of the above dermal filler(s), the structural cells are between about 30,000 and about 75,000 μm 2 The grains may have an average projected grain area in the range of

[0268] In yet another embodiment of any of the above dermal filler(s), the dermal filler can be sterilized.

[0269] In yet another embodiment of any of the above dermal filler(s), sterilization may be by gamma sterilization.

[0270] In yet another embodiment of any of the above dermal filler(s), the dermal filler may be formulated for subdermal injection, deep dermal injection, subcutaneous injection (e.g., subcutaneous fat injection), or any combination thereof.

[0271] In another embodiment of any of the above dermal filler(s), the dermal filler may be provided in a syringe or injection device.

[0272] In another embodiment, provided herein is the use of any of the dermal filler(s) as described herein as a soft tissue filler, for reconstructive surgery, or both.

[0273] In another embodiment, provided herein is a use of any of the dermal filler(s) as described herein for improving the cosmetic appearance of a subject in need thereof.

[0274] In another embodiment, provided herein is the use of any of the dermal filler(s) as described herein for increasing tissue volume, smoothing wrinkles, or both, in a subject in need thereof.

[0275] In another embodiment, a method for improving cosmetic appearance, increasing tissue volume, smoothing wrinkles, or any combination thereof in a subject in need thereof, comprising: administering or injecting any of the dermal filler(s) as described herein into the area in need thereof; thereby improving the cosmetic appearance of the subject, increasing tissue volume, smoothing wrinkles, or any combination thereof. A method is provided herein.

[0276] In another embodiment of the above use(s) or method(s), the subject's native cells may infiltrate the dermal filler.

[0277] In yet another embodiment of the above use(s) or method(s), the dermal filler may be non-absorbable such that the decellularized plant or fungal tissue remains substantially intact within the subject.

[0278] Further details related to plant-derived dermal fillers are described in U.S. Provisional Patent Application No. 63 / 036,126, entitled "Dermal Fillers," which is incorporated herein by reference in its entirety. [Example] [Example 1]

[0279] Aerogels prepared from decellularized plant tissue Plant-derived scaffolds can provide desirable biological / physical properties (e.g., in vitro / in vivo biocompatibility), can be easily produced, and can provide fixed mechanical / structural properties. However, many plant-derived scaffolds do not offer a significant level of control over parameters such as surface biochemistry, tunable mechanical properties, tunable micro / macro-scale architecture, and / or scalable production methods.

[0280] This example describes the development of plant-derived scaffolds focused on providing one or more (or all) of the following characteristics: derived from decellularized plant material; ability to retain desired plant microarchitecture; amendable to scalable production method(s); ability to provide a wide range of scaffold biochemistries; ability to provide tunable mechanical properties; ability to provide tunable porosity; in vitro biocompatibility; in vivo biocompatibility; and / or stable during cooking conditions (if food applications are desired).

[0281] This example describes the development of scaffolds that meet all of the above characteristics. In this example, these scaffold materials are prepared by first decellularizing plant material, followed by a mercerization process in which the decellularized material is treated at high temperature under basic conditions to separate the plant tissue into single, intact, decellularized plant structural cells (or groups of structural cells containing small clusters of connected structural cells). A strong oxidizing agent is then introduced to whiten the resulting cell slurry. Whitening is performed to produce a final product that provides a blank canvas for various applications where coloration may be desired (e.g., in food). The slurry is then neutralized and centrifuged, resulting in a thick paste containing a high concentration of decellularized plant structural cells. This resulting product may then be mixed with a variety of hydrogels with varying biochemical properties to produce complex hydrogel mixtures. At this point, the hydrogel can be placed into a large mold and freeze-dried to produce the final product in the form of a lightweight, stable, large-format aerogel or foam. A library of these aerogels or foams with varying mechanical, structural, and biochemical properties was created in this example that may be useful for a variety of different applications. Furthermore, upon (re)hydration, the aerogels and foams (also referred to herein as hydrogels upon rehydration with a liquid, most often water or an aqueous solution) can be further crosslinked and / or further modified for downstream uses.

[0282] Materials and Methods: The process used to produce the aerogel formulation of this example is as follows:

[0283] Decellularization: Decellularization of plant tissue was performed as described in PCT Patent Publication WO 2017 / 136950, entitled "Decellularized Cell Wall Structures From Plants and Fungus and Use Thereof as Scaffold Materials," which is incorporated herein by reference in its entirety. A 5-day protocol was used as follows: Day 1: Apples were peeled and then sliced ​​with a mandolin to a thickness of 1 mm. The slices were added to a 4 L beaker with 0.1% SDS solution and shaken at 130 RPM. Appropriate lot numbers were assigned and batch manufacturing records were maintained. Day 2: The 0.1% SDS solution was removed from the beaker and replaced with fresh 0.1% SDS solution. Shaking was resumed at 130 RPM. Day 3: The 0.1% SDS solution was removed from the beaker and replaced with fresh 0.1% SDS solution. Shaking was resumed at 130 RPM. Day 4: The 0.1% SDS solution was removed from the beaker and replaced with fresh 0.1M CaCl2 solution. Shaking was resumed at 130 RPM. Day 5: The 0.1 M CaCl2 solution was removed and the contents were washed three times with 1 L of sterile water. After removing the water, the beaker was filled with 1 L of 70% ethanol and incubated for 30 minutes. Finally, the ethanol was removed and the contents were washed three times with 1 L of sterile water.

[0284] Mercerization: Mercerization was most often performed on day 5 of the above protocol after a final wash with sterile water. However, the product obtained from the day 5 step could alternatively be stored refrigerated until needed. Typically, the decellularized plant material used in these studies was stored refrigerated for no more than two weeks, but it is anticipated that such plant material could be stored longer if necessary or desired. Freezing the decellularized plant material or lyophilizing it is also a step that could be considered for preserving the day 5 product, but this was not typically performed in these studies.

[0285] In this example, mercerization was carried out as follows: Day 5 (continued): Mercerization was performed as follows: Important chemicals and solutions: Sterile water (Baxter, catalog number JF7624) Sodium hydroxide (Acros Organics 259860010) Hydrochloric acid (Fisher, CAS 7732-18-5) Hydrogen peroxide (30% aqueous solution, Fisher Chemical, CAS 7722-84-1) Tools and materials: Draft 4L beaker pH meter Label stickers Centrifuge: 1L capacity, 8000rpm. · Sterile sieve for initial water removal. Procedure: The following protocol was followed: Clean the work station with Accel TB solution and then with 70% ethanol. Manually press the water out of the decellularized material using a sterile sieve placed over a waste beaker. Divide into 500g portions using a balance. All handling is performed using sterile surgical gloves and aseptic technique in a biosafety cabinet. Place 500g of material into a clean, sterile 4L beaker. Add 2.5 L of 1 M NaOH to the beaker. Raise the temperature to 80°C. Add 125 mL of 30% hydrogen peroxide. Note: This 30% hydrogen peroxide solution is the stock concentration. Simply add the stock to make it 30%. Place a clean, sterile magnetic stir bar into the beaker. Stir at 80°C for 1 hour. Ensure that the stirring is adequate to provide movement of the material but not scattering. Check to make sure the color is clear or off-white. If it is still yellow, allow the reaction to proceed until the color disappears. Turn off the heat and remove the beaker from the heat source. Allow the solution to cool to room temperature. Using a pH meter, neutralize the solution with stock HCl until the pH is 6.8-7.2. Record the pH value. Centrifuge the material at 8000 rpm for 15 minutes. Ensure the centrifuge is properly balanced and the correct rotor is used. Use clean, sterile 1 L centrifuge vessels that correspond to the rotor, identified by the maximum speed (8000 rpm). Remove the supernatant by pouring the liquid into a clean waste beaker. Manually break up the pellet using a sterile spatula. Resuspend the material in 0.75 L of water for each centrifuge vessel (1 L vessel). Seal the centrifuge vessel lid and shake to resuspend the material. Pour back into the 4 L beaker for neutralization. Repeat the neutralization and centrifugation cycle until the pH remains within 6.8-7.2 for successive measurements after centrifugation and resuspension. Record the final pH and number of cycles. · Finally, the material is centrifuged one more time to concentrate the mercerized material. Discard the supernatant and transfer the pellet of mercerized material to a sterile 50 mL Falcon tube. · Proper labeling and identification of container contents. Store the sample refrigerated at 4°C.

[0286] result: The results are shown in Figures 1-4.

[0287] Figure 1 shows the results of AA (apple) mercerization and discoloration in a smaller sample of AA (100 g in the image). 100 g of decellularized AA (apple) material was mercerized in 500 mL of 1 M NaOH at 80 °C for 1 hour. A total of 75 mL of HO was added throughout the mercerization process to discolor the sample (the reaction formed NaO (sodium peroxide), a strong oxidizing agent). Figure 1(A) shows the AA sample in NaOH (T = 0 min). Figure 1(B) shows the AA sample in NaOH immediately after the addition of 25 mL of HO. The discoloration process began immediately after the addition (T = 2 min). In Figure 1(C), the sample appears yellowish (T = 10 min). In Figure 1(D), the AA sample appears off-white 60 min after mercerization in NaOH and HO addition.

[0288] Figure 2(A) shows the decellularized AA tissue used as the starting material for the mercerization process. Figure 2(B) shows the product obtained after mercerization. The product is shown after follow-up neutralization and centrifugation. The resulting product material shown in Figure 2(B) is extremely thick and viscous, resembling a type of apple "paste."

[0289] Figure 3 shows images of decellularized single structural cells (and some groups of structural cells containing a few single structural cells linked together) from apples obtained / isolated after mercerization. In Figure 3, dilution and fluorescent staining of the structural cells with Congo Red dye showed that the cellular microarchitecture was intact.

[0290] Figure 4 shows the particle size distribution of mercerized (1 M NaOH) decellularized AA with added HO (N=10 analyzed images). The average size confirms the presence of intact, single-structure cells that maintain their microarchitectural features.

[0291] In a study to determine the yield of material after drying, seven samples were prepared from the mercerized material prepared as described immediately above, each with an initial mass of 1 g. After freeze-drying, the samples were recovered and the dry mass was weighed; the average mass was 0.052±0.005 g, or approximately 5%, indicating that the mercerized paste was approximately 95% water.

[0292] Mercerization: Optimization Based on several experiments and observation and analysis of the results, several preparation steps in the above procedure were determined / optimized.

[0293] First, traditional mercerization / maceration protocols used for other applications often involve adding H2O2 at the beginning of the process using a base / acid (mercerization / maceration, respectively). In this study, we now know that early use of peroxide can cause a highly exothermic reaction, which can make the solution more difficult to handle, and importantly, the reaction produces significantly more foam. By leaving the peroxide step later in the mercerization process, we now know that less foam was produced. Furthermore, if the peroxide was left at the end of the processing steps, less foam and gas buildup would occur during the subsequent neutralization and centrifugation steps.

[0294] Second, studies were conducted to determine the optimal amount of NaOH to be used in the reaction, currently set at a 1:5 ratio of AA:NaOH (mass:volume, e.g., 500 g:2.5 L). To evaluate these ratios, a series of experiments was conducted to determine the minimum ratio of AA material to sodium hydroxide solution (NaOH) that would result in properly mercerized AA. Three different ratios were tested using a mercerization protocol (i.e., 1:1, 1:2, and 1:5); all samples were mercerized at 80°C for 60 minutes, then neutralized and centrifuged until a stable pH was achieved. The protocol was as follows: 1. Three portions of decellularized AA were weighed: 20 g, 50 g, and 100 g. All AA (apple) material was pressed to remove excess water. 2. Fill three 1 L beakers with 100 mL of 1 M NaOH and place on a magnetic stir plate. 3. All solutions were heated to 80°C, then a stir bar and a portion of decellularized AA was added to each, labelling appropriately to correspond to the weight of AA added. 4. 5 mL of 30% hydrogen peroxide (H2O2) was added to each beaker. 5. All three solutions were stirred at 80° C. for 1 hour. 6. After mercerization, all beakers were removed from their respective hot plates and allowed to cool completely. 7. Once cooled, all three solutions were neutralized separately until a neutral and stable pH was obtained and centrifuged. 8. The three conditions tested (i.e., 20 g AA in 100 mL NaOH, 50 g AA in 100 mL NaOH, and 100 g AA in 100 mL NaOH) were stored separately in their respective 50 mL Falcon tubes and kept refrigerated for microscopy. 9. For particle analysis, each of the three AA vs. NaOH conditions was resuspended in distilled water, stained with Congo red for 10 minutes, and then mounted on a microscope slide. Slides were imaged using a fluorescent microscope (BV light filter) using a 10.SZX16 Olympus microscope and saved for further analysis using ImageJ software.

[0295] Figure 5 shows the color change of the AA-NaOH solution throughout 60 minutes of mercerization for all three ratio conditions (i.e., 20 g, 50 g, and 100 g of AA in 100 mL of 1 M NaOH). Figure 6 shows that after mercerization in the various solutions, isolated single AA cells were imaged and their Ferret diameters were measured. The results show that there were no significant differences in the average size, number, and distribution of mercerized cells isolated under each condition.

[0296] A 1:1 solution of AA:NaOH was able to process the most amount of decellularized AA and was therefore the most efficient, but not the optimal approach under the conditions tested. At a 1:1 dilution, the solution became extremely concentrated, requiring more peroxide and leading to foaming difficulties. Therefore, it was determined that a workable, safely scalable solution was preferred for generating raw mercerized material in these studies, and a 1:5 dilution was the preferred approach.

[0297] Fabrication of aerogels, foams, and hydrogels (Relevant experimental results for the preparation of aerogels, foams, and hydrogels are also described in Example 2 below.) It is contemplated that the process for producing mercerized apple "paste" as described herein may offer various advantages. First, this raw product can be produced entirely through liquid-based steps from start to finish. Except for the initial peeling of the apples and preparation for decellularization (a process for which automated industrial equipment is available), all further steps can be carried out in liquid solution on a large scale, if necessary. This can provide for the production of large quantities of validated raw products of decellularized plant-tissue-derived structural cells with intact microarchitecture (single-cell units), as opposed to fully dissolved cellulose. Second, protocols have been developed and are described herein for blending the raw product with other hydrogels to create composite biomaterials with controllable structural properties.

[0298] Freezing and freeze-drying methods have been developed and described herein that allow for control of the architecture of materials that, when mixed and dispersed in hydrogels, can be used to produce highly porous, ultralightweight, dry "foams" and "aerogels." Aerogel and foam formats are advantageous and desirable because they can be highly stable, can be stored under vacuum, can be extremely light, and can possess mechanical properties relevant to tissue engineering (e.g., tens to hundreds of kPa). Furthermore, it is contemplated that they can then be rehydrated to a hydrogel form while maintaining their structural integrity for use in biological contexts.

[0299] Further materials are provided in the preparation of aerogels, foams, and hydrogels in Example 2 below. Results of some such aerogel preparations, as prepared in this example, are shown in Figures 7-9. Figure 7 shows images of aerogels containing single structural cells, groups of structural cells, or both obtained from apple tissue decellularized by mercerization. The single structural cells, groups of structural cells, or both are dispersed within a carrier, which is derived from a freeze-dried hydrogel, in this case, a 5% alginate hydrogel. In this example, the single structural cells, groups of structural cells, or both were mixed with a 5% alginate hydrogel, and the mixture was then frozen in a mold and subsequently freeze-dried to provide the aerogel shown, which is 6 cm in diameter and 0.7 cm thick. Figure 8 shows a microscopic image of an aerogel similarly prepared, this time using a 50% alginate hydrogel (scale bar = 500 μm). FIG. 9 shows the cross-linked hydrated morphology of a similar aerogel prepared using 50% alginate hydrogel; the hydrated aerogel (also referred to herein as hydrogel or hydrogel composite) is approximately 1 cm in diameter and 4 mm thick.

[0300] Aerogel, Foam and Hydrogel Application Examples bone tissue engineering Given the highly porous nature of aerogels, foams, and hydrogels and their similarity to bone tissue, it is contemplated that the aerogels, foams, and hydrogels described herein can be used for bone tissue engineering. Ongoing small-scale calvarial defect studies evaluating the utility of alginate- and pectin-based rehydrated aerogels (containing decellularized single structural cells and / or clusters of structural cells as described) in bone tissue engineering support such applications. SEM and optical imaging of aerogel scaffolds are further described in Example 2 below. The generation and short-term stability of scaffolds for bone repair are also further described in Example 12 below.

[0301] Food Application and Cooking Various food formulations have also been developed and cooking tests are being conducted. Results of ongoing research indicate that rehydrated aerogel can be colored using beet juice and / or food dyes.

[0302] Results also show that the rehydrated aerogel can be pan-fried with butter. Formulations using alginate have been tested (further testing is currently underway) and results obtained so far show that the shape is stable, a crisp exterior is produced, and what appears visually to be a robust / solid interior has been observed.

[0303] It is further contemplated that composite materials can be produced by "gluing" aerogel scaffolds together to create larger structures. Agar has been tested as an adhesive, with favorable results.

[0304] Modification of these materials to add amine groups to the cellulose and / or cellulose derivatives is also contemplated. The chemistry of the initial glycine-based modification is described in Example 3 below. One purpose of adding this functional group to the material may be to utilize the enzyme transglutaminase (also known as "meat glue"). This could offer the possibility of using edible meat glue (transglutaminase) to bond aerogel scaffolds to each other or to large formats together with sections of real meat, with the potential to control a long range of structure, mechanical properties, and / or other related properties.

[0305] Figure 10 shows an example of a hydrated aerogel as described herein (in this example, alginate-based) on a frying pan with butter at the beginning of cooking. Figure 11 shows the same aerogel after several minutes of cooking; it can be seen that the aerogel has maintained its shape and integrity and that a crust has formed. Figure 12 shows a comparison of "raw" (left) and cooked (right) aerogels.

[0306] Directional freezing to create structural features in aerogels, foams, and hydrogels Directional freezing approaches are described in more detail below. These approaches can, for example, provide muscle cell templates for growth into aligned myotubes on aerogel scaffolds. It is contemplated that directional freezing can be used to generate structural features in aerogels, foams, and hydrogels, which may be useful for a variety of applications, including, for example, spinal cord repair. While directional freezing is primarily described below in terms of directional freezing in one direction, it will be understood that directional freezing in multiple directions can also be used as needed to provide various configurations of structural features. Typically, directional freezing is achieved by placing a container containing the solution to be frozen on a cold plate that ensures that ice crystals form at one end and grow linearly away from the cold end. However, it is also contemplated to begin the freeze-casting process in this manner and slowly move the container so that the position of the cold side changes over time. Conversely, the cold plate itself can be moved to a different position above the container to nucleate different groups of ice crystals that grow in a different direction than the initial setting. In yet another embodiment, the vessel may have two or more cold plates attached, which can be turned on simultaneously or at different points during the freezing process to, for example, create highly complex yet controlled architectures in the resulting aerogel.

[0307] The directional freezing approach has been utilized in polymer science applications and is contemplated herein as a strategy for creating aligned biomaterials for, for example, tissue engineering applications. By creating a larger thermal gradient on one side of the hydrogel, straight, highly aligned ice crystals can be formed from the cold side. This can cause surrounding hydrogel polymer to form around the ice crystals, creating aligned microscale channels. After freeze-drying the resulting material, a scaffold with numerous microchannels can be created.

[0308] To achieve directional freezing in this example, a custom-built device was designed around the Peltier module. Briefly, a Phanteks CPU cooler (PH-TC14PE) with a 140 mm fan was used to extract heat and placed in an upside-down configuration (any similarly large CPU cooler and fan could potentially be used). The Peltier element (TEC-12706) was placed on the CPU block, hot side down and cold side up. Finally, a 4 x 4 inch copper plate was then attached on top of the Peltier element to provide an efficient cooling surface. Thermal compound (Arctic MX-4) was placed between each interface to ensure efficient heat transfer.

[0309] The Peltier element was sourced from AEP's collection of parts. Based on its power draw (12V / 4.2A), it is assumed to be a TEC-12706 element, but there was no code on the element itself. Finally, a k-type thermocouple was embedded on the bottom side of the copper plate as close as possible to the Peltier element to track the temperature and freezing rate.

[0310] To power the device, 12V was supplied directly to the Peltier element and also to a voltage step-down converter. The step-down converter was used to provide 12V to the fan. This allows for the eventual use of a higher voltage to drive the Peltier while only supplying 12V to the fan.

[0311] Figure 13 shows an image of the custom-built directional freezing apparatus, and Figure 14 shows a schematic diagram of the directional freezing apparatus. Because Peltier elements can reach lower temperatures when the ambient temperature is lower, for the purposes of this study, the device itself was operated in a refrigerator. The device was allowed to cool and equilibrate for several hours. The copper plate reached an initial temperature of approximately 5°C. For initial testing (no material on the copper plate), power was supplied using a 12V / 10A power supply. Within approximately 15 minutes, the temperature of the copper plate reached approximately -20°C. After one hour, the plate was equilibrated at approximately -25°C.

[0312] Mixing or dispersing single structural cells, groups of structural cells, or both (obtained from mercerized decellularized plant tissue) with a hydrogel to provide a mixture: Alginate hydrogels were prepared by autoclaving alginate powder in dH2O at a concentration of 5% (w / v). The final alginate concentration was 1%. A composite biomaterial gel was produced containing 7.5 g of mercerized apple (i.e., single structural cells, clusters of structural cells, or both obtained from mercerized decellularized apple tissue), 3 mL of 1% alginate, and 4.5 mL of water. The alginate hydrogel and composite biomaterial gel were mixed using two 50 mL syringes connected with a f / f Luer-lock connector. The mixture was pumped back and forth 30 times. The syringe mix is ​​shown in Figure 15.

[0313] Freezing and dehydrating, lyophilizing or freeze-drying the mixture to provide an aerogel or foam: To create a container for directional freezing, the tip of a 15 mL Falcon tube was cut off and the cap end was tightly sealed with a double layer of Parafilm. This allowed the prepared hydrogel mixture to be delivered through the open top end, while the bottom end remained on top of the copper plate. The Parafilm layer ensured an extremely thin interface between the cold surface and the gel. In this case, approximately 3–4 mL of hydrogel mixture was delivered into the tube (approximately 3 cm high when standing vertically). The tube was first cooled in the refrigerator on the copper plate for at least 1 hour, and then the power was turned on. After cooling, the device was powered for 2 hours to allow time for the entire sample to freeze. Upon freezing, linear features were observed in the frozen material, but they were difficult to photograph. After freezing, the tube was immediately placed in a freeze dryer and operated for 36 hours. The resulting aerogel sample was removed and a porous biomaterial was observed. Multiple images were taken.

[0314] It was subsequently determined that additional freezing prior to freeze-drying was beneficial. Specifically, after freezing in the directional freezer, the samples were placed in a -20°C freezer overnight to ensure the entire sample was frozen. The samples were then freeze-dried the following day. This approach ensured that the resulting aerogels and foams did not collapse.

[0315] Figures 16-18 show images of the resulting aerogels produced after freeze-drying. Figure 16 shows a top view of the aerogel still in the Falcon tube, where the porous structure is observable. Figure 17 shows images of two aerogels after they were removed from the Falcon tube. Figure 18 shows an aerogel obtained without additional freezing after directional freezing and before freeze-drying (left), where the aerogel collapsed during freeze-drying, and an aerogel that was subjected to additional freezing overnight in a -20°C freezer after directional freezing and before freeze-drying, where no collapse was observed. The scaffolds shown are approximately 3 cm high.

[0316] result Optical microscopy and SEM were performed. Two scaffold sections, perpendicular or parallel to their long axes, were prepared, then cross-linked / rehydrated in 0.1 M CaCl2 and imaged by optical microscopy or SEM. Figure 19 shows a reflected light image of the entire aerogel cross section (1x condenser, 0.75x magnification). Figure 20 shows a bright-field cross section perpendicular to the axis of the cylinder (stereomicroscope 2x condenser, 1.25x zoom). Figure 21 shows a bright-field cross section parallel to the axis of the cylinder (stereomicroscope 2x condenser, 1.25x zoom). Figure 22 shows a dark-field cross section perpendicular to the axis of the cylinder (stereomicroscope 2x condenser, 1.25x zoom). Figure 23 shows a dark-field cross section parallel to the axis of the cylinder (stereomicroscope 2x condenser, 1.25x zoom). Figure 24 shows an SEM cross section perpendicular to the axis of the cylinder, showing the microchannels. Figure 25 shows an SEM cross section perpendicular to the axis of the cylinder showing the microchannels. Figure 26 shows an SEM cross section perpendicular to the axis of the cylinder. Figure 27 shows an SEM cross section perpendicular to the axis of the cylinder. Figure 28 shows an SEM cross section parallel to the axis of the cylinder showing long range alignment. Figure 29 shows an SEM cross section parallel to the axis of the cylinder. Figure 30 shows an SEM cross section parallel to the axis of the cylinder. Figure 31 shows an SEM cross section parallel to the axis of the cylinder.

[0317] Figure 32 shows images of a dried aerogel section (left) and a rehydrated aerogel section treated with 0.1 M CaCl (right). The images were taken at approximately the same height and magnification. The aerogel section remained intact, maintained its microstructure, and could be picked and manipulated. In this case, rehydration with CaCl solution crosslinked and stabilized the alginate in the rehydrated aerogel (right).

[0318] Other approaches to directional freezing were also attempted. Another device was custom-built in a manner nearly identical to the device described above. However, the Peltier element was removed, along with all electronics and the fan. The passive directional freezer was then placed inside a Styrofoam box, and liquid nitrogen was poured in so that it only covered the CPU cooler fins. In this embodiment, the LN2 draws heat from the copper surface on which the sample rests, via the CPU cooler's heat fins and heat pipes. The plate temperature reaches approximately -130°C within a few minutes, and the sample freezes in approximately 15 minutes, compared to 2 hours with the original device. The freezing apparatus is depicted in Figure 33.

[0319] Figure 34 shows three formulations of aerogels prepared in either A) PBS, B) 0.9% saline, or C) water as the solvent to assess whether salt alters ice crystal formation and channel alignment / architecture during directional freezing (scale bar = 2 mm, applies to all). In all cases, aligned channels were not observed because the material froze rapidly and without significant ice crystal formation. This process resulted in a very dense, soft foam.

[0320] Figure 35 shows (A) a water-based alginate mixture directionally frozen in the LN2 system (scale bar = 2 mm). The scaffolds were very dense, soft, and appeared homogeneous to the naked eye. This was in stark contrast to the scaffolds produced with the Peltier-based directional freezing platform described above, where the channeled architecture was clearly visible to the naked eye. However, as shown in (B) at higher resolution (scale bar = 200 μm), the small pore size of the scaffolds becomes visible, creating opportunities for cell infiltration as well as several other potential applications, for example, in tissue engineering and food science.

[0321] The results show that the very rapid freezing achieved with LN2 prevented the creation of large, long-range ice crystals and therefore prevented the hydrogel mixture from organizing into channeled, aligned structures. The result is a dense, highly uniform aerogel scaffold. It is contemplated that amorphous, uniform scaffolds created in this manner may be useful, for example, in tissue engineering and food applications. These results further expand the catalog of potential scaffold architectures, offering additional tunable options and material properties that can be used in a variety of applications.

[0322] Based on the arbitrarily selected results herein, it is contemplated that directional freezing can be used to impart microstructure to aerogels, foams, and hydrogels as described herein, which may provide a variety of beneficial properties for a variety of different applications.

[0323] As an example, directional freezing can be used to provide aerogels, foams, and / or hydrogels for use in spinal cord repair. In certain embodiments, it is contemplated that the aligned structures produced by controlled directional freezing (as in the first method above using Peltier) may result in a biocompatible scaffold that may be particularly well suited for spinal cord repair by providing directional microchannels for aligning / directing spinal cord cells after implantation of the aerogel, promoting healing. Such aerogel scaffolds can be produced in a scalable, controllable manner.

[0324] As another example, directional freezing can be used to provide aerogels, foams, and / or hydrogels for use in various food applications. It was further observed that when the same hydrogel mixture described above was placed in a larger format container (e.g., a 60 mm diameter Petri dish) that was shallower and wider than a Falcon tube, long-range alignment tended to occur parallel to the surface of the freezing plate. This is an unexpected result and may be desirable for some applications. For example, in this case, the creation of large, flat "sheets" of material with long-range alignment parallel to the plane of the sheet may be desirable for applications in cultivated meat and plant-based meat, for example. In these applications, it is contemplated that cells will align with the structure in the aerogel / hydrogel scaffold to create cultivated muscle tissue that more closely resembles real tissue. Furthermore, these highly structured scaffolds may also have structural and mechanical properties similar to real meat and / or may be valuable for solely plant-based meat. Additionally, in certain embodiments, it is contemplated that cultured and solely plant-based scaffolds can be produced and combined with real meat to provide, for example, a new class of meat substitute products that are partly plant-based and partly animal-based.

[0325] As yet another example, it is contemplated that fine-tuning the formulation used in directional freezing can provide further control over the resulting structural features in the aerogel / foam. For example, it is contemplated that including various salts in the formulation can be used to alter and potentially control the microarchitecture of the aligned structural features by enhancing ice crystal formation. It is also contemplated that a channeled mold can be used to form aligned structures around pillars, which can then be removed from the scaffold to impart larger sizes to the channel array. Alternatively, or in addition, it is contemplated that pressurizing a needle array through a scaffold can be used to create alternative channel sizes that complement, for example, the aligned structures from directional freezing.

[0326] In this example, decellularized AA (apple) was produced according to a 4-day process and used as the starting material. The wet decellularized AA was then broken down into a slurry of single, intact AA structural cells in a 1-day liquid-based mercerization process. After a final centrifugation step, a clean, wet paste was isolated and used in further processing steps. The paste was malleable but retained its shape (it did not easily settle or flow and was highly viscous). The material was white in color. Approximately 150 g of wet paste (95% water) was produced from 30 apples. Chemicals used at the concentrations considered GRAS (SDS, NaOH, HCl, HO, CaCl, HO). The final product was designed to contain either zero or only trace amounts of these chemicals due to extensive washing and neutralization steps. While not as extensively analyzed as apples, pears and asparagus also responded in a similar manner to decellularized AA in the above process. It is contemplated that many different plant species can be used.

[0327] A variety of different aerogel, foam and hydrogel products and precursors thereof may also be prepared according to the methods as described herein.

[0328] For example, a resulting product obtained from mercerization of decellularized plant or fungal tissue may be provided, the product comprising single structural cells, groups of structural cells, or both, as described herein, and the product may be provided as a paste or gel, or as a dry, sticky powder (if lyophilized or otherwise dried without a carrier hydrogel). It is contemplated that such products may generally be stable, may be sterilized using EtOH, or, in certain embodiments, may be sterilized by gamma sterilization. In certain embodiments, such products may be mixed with other liquids or gels. Generally, such products do not readily dissolve in aqueous or alcohol-based solutions.

[0329] Aerogel products or aerogel precursors may also be provided. By way of example, in certain embodiments, a paste, gel, dry sticky powder, or other such product as described in the immediately preceding paragraph may be mixed with one or more (optionally food-grade) hydrogels, such as, but not limited to, gelatin, agar, pluronic acid, alginate, pectin, methylcellulose (MC), and / or carboxymethylcellulose (CMC) hydrogels, to provide an aerogel precursor. In certain embodiments, the aerogel precursor product may comprise about 10% to about 50% (e.g., about 10%, about 20%, or about 50%) (m / m) of a paste, gel, dry sticky powder, or other such product as described in the immediately preceding paragraph, although other concentrations are contemplated as this can be controlled over the entire range. The aerogel precursor may then be placed into any appropriately sized container or mold, which will dictate its final size and thickness. The aerogel precursor product can be frozen (typically overnight at -20°C) and then lyophilized (typically for at least about 24 hours), resulting in a highly porous dried aerogel or foam product. Controlling the freezing temperature (e.g., -20°C, -80°C, -130°C) and the formulation percentage (m / m) can allow for control over the porosity of the resulting aerogels and foams. Results indicate that control over porosity can be achieved from levels below those of the original AA scaffold. The 10% (m / m) formulation had very low porosity but was very brittle and therefore may be reserved for applications where brittleness is not a concern. The 50% formulation provided the best user experience for most applications. The freezing method (directional vs. nondirectional) was used to provide control over the microarchitecture shape (aligned vs. homogeneous porosity), as needed for a particular application or product. Initial studies have shown, for example, that the solvent (e.g., DMSO vs. HO) may also allow control over porosity and microarchitecture. It is contemplated that such products may be sterilizable using EtOH and may also be capable of gamma sterilization.

[0330] Additional products, such as rehydrated aerogels or foams as described herein, are also contemplated, in which a liquid, such as water or an aqueous solution (e.g., a cell buffer) or another liquid or solution (e.g., an alcohol), has been introduced. In the studies described herein, rehydration of aerogels and foams resulted in stable hydrogels with intact microarchitecture. Alginate- and pectin-based aerogels and foams could be rehydrated with CaCl2 to provide crosslinking. Rehydrated aerogels and foams were stable in aqueous and ethanol-based solutions for hours / days under shaking. Pectin-based aerogels and foams were not stable in 0.9% saline and underwent rapid degradation, but they were stable in PBS, H2O, and EtOH. Such rehydrated aerogels and foams have also been tested in cell culture for up to at least two weeks using NIH3T3 and C2C12 cells in ongoing studies. Indeed, the results indicate that rehydrated aerogels and foams as described herein are predicted to behave similarly to decellularized plant-derived scaffold biomaterials such as those described in WO 2017 / 136950 with respect to cell culture. Alginate- and gelatin-based rehydrated aerogels and foams outperformed pectin-based aerogels and foams (which disintegrated over time) under the conditions tested. Alginate- and pectin-based rehydrated aerogels and foams are predicted to be fully compatible for implantation in vivo (e.g., for bone tissue engineering applications). It is contemplated that such products can be sterilized with EtOH (e.g., by shaking in EtOH for 60 minutes) and may also be capable of gamma sterilization.

[0331] The results described herein demonstrate that aerogels and foams, as well as rehydrated aerogels and foams, as described herein, may allow for control of the surface biochemistry of the aerogels and foams and rehydrated aerogels and foams, and can be formulated with specific biochemistry (gelatin, alginate, pectin, MC, CMC, etc.) as needed. Various "plant-based" hydrocarbon polymers, primarily composed of sugars, can be used as hydrogels or carriers. The results also demonstrate that control over the mechanics of aerogels, foams, rehydrated aerogels, and rehydrated foams can be achieved. Aerogels, foams, rehydrated aerogels, and rehydrated foams as described herein may have controllable mechanical properties that can vary as a function of formulation percentage. Generally, mechanical properties have been observed to vary from about 1 to about 200 kPa under the conditions tested. The exact values ​​may vary depending on the type of hydrogel and the dry and wet form / state of the aerogel or foam. The observed rule of thumb was that the rehydrated aerogels and foams were approximately 10x softer than their dried aerogel or foam equivalents. Control over porosity can also be achieved. The results indicate that porosity can be controlled by varying the formulation percentage, freezing temperature, freezing method, and / or solvent used. The observed rule of thumb was that under the conditions tested, porosity could be comparable to or reduced (i.e., higher density, lower pore size) from the original AA scaffold (after decellularization, before further processing by mercerization, etc.). The results also indicate that control over size can be achieved. The freezing container / mold for the hydrogel mixture before lyophilization and crosslinking dictated the final size of the resulting aerogel or foam product. It is further contemplated that sterilization can be easily achieved. In general, it is contemplated that all product types can be EtOH sterilized, and gamma sterilization may also be possible. The results further indicate that the rehydrated aerogels and foams as described herein may be suitable for in vitro cell culture.Cell culture was successful with alginate-, pectin-, and gelatin-based rehydrated aerogels and foams. Agar- and pluronic acid-based rehydrated aerogels and foams have not yet appeared compatible with cell culture under the conditions tested, but these may also be beneficial, for example, for applications where cell growth is not desired. Alginate-based rehydrated aerogels and foams have been the best-performing products to date for in vitro cell culture applications under the conditions tested. [Example 2]

[0332] Additional aerogels and foams prepared from decellularized plant tissue In this example, a library of different aerogels and foams was prepared and tested using various hydrogels and single structural cells and / or groups of structural cells obtained from plant tissue decellularized by a mercerization process.

[0333] Materials and Methods: Stock solution: 5% Alginate Stock Solution: 10g sodium alginate (Modernist Pantry; Lot No. 14933) 200ml distilled water A. Weigh out 10 g of sodium alginate. B. Mix the powder in 200 mL of distilled water. C. Sterilize the solution by autoclaving for approximately 1 hour. D. Keep warm in a water bath (37-50°C) before use.

[0334] 5% pectin stock solution: 10g low methoxyl pectin (Modernist Pantry; Lot No. 14896) 200ml distilled water A. Weigh out 10 g of low methoxyl pectin. B. Mix the powder in 200 mL of distilled water. C. Sterilize the solution by autoclaving for approximately 1 hour. D. Keep warm in a water bath (37-50°C) before use. The final 5% alginate and pectin stock solutions are shown in FIG.

[0335] 5% agar stock solution: 10g Super Agar (Modernist Pantry; Lot No. 13198) 200ml distilled water A. Weigh out 10 g of low methoxyl pectin. B. Mix the powder in 200 mL of distilled water. C. Sterilize the solution by autoclaving for approximately 1 hour. D. Keep warm in a water bath (37-50°C) before use.

[0336] 40% Pluronic stock solution: 40 g of Pluronic F-127 (Sigma Aldrich; Lot No. BCCC2327) 100ml distilled water Ice bath (approximately 0°C) A. Weigh out 40 g of Pluronic F-127. B. Add 100 mL of distilled water to a 300 mL beaker and place it in an ice bath until the water temperature is between 4 and 10°C. C. Remove the beaker from the ice bath and place on a stir plate with a stir bar; slowly pour in 40 g of Pluronic while stirring. D. Continue stirring until the Pluronic powder is thoroughly mixed into solution (no large clumps visible); ensure the solution remains cool by frequently placing the beaker back into the ice bath. E. Keep refrigerated (approximately 4-10°C) before use. The Pluronic stock solution preparation procedure is shown in Figure 37.

[0337] Methylcellulose stock solution: Methylcellulose NaOH solution (sodium hydroxide, ultrapure water, 50% by weight aqueous solution, Acros Organics, CAS 1310-73-2, lot number A0408208) Glycine (Glycine, Fisher, BP381-1, CAS 56-40-6, Lot No. 121382) A. Weigh out 4 g of methylcellulose and mix it with 80 mL of 2 M NaOH in a beaker. B. Place the beaker containing the mixture in an ice bath and stir for 1 hour. C. Add 40 mL of a 10% w / v glycine solution prepared in 2 M NaOH to the sample. D. Place the beaker back in the ice bath and stir for 1 hour. E. Collect the sample.

[0338] 20% gelatin stock solution: 40g fish gelatin powder (250 Bloom; Modernist Pantry; lot number 14048) 200ml distilled water A. Weigh out 40 g of low methoxyl pectin. B. Mix the powder in 200 mL of distilled water. C. Autoclave the solution for approximately 1 hour to sterilize. D. Keep warm in a water bath (37-50°C) before use.

[0339] 20% Pluronic stock solution: 20g Pluronic F-127 (Sigma Aldrich; Lot No. BCCC2327) 100ml distilled water Ice bath (approximately 0°C) A. Weigh out 20 g of Pluronic F-127. B. Add 100 mL of distilled water to a 300 mL beaker and place it in an ice bath until the water temperature is between 4 and 10°C. C. Remove the beaker from the ice bath and place on a stir plate with a stir bar; slowly pour in 20 g of Pluronic while stirring. D. Continue stirring until the Pluronic powder is thoroughly mixed into solution (no large clumps visible); ensure the solution remains cool by frequently placing the beaker back into the ice bath. E. Keep refrigerated (approximately 4-10°C) before use.

[0340] AA (apple) mercerization and neutralization: NaOH solution (sodium hydroxide, ultrapure water, 50% by weight aqueous solution, Acros Organics, CAS 1310-73-2, lot number A0408208) Hydrogen peroxide solution (30% aqueous solution, Fisher Chemical, CAS 7722-84-1, lot number 197718) Decellularized AA material HCl solution for neutralization (HCl solution 6N, Fisher Scientific, CAS 7732-18-5, Lot No. 116660, Exp: 11 / 2013, diluted to 1N with dH2O) A. Remove excess water from the decellularized AA sample by pressing the sample and weigh 100 grams of this material. B. Prepare 500 mL of 1 M NaOH and heat to 80°C (300 RPM). C. Add the AA sample to the NaOH solution and add 25 mL of H2O2 (maintain the solution at 80°C throughout the mercerization). D. After 20 minutes, add an additional 25 mL of H2O2. E. After another 20 minutes, add an additional 25 mL of H2O2. F. After 1 hour of mercerization, allow the sample to cool. At this point, the AA sample should be mercerized and the solution should be off-white in color. G. Neutralize the sample using 1M HCl solution (pH 7). H. Centrifuge the solution at 5000 RPM for 15 minutes to pellet the mercerized AA. I. Remove the supernatant. Using a pH meter, confirm that the pH is still 7 by mixing the pelleted sample with dH2O. If the sample is not neutral, re-neutralize and repeat step H. J. Repeat steps H and I until the sample is neutralized. Keep the sample at 4 °C until further use for aerogel preparation.

[0341] Aerogel preparation - mixing, freeze-drying and processing: Alginate aerogel: A. Weigh out the appropriate mass of mercerized AA (according to Table 2 below) and mix into the appropriate volume of alginate stock solution and distilled water (final volume of 15 mL). B. Place each AA sample solution (6 total: 3 x 1.5 g AA and 3 x 7.5 g AA) directly into a 60 mm culture dish. C. Combine AA with gel by mixing thoroughly using a syringe connected with a luer lock connector. D. Freeze the samples in a -20°C freezer. E. Place samples on a LabConco freeze dryer for 48 hours to freeze dry at 55 mBar and -47°C. F. After 48 hours, remove the sample from the freeze dryer. G. Using a 10 mm biopsy punch, cut the sample from the frozen aerogel. H. Place punches in 0.1 M CaCl2 for 1 hour for cross-linking. I. Sterilize the sample in 70% ethanol for 30 minutes. J. Wash the aerogels three times with PBS and then place them in DMEM medium (10% FBS, 1% P / S). Place the aerogels to be used for wet mechanical testing in 60 mm culture dishes (5-6 samples), and place the samples to be used for cell seeding in 24-well plates (6 samples).

[0342] Pectin aerogel: A. Weigh out the appropriate mass of mercerized AA (according to Table 2 below) and mix into the appropriate volume of pectin stock solution and distilled water (final volume of 15 mL). B. Place each AA sample solution (6 total: 3 x 1.5 g AA and 3 x 7.5 g AA) directly into a 60 mm culture dish. C. Combine AA with gel by mixing thoroughly using a syringe connected with a luer lock connector. D. Freeze the samples in a -20°C freezer. E. Place samples on a LabConco freeze dryer for 48 hours to freeze dry at 55 mBar and -47°C. F. After 48 hours, remove the sample from the freeze dryer. G. Using a 10 mm biopsy punch, cut the sample from the frozen aerogel. H. Place punches in 0.1 M CaCl2 for 1 hour for cross-linking. I. Sterilize the sample in 70% ethanol for 30 minutes. J. Wash the aerogels three times with PBS and then place them in DMEM medium (10% FBS, 1% P / S). Place the aerogels to be used for wet mechanical testing in 60 mm culture dishes (5-6 samples), and place the samples to be used for cell seeding in 24-well plates (6 samples).

[0343] Agar aerogel: A. Weigh out the appropriate mass of mercerized AA (according to Table 2 below) and mix into the appropriate volume of agar stock solution and distilled water (final volume of 15 mL). B. Place each AA sample solution (6 total: 3 x 1.5 g AA and 3 x 7.5 g AA) directly into a 60 mm culture dish. C. Combine AA with gel by mixing thoroughly using a syringe connected with a luer lock connector. D. Freeze the samples in a -20°C freezer. E. Place samples on a LabConco freeze dryer for 48 hours to freeze dry at 55 mBar and -47°C. F. After 48 hours, remove the sample from the freeze dryer. G. Using a 10 mm biopsy punch, cut the sample from the frozen aerogel. H. Place punches in 0.1 M CaCl2 for 1 hour for cross-linking. I. Sterilize the sample in 70% ethanol for 30 minutes. J. Wash the aerogels three times with PBS and then place them in DMEM medium (10% FBS, 1% P / S). Place the aerogels to be used for wet mechanical testing in 60 mm culture dishes (5-6 samples), and place the samples to be used for cell seeding in 24-well plates (6 samples).

[0344] Pluronic aerogel: A. Weigh out 40 grams of Pluronic F-127 to use to achieve a final concentration of 40% (w / v) Pluronic solution. B. Weigh out the appropriate mass of mercerized AA (according to Table 2 below) and mix into the appropriate volume of distilled water. C. Pour 100 mL of distilled water into a beaker and place in an ice bath until a temperature of 4-10°C is reached. D. Once at the appropriate temperature, remove the beaker from the ice bath and place on a stir plate; mix 40 g of Pluronic powder into the distilled water and stir thoroughly until there are no large clumps of Pluronic, ensuring the Pluronic solution remains cool. E. Combine AA with gel by mixing thoroughly using a syringe connected with a luer lock connector. F. After the solution is thoroughly mixed, pour the required volume of 40% (w / v) Pluronic (as described in Table 2 below) into each of the six dishes. G. Store all dishes in an incubator or oven at approximately 37°C for 1 hour. H. Finally, store all dishes in a -20°C freezer, freeze for 1 hour, and then place on a freeze dryer for lyophilization. I. Note: The final freeze-dried foam could not be sterilized due to disintegration in 70% EtOH and therefore was not used for cell culture.

[0345] Methylcellulose aerogel: A. Weigh out an appropriate mass of mercerized AA (according to Table 2 below) and mix into an appropriate volume of methylcellulose gel (approximately 15 mL final volume). B. Combine AA with the gel by mixing thoroughly using a syringe connected with a luer lock connector. C. Place each AA sample solution (6 total: 3 x 1.5 g AA and 3 x 7.5 g AA) directly into a 60 mm culture dish. D. Allow the sample to incubate at room temperature for 24 hours. E. Freeze the samples in a -20°C freezer. F. Place samples on a LabConco freeze dryer for 48 hours and freeze dry at 55 mBar and -47°C for 48 hours. G. After 48 hours, remove the sample from the freeze dryer. H. Using a 10 mm biopsy punch, cut the sample from the frozen aerogel. I. Note: The final freeze-dried foam could not be sterilized due to disintegration in 70% EtOH and therefore was not used for cell culture.

[0346] Gelatin aerogel: A. Weigh out a suitable mass of mercerized AA (according to Table 2 below) and mix into a corresponding volume of distilled water in a 15 mL Falcon tube. B. The AA solution is then transferred into a 50 mL plastic syringe and an appropriate volume of 20% gelatin stock solution (see Table 2) and approximately 150 μL of glutaraldehyde (GA) is added for cross-linking. C. Attach a second empty 50 mL syringe to the first using a Luer Lock connector and pump the total volume of the AA solution (approximately 15 mL) back and forth between the two syringes (approximately 30 times) to mix thoroughly. D. Dispense the final AA solution (15 mL total volume) into 60 mm culture dishes and store in a 4° C. refrigerator for 24 hours. E. Incubate with 10 mg / mL sodium borohydride on ice for 1 hour, then wash three times with PBS. Store in a refrigerator at -20°F for 4 hours. G. Place samples on a LabConco freeze dryer for 48 hours to freeze dry at 55 mBar and -47°C. H. After 48 hours, remove the sample from the freeze dryer. I. Using a 10 mm biopsy punch, cut the sample from the frozen aerogel. J. Sterilize the sample in 70% ethanol for 30 minutes. K. Wash the aerogels three times with PBS and then place them in DMEM medium (10% FBS, 1% P / S). Place the aerogels to be used for wet mechanical testing in 60 mm culture dishes (5-6 samples), and place the samples to be used for cell seeding in 24-well plates (6 samples). FIG. 38 shows the preparation of gelatin-AA aerogels as described above.

[0347] Pluronic + Pectin Aerogel: Preparation of AA sample solution: A. Weigh out 7.5 g of mercerized AA and repeat for a total of three 7.5 g portions of AA. B. Prepare a 5% pectin (w / v) stock solution and a second 20% pluronic stock solution. C. Add 4.5 mL of 5% pectin to the syringe. D. Then add 7.5 mL of 20% Pluronic stock solution for a total volume of 19.5 mL. E. Combine AA with gel by mixing thoroughly using a syringe connected with a luer lock connector. Preparation of Pluronic-AA gel: G. Once all components are mixed together in their respective culture dishes, all dishes are placed in an incubator or oven at 37° C. for 1 hour. H. Remove the dishes from the incubator and add 2 mL of 0.1 M CaCl to each dish for cross-linking. Mix all dishes thoroughly and leave at room temperature for 1 h to gel. I. Finally, all dishes are stored in a -80°C freezer for 2-3 days until fully frozen, and then placed on a freeze dryer for lyophilization. J. After freeze-drying, remove the foam from the freeze-dryer and cut using a 10 mm biopsy punch to cut small foam aerogels to be used for dry mechanical testing. K. Note: The final freeze-dried foam could not be sterilized due to disintegration in 70% EtOH and therefore was not used for cell culture.

[0348] Pluronic + Alginate Aerogel: Preparation of AA sample solution: A. Weigh out 7.5 g of mercerized AA and repeat for a total of three 7.5 g portions of AA. B. Prepare a 5% alginate (w / v) stock solution and a second 20% pluronic stock solution. C. Place each 7.5 g portion of AA into a syringe. D. Add 4.5 mL of 5% alginate. E. Then add 7.5 mL of 20% Pluronic stock solution for a total volume of 19.5 mL. F. Combine AA with gel by mixing thoroughly using a syringe connected with a luer lock connector. Preparation of Pluronic-AA gel: G. Once all components are mixed together in their respective culture dishes, all dishes are placed in an incubator or oven at 37° C. for 1 hour. H. Remove the dishes from the incubator and add 2 mL of 0.1 M CaCl to each dish for cross-linking. Mix all dishes thoroughly and leave at room temperature for 1 h to gel. I. Finally, all dishes are stored in a -80°C freezer to allow them to freeze thoroughly for 2-3 days before being placed on a Labconco freeze dryer. Samples are left at 55 mBar and -47°C for 48 hours. J. After 48 hours, remove the sample from the freeze dryer. K. Using a 10 mm biopsy punch, cut the sample from the frozen aerogel. L. Place punches in 0.1 M CaCl2 for 1 hour for cross-linking. M. Sterilize the samples in 70% ethanol for 30 minutes. N. Wash the aerogels three times with PBS and then place them in DMEM medium (10% FBS, 1% P / S). Place the aerogels to be used for wet mechanical testing in 60 mm culture dishes (5-6 samples), and place the samples to be used for cell seeding in 24-well plates (6 samples).

[0349] mixture To create a homogenous mixture of the mercerized material and base hydrogel, the components were loaded into syringes connected with F / F Luer lock connectors. The solution was passed through the syringe 30 times. The syringe-based mixing device is shown in Figure 39.

[0350] cell culture Sterilized, hydrated aerogels were placed in a 24-well plate with 2 mL of DMEM (one sample per well). GFP3T3 cells were cultured in a 100 mm Petri dish in DMEM medium (10% FBS, 1% P / S) at 37°C and 5% CO2. The cells were washed with PBS and trypsinized using 0.25% trypsin. The cells were pelleted and resuspended in DMEM at 2 x 10 6 The cells were resuspended at a concentration of 1000 cells / mL. 25 μL of the cell suspension was pipetted onto each sterilized, hydrated aerogel, meaning that 50,000 cells were seeded onto each aerogel. After 4 hours of incubation at 37°C and 5% CO2, 2 mL of DMEM was added to each well containing the seeded aerogels, and the plate was returned to the incubator.

[0351] After 7 days of incubation, the aerogels were seeded again with GFP 3T3 cells using the same method described above. A total of two weeks after the first seeding (there were two seedings—days 1 and 7), the cells were fixed on the aerogels. The samples were washed twice with 1 mL of PBS. The cells were then incubated in 3.5% paraformaldehyde for 10 minutes for fixation. The samples were washed twice with 1 mL of PBS and stained with 0.1% Congo red for 10 minutes. Finally, the samples were washed with PBS and stored in 2 mL of PBS at 4°C.

[0352] Mechanical testing 10 mm biopsy punches of all the different aerogel formulations were mechanically tested (dry samples) using a CellScale Univert instrument. Additionally, formulations seeded with GFP 3T3 cells were also mechanically tested wet using the same set / compression cycle.

[0353] The sample was compressed (one repetition) at 90% of its height for 20 seconds (single duration). Five or six samples per formulation were mechanically tested.

[0354] result: AA mercerization Merceration of 100 g of wet decellularized AA yields approximately 30-40 g of mercerized AA material.

[0355] By using hydrogen peroxide during mercerization rather than separating the mercerization and discoloration steps, time was saved (the same amount of mercerized AA material was obtained in about four times less time). When the two steps are combined at the same time, it takes about one hour to obtain an off-white mercerized material. Figures 1 and 2, described in Example 1 above, show the AA mercerization and decolorization and the starting material and product obtained from mercerization.

[0356] Table 2 shows the various aerogel formulations prepared for the library in this example. Figure 40 shows a representation of the various aerogel formulations prepared as part of the library generated in this example. The aerogels are shown before and after freeze-drying of the samples. Table 3 shows a summary of the cell culture results for the aerogels tested in this example.

[0357] [Table 2]

[0358] [Table 3]

[0359] Agar and pectin (1.5) aerogels became very brittle upon hydration and broke into smaller pieces.

[0360] Some formulations were not well suited for cell growth because they were either too brittle, crumbled upon hydration, or disintegrated during the sterilization step. This was the case for Pluronic, methylcellulose, and Pluronic + pectin aerogels. Therefore, these staples were not seeded with GFP 3T3 cells.

[0361] Figure 41 shows GFP 3T3 cells (green) seeded onto certain aerogel(s) (as indicated) and stained with Congo red (red). Agar, alginate, pectin, and gelatin hydrogels were used in combination with 1.5 g of decellularized, mercerized apple (10%) or 7.5 g of decellularized, mercerized apple (50%) (Scale = 200 μm). Images were acquired at 10X on a BX53 upright microscope using a GFP filter for the cells and a TXRED filter for the scaffold.

[0362] The results of mechanical testing of the dry aerogel samples are shown in Figures 42-54, and the results of mechanical testing of the hydrated aerogel samples are shown in Figures 55-64, as follows: Figure 42 shows the stress-strain curve of a dry agar-based gel containing 1.5 g of mercerized AA. Figure 43 shows the stress-strain curve of a dry agar-based gel containing 7.5 g of mercerized AA. Figure 44 shows the stress-strain curve of a dried alginate-based gel containing 1.5 g of mercerized AA. Figure 45 shows the stress-strain curve of a dried alginate-based gel containing 7.5 g of mercerized AA. Figure 46 shows the stress-strain curve of a dried pectin-based gel containing 1.5 g of mercerized AA. Figure 47 shows the stress-strain curve of a dried pectin-based gel containing 7.5 g of mercerized AA. Figure 48 shows the stress-strain curve of a dried gelatin-based gel containing 1.5 g of mercerized AA. Figure 49 shows the stress-strain curve of a dried gelatin-based gel containing 7.5 g of mercerized AA. FIG. 50 shows the stress-strain curve of a dried methylcellulose-based gel containing 1.5 g of mercerized AA. FIG. 51 shows the stress-strain curve of a dried methylcellulose-based gel containing 7.5 g of mercerized AA. FIG. 52 shows the stress-strain curve of a dried Pluronic-based gel containing 1.5 g of mercerized AA. Figure 53 shows the stress-strain curves of dried Pluronic and alginate-based gels containing 7.5 g of mercerized AA. Figure 54 shows the Young's modulus of the dry samples with their hydrated counterparts. The volumes of mercerized AA are indicated by 1.5 and 7.5, both in grams, corresponding to 10% and 50% solutions, respectively. 1% agar, alginate, and pectin base hydrogels were used. Gelatin was at 5% final solution. Figure 55 shows the stress-strain curve of a hydrated agar-based gel containing 1.5 g of mercerized AA. Figure 56 shows the stress-strain curve of a hydrated agar-based gel containing 7.5 g of mercerized AA. Figure 57 shows the stress-strain curve of a hydrated alginate-based gel containing 1.5 g of mercerized AA. Figure 58 shows the stress-strain curve of a hydrated alginate-based gel containing 7.5 g of mercerized AA. Figure 59 shows the stress-strain curve of a hydrated pectin-based gel containing 1.5 g of mercerized AA. Figure 60 shows the stress-strain curve of a hydrated pectin-based gel containing 7.5 g of mercerized AA. Figure 61 shows the stress-strain curve of a hydrated gelatin-based gel containing 1.5 g of mercerized AA. Figure 62 shows the stress-strain curve of a hydrated gelatin-based gel containing 7.5 g of mercerized AA. Figure 63 shows the stress-strain curves of hydrated Pluronic and alginate-based gels containing 7.5 g of mercerized AA; and Figure 64 shows the Young's modulus of the hydrated samples. The volumes of mercerized AA are indicated by 1.5 and 7.5, both in grams, corresponding to 10% and 50% solutions, respectively. 1% agar, alginate, and pectin base hydrogels were used. Gelatin was at 5% final solution.

[0363] The results in Figures 42-64 show that the mechanical properties of the material can be controlled. These results also show bimodal mechanical properties (i.e., change in mechanical properties upon compression) where stiffness increases between a lower value at small strain and a higher value at high strain. The ability to have different regimes is desirable. While a linear elastic regime is desirable, different plastic regimes and mechanics of failure may be more desirable for certain applications, such as food applications and for example, tailored mouthfeel.

[0364] Swelling To determine the importance of swelling to aerogel size, the approximate diameters of aerogels used for dry and wet mechanical testing were measured. The effect of liquid retention was observed after foam aerogels were stored in DMEM in an incubator for several days. Due to collapse upon sterilization of some aerogel types (i.e., methylcellulose and Pluronic), diameter data was not obtained for all aerogel formulations. Dry and wet diameter measurements were obtained for agar, alginate, and pectin AA formulation aerogels. From these measurements, the approximate area, height, and volume of the AA aerogels were determined and are shown below in Tables 4, 5, and 6.

[0365] For statistical analysis, t-tests were performed between the dry and wet measurements for each aerogel type. All aerogel area measurements, except for the alginate and gelatin aerogels (both 1.5 g and 7.5 g conditions), decreased in size upon wetting, likely due to the samples breaking down somewhat in the liquid and losing some stability. Analysis of variance (ANOVA) was also performed to determine the significance of the interaction between gel type and AA concentration (i.e., 1.5 g AA vs. 7.5 g AA). Overall, no significant differences were observed between the AA concentrations used in the aerogels. However, there were significant differences when comparing gel types.

[0366] Regarding aerogel height, the alginate and gelatin formulations were the only AA aerogel types that showed a significant increase due to aerogel swelling after immersion in DMEM. A similar increase in volume was observed with the alginate and gelatin aerogels after hydration, while the remaining aerogel formulations all demonstrated a significant decrease in aerogel volume upon wetting, likely due to some aerogel degradation. Furthermore, the ANOVA for height showed significant differences between the different concentrations, indicating that variability in the freeze-drying process or packing method may somehow affect aerogel height. Furthermore, the gel type and interaction effects were also significant at the 0.05 level. These findings can be observed in Tables 4, 5, and 6 below.

[0367] [Table 4]

[0368] [Table 5]

[0369] [Table 6]

[0370] Figure 65 shows SEMs of alginate-based aerogels containing 1.5 g (10%) and 7.5 g (50%) of decellularized, mercerized AA. Figure 66 shows SEMs of pectin-based aerogels containing 1.5 g (10%) and 7.5 g (50%) of decellularized, mercerized AA.

[0371] Alginate aerogels containing 7.5 g of AA were imaged using a confocal microscope. Figure 67 shows a maximum intensity z-projection of a confocal image of alginate foam containing 7.5 g of mercerized AA (50%). Red is the scaffold stained with Congo red. Green is GFP from stably transfected 3T3 cells, and blue is the nuclei of GFP 3T3 cells.

[0372] This example provides data demonstrating that an array of different formulations of aerogels and foams with different properties can be prepared. The leading candidates for aerogels and foams for a wide variety of applications are 50% decellularized, mercerized AA in alginate and gelatin gels, followed by pectin gels. Furthermore, most of these gels, with the exception of the gelatin gel, were manually mixed by manual stirring. The gelatin sample was more thoroughly mixed using a Luer-Lock connection system with two syringes. It is contemplated that application of this technique to additional formulations will result in less sample variability and more uniform gels. [Example 3]

[0373] Dissolving cellulose hydrogels prepared from decellularized plant tissue and / or other cellulose sources This example describes several approaches for creating dissolving cellulose-based hydrogels from decellularized plant tissue and other synthetic cellulose sources. In the following examples, the goal was to combine mercerized plant cellulose materials, such as structural cells, with newly developed cellulose-based hydrogels to create complex aerogels, foams, and other scaffolds. Because the resulting aerogels (e.g., both the structural cells and the carrier / hydrogel) are produced entirely from decellularized plant tissue, this may be desirable for several different applications.

[0374] Cellulose dissolution and regeneration: This example describes the dissolution of cellulose from a decellularized apple scaffold using dimethylacetamide and lithium chloride and its regeneration by solvent exchange using 95% ethanol.

[0375] Materials and Methods: Solvent preparation: Dimethylacetamide (DMAc) is dried at 115°C for 15 minutes. LiCl is dried at 180°C for 48 hours and then maintained at 80°C.

[0376] Solvent exchange: Obtain 50g of decellularized apples. Transfer to a 50 mL Falcon tube with acetone. Place in an ultrasonic bath for 15 minutes. Remove the acetone Repeat three times Remove acetone and add DMAc Place in an ultrasonic bath for 15 minutes. Centrifuge to exchange acetone and DMAc Remove the acetone Repeat three times

[0377] LiCl addition: Ratio: 6g LiCl per 50mL DMAc Transfer the scaffolds to dry DMAc in a Duran bottle equipped with a magnetic stir bar. Maintain at 100°C for 1 hour, then reduce to 50°C with continuous stirring for 72 hours.

[0378] Cellulose regeneration: Exchange with 95% ethanol The dissolution solution was centrifuged to remove any undissolved material. The dissolved cellulose was then poured into a 60 mm Petri dish to cover the bottom surface. 95% ethanol was then poured on top, and a thin wafer began to form. · The film may have small wrinkles and imperfections. The film could be pressed with a spatula and bound into a gel mass. · When left undisturbed, a flat disk forms which can be manipulated. The material was soft and gel-like. Alternatively, the dissolved cellulose was placed in a Falcon tube with a hole cut in the lid. A dialysis membrane was placed over the opening of the tube, and the cut lid was then secured on top. The tube was inverted in 95% ethanol to allow for solvent exchange.

[0379] result The proposed mechanism of cellulose dissolution in DMAc / LiCl, as proposed by McCormick et al. (a) and Morgenstern et al. (b), is as follows:

[0380] [ka]

[0381] A possible reaction scheme for cellulose dissolution using DMAc and LiCl may also proceed as follows (showing the interactions between Li+ cations, Cl− anions, and DMAc when cellulose is dissolved in the DMAc / LiCl system):

[0382] [ka] dissolve

[0383] Figure 68 shows the dissolution solution of decellularized apple with DMAc and LiCl after 72 hours of reaction. Figure 69 shows the dissolution solution of decellularized apple with DMAc and LiCl after centrifugation to remove undissolved material. Figure 70 shows the regeneration of a cellulose film. The dissolved cellulose was poured into a 60 mm Petri dish to cover the bottom surface. 95% ethanol was poured on top of the dissolution solution to facilitate solution exchange and regenerate the cellulose. Wrinkles are observed as the film forms. Figure 71 shows that within 5 minutes of adding the ethanol, the film could be pressed with a spatula and bundled. Figure 72 shows the recovered regenerated cellulose gel. Figure 73 shows the regenerated cellulose film when left undisturbed. Figure 74 shows the regenerated cellulose file titled to show the wafer slide in the Petri dish. Figure 75 shows regenerated cellulose with a density gradient. Solvent exchange was achieved using a dialysis membrane. Regeneration occurred in a 50 mL Falcon tube. The ends of the cylinders were in contact with the membrane and had the greatest amount of solution exchange. They were more rigid and maintained their shape compared to the less rigid, less dense tail region. Figure 76 shows a regenerated cellulose film setup using a dialysis membrane secured by a lid with a hole cut in the center. Figure 77 shows a freeze-dried section of the dense region from Figure 76. Freeze-drying led to scaffold collapse. Figure 78 shows a 5 mm regenerated cellulose punch from regenerated film bleached with HO (30%). The material was light brown before treatment and transparent after treatment with peroxide. In fact, they were difficult to see due to their transparency. Figure 79 shows a 5 mm regenerated cellulose punch from regenerated film bleached with HO (30%) imaged by dark-field imaging. Figure 80 shows a 5 mm regenerated cellulose punch from regenerated film bleached with HO (30%) stained with Congo red to visualize the microstructure. The surface was extremely flat and had small pores. This is a fluorescent image using TRITC.

[0384] In this example, mercerized material (i.e., single structural cells, clusters of structural cells, or both obtained from the mercerization process of decellularized apple tissue as described hereinabove) was mixed with regenerated cellulose obtained as described above. In an attempt to avoid premature regeneration, the mercerized material (1 g) was mixed with acetone and sonicated for 5 minutes. The material was then centrifuged at 5000 rpm for 7 minutes. The mercerized cellulose (in which the water had been exchanged with acetone) was mixed with the DMAc LiCl-dissolved cellulose mixture (5 mL). The combination was mixed in a dual syringe, luer-lock connector setup. Figure 81 shows the DMAc LiCl-dissolved cellulose (the color came from the DMAc LiCl-dissolved cellulose solution; the mercerized material was white) mixed with mercerized AA.

[0385] Figure 82 shows dissolved cellulose mixed with mercerized AA. The film was regenerated by covering it overnight with a layer of 95% ethanol. A composite film was obtained. Figure 83 shows a fluorescent microscope image of regenerated cellulose mixed with mercerized material. It can be seen that the apple structure cells from the mercerized material are packed together. This topography is different from the smooth material obtained from pure regenerated cellulose.

[0386] Freeze-dried composite aerogels produced from a mixture of regenerated cellulose and mercerized materials: After forming a mixture of regenerated cellulose and mercerized material, the hydrogel was frozen and lyophilized (as described above) to form an aerogel / foam that could be dried or rehydrated. Several formulations were prepared as follows:

[0387] [Table 7]

[0388] Figure 115 shows freeze-dried aerogels produced using the formulations listed above (samples P1, P2, P3, P4, P5, P6), approximately 1 cm in diameter. Figure 116 shows larger scale freeze-dried (3 cm diameter) aerogels produced using the formulations listed above; P2 (left), P7 (center), and P3 (right) images.

[0389] Methylcellulose-based gels were also prepared. In this next example, all cellulose materials were prepared using methylcellulose and mercerized material (i.e., single structural cells, groups of structural cells, or both obtained from the mercerization process of decellularized apple tissue as described herein above).

[0390] Preparation of mercerized decellularized material Decellularized apples were mercerized in 1M NaOH for 1 hour. To lighten the color, hydrogen peroxide (30% stock) was added to the mixture (5% v / v of the 30% stock) during the 1-hour mercerization process. The solution was then neutralized with HCl and centrifuged to recover the material. To ensure the pH remained stable, the pellet was resuspended in dH2O and the solution was neutralized again. This process was repeated for subsequent cycles until the pH was 6.8-7.2.

[0391] Gel formulation The gelation process involved dissolving methylcellulose in 10 mL of 2 M NaOH for 1 hour with stirring on ice. A glycine solution was also prepared by dissolving glycine in 2 M NaOH. After 1 hour, 5 mL of glycine solution was added, and the mixture was stirred on ice for an additional hour. The mercerized apples were introduced in one of two different stages. One method of introduction involved mixing the mercerized apples with the viscous solution after the second hour of glycine treatment. This particular mixing method involved using a syringe connected with a F / F Luer-Lock system. For higher methylcellulose concentrations (1 g), mixing using a syringe was very difficult. As a result, a second preparation method was developed. In this approach, the mercerized apples were added directly to the 2 M NaOH solution along with the methylcellulose at the start of the reaction. Mixing was achieved using magnetic stirring. See Table 7 for the formulations tested. When glycine was added, the viscosity of the mixture was observed to increase, which was likely due in large part to physical crosslinking induced by the increased temperature. The gel was allowed to crosslink overnight at room temperature.

[0392] [Table 8]

[0393] result: Figure 84 shows the reaction setup. The reaction was carried out in small beakers containing a magnetic stir bar. These beakers were covered with parafilm and placed in a larger beaker containing an ice bath. Figure 85 shows methylcellulose and mercerized AA. Methylcellulose mixed with glycine (top in a weighing boat) and mercerized AA (bottom in a Petri dish). 1 g of methylcellulose was more viscous (right two images) compared to 0.5 g (left two images). Figure 86 shows a methylcellulose gel containing mercerized AA (apple) and glycine (AA introduced after glycine addition) after overnight incubation at room temperature for crosslinking. The gel was removed from the Petri dish and was able to maintain its shape. The 1 g methylcellulose gel was more rigid. Figure 87 shows a methylcellulose and mercerized AA gel. 1 g of methylcellulose and 1 g of AA mixed in 10 mL of 2 M NaOH were mixed for 1 hour with magnetic stirring in an ice bath. 5 mL of 30% glycine in 2 M NaOH was then added and stirred on ice for an additional hour. The gel was allowed to crosslink overnight at room temperature in a 60 mm Petri dish. The gel was able to be handled and maintain its shape. Figure 88 shows the same gel from Figure 87 cut into two halves with a scalpel blade. One half was kept and the other half was used to test neutralization. Neutralization was performed with 5% acetic acid for 1 hour, followed by 10 washes with water. After this, we also tested whether there was a slow release of NaOH, which would result in an increase in pH. This occurred. Consequently, one half of the aerogel was washed 70 times and neutralized with 30% acetic acid.

[0394] Figure 89 shows that the excess washed "half aerogel" from Figure 88 was frozen at -20°C and then freeze-dried at -46°C and 0.050 mbar (top). The dried material appeared brittle but was actually quite rigid to the touch. Directional freezing was also observed. A section was then peeled off and immersed in dH2O (bottom image). It remained intact and had a soft, sticky texture. Figure 90 shows that the second half of the cut aerogel from Figure 88 was neutralized. Neutralization was performed immediately with 30% acetic acid. This had a similar but opposite result: the pH drifted toward acidic values, and the slow release of acetic acid caused the pH to drift to lower values ​​over time. This was corrected with a slow titration using 1 M NaOH. Nevertheless, this indicates that an optimal neutralization step of approximately between 5% and 30% acetic acid is likely a faster, more efficient approach. The neutral sample was kept for future dye testing.

[0395] Neutralization of aerogels of this size was found to be a challenge because of the slow release of NaOH or neutralizing solution. 5% acetic acid was insufficient to fully neutralize the NaOH (as shown above). This was surprising. In comparison, the addition of 30% acetic acid had the opposite effect: the acid used for neutralization was released slowly from the aerogel, requiring further base treatment. 12-15% acetic acid was found to be a suitable concentration for neutralization without pushing the pH too far to one extreme.

[0396] Figure 91 shows a methylcellulose (1:1) half aerogel with mercerized AA neutralized with 15% acetic acid. It was also found that the methylcellulose gels (with or without AA) swelled significantly. This can occur during freezing and freeze-drying as well. Figure 92 shows a methylcellulose (1:1) half aerogel with mercerized AA neutralized with 15% acetic acid. The aerogels shown in Figure 92 were neutralized as half aerogels (Figure 91). They expanded to fill a 60 mm Petri dish upon freezing. Once freeze-dried, they produced a white foam that was easily handled and relatively rigid. Once hydrated, they expanded, and if they continued to expand, they turned into a loose material with a sticky consistency.

[0397] Figure 93 shows the expansion of methylcellulose (1:1) with mercerized AA. For comparison, half of the aerogel was placed on top of its original 60 mm dish. Figure 94 shows that the methylcellulose (1:1) with mercerized AA continued to expand to a loose material.

[0398] In an attempt to control swelling, the concentration of glycine was increased. It was found that a 30% glycine solution was approaching the saturation point. At 40%, heating was required to dissolve the glycine. Because the gel was thermoresponsive, the glycine had to be cooled before addition to the methylcellulose and mercerized AA mixture; however, upon cooling, the glycine precipitated out of solution. Figure 95 shows the crystallization of glycine at low temperatures (approximately 4°C) from a 40% solution. The strong effect of temperature on methylcellulose and its increased hydrophobicity compared to microcrystalline cellulose led to the investigation of the role of glycine. While glycine can crosslink microcrystalline cellulose, we tested whether similar gels could be obtained simply using the effect of temperature. This was achieved.

[0399] Figure 96 shows that carboxymethylcellulose gels in the absence of glycine result in similar physically cross-linked materials. [Example 4]

[0400] Use of aerogels and foams for bone tissue engineering This example describes the use of aerogels and foams as described herein, such as those prepared in Examples 1 and 2, for bone tissue engineering.

[0401] overview This example describes a standard operating procedure for implantation and extraction of decellularized biomaterials into a drilled calvarial defect. The study was conducted to evaluate the potential of aerogels and foams as described herein for bone regeneration applications in a critical-size bilateral defect model in rats. Biomaterials (alginate- and pectin-based aerogels) were implanted into rats for periods of 4 and 8 weeks. 5 mm bilateral circular defects were created in the rat calvaria. Once the bone defect was excised, aerogel (alginate or pectin aerogel formulations; Table 2 provides the formulations of 5% alginate aerogel and 5% pectin aerogel used in the bone tissue engineering examples) biomaterials (5 mm diameter x 1 mm thick) were placed into the defect. The overlying skin was sutured, and the rats were allowed to recover for periods of 4 to 8 weeks. Specimens were collected at each time point, and computed tomography (CT) scans were performed for implant dislocation, mechanical testing, and histological examination.

[0402] Important Chemicals and Solutions 1. Marcerated apple paste made from neutralized decellularized McIntosh apples 2.5% alginate 3.5% pectin 4. Calcium chloride

[0403] Table 2 provides the formulations of 5% alginate aerogel and 5% pectin aerogel used in this bone tissue engineering example.

[0404] Procedure - Porting 1. Prepare the rat for anesthesia and administer isoflurane until loss of consciousness is observed 2. The rat is then transferred to the preparation area, saline is administered via syringe, and tear gel is applied onto the eye to reduce corneal drying. 3. The top of the head is shaved from the bridge of the nose between the eyes to the caudal end of the skull, and the fur is then aspirated. 4. The rat is then transferred to the surgical area and secured in a stereotaxic apparatus. 5. Wash the skin with water and sterilize with chlorhexidine. 6. Photograph the biomaterial in sterile saline next to a ruler. 7. Secure the trephine to the drill and place it next to the surgical area. 8. Once the investigator is donning a sterile gown and gloves, a subperiosteal incision is made with a scalpel on the scalp from the nasal bone to just caudal to the mid-sagittal crest. 9. Using a 5.5 mm alum retractor, the skin is opened to the underlying bone. 10. The periosteum is divided and dissected along the sagittal midline. 11. Clean the bone with a sterile cotton swab. 12. Make an incision in the left parietal bone using a 5 mm trephine at 1500 rpm under constant irrigation with sterile saline. 13. Move the elevator blade circumferentially around the defect edge, applying gentle pressure to complete the defect. 14. Use the elevator blade to slide down and remove the bone 15. Remove the right bone in the same way. 16. A non-sterile researcher brings the biomaterials into the surgical area and places them where indicated. 17. Carefully place each biomaterial into each parietal bone defect. 18. Photographing biomaterial next to a ruler. 19. Remove the Alm retractor and close the incision using interrupted sutures. 20. Apply bupivacaine to the sutures and transfer the rat to the recovery station.

[0405] Figure 97 shows alginate (left) and pectin (right) aerogel scaffolds prior to implantation into a burr hole defect. Figure 98 shows alginate (left) and pectin (right) aerogel biomaterials implanted into a burr hole defect in the parietal bone.

[0406] Extraction Procedure: After allowing the rats to recover for the desired amount of time (e.g., 8 weeks), specimens were collected and scanned using computed tomography (CT). Histology was then performed. 1. Transfer the Animal to the CO2 Euthanasia Box and Set the Correct Flow Rate 2. After at least 5 minutes, once the rat has stopped breathing for at least 1 minute, it is removed from the box. 3. Check vital signs and perform a thoracotomy followed by a complete blood draw. 4. Place the rat in a prone position and lift the skin over the skull and remove it with scissors to expose the graft. 5. Using a scalpel, cut away the muscles on either side of the skull 6. Then, using a drill bit, separate the front of the calvarium from the rest of the skull. 7. Then, use forceps to lift the calvarium and cut away the tissue underneath. 8. Once removed, make a small incision in the lower left of the calvarium to indicate the orientation of the specimen and take a photograph of the graft within the burr hole. 9. The calvaria are then placed in a tube containing formalin solution for 72 hours, followed by 70% ethanol, and then stored at 4°C. 10. Once in ethanol, the samples were delivered for CT scanning. Each sample was rotated 180° and imaged every 0.7°.

[0407] Figure 99 shows an alginate aerogel implant in a rat calvaria before extraction. Figure 100 shows an extracted rat calvaria. Figure 101 shows a rat calvaria with a burr hole defect, extracted after 8 weeks and scanned by computed tomography (CT). Alginate biomaterial (left) and pectin biomaterial (right). The results show that the aerogel biomaterial supports cell infiltration and regeneration in vivo. [Example 5]

[0408] Peroxide ratio for mercerization This example describes a study of the peroxide ratio of mercerization processes as described herein, such as those used to prepare structural cells of aerogels and foams as described herein, such as those in Examples 1 and 2.

[0409] To test various ratios of peroxide, a fixed ratio of decellularized apple to NaOH was used. This was 100 g of decellularized apple per 500 mL of 1 M NaOH. The amounts of 30% stock hydrogen peroxide added to this ratio were 20 mL, 10 mL, and 5 mL. These amounts correspond to final concentrations of 1.15%, 0.58%, and 0.30% (relative to the concentration in 1 M NaOH), respectively. Clearly, the volume of apple slightly alters these concentrations when added to the solution, as shown in Figures 102-105.

[0410] Figure 102 shows bleaching during mercerization over the course of 1 hour using 20 mL of hydrogen peroxide. Figure 103 shows bleaching during mercerization over the course of 1 hour using 10 mL of hydrogen peroxide. Figure 104 shows bleaching during mercerization over the course of 1 hour using 5 mL of hydrogen peroxide.

[0411] It should be noted that peroxide treatment may also be performed after mercerization, although the high temperature and basic conditions of mercerization have been observed to speed up the mitigation process.

[0412] Figure 105 shows that (A) after 1 hour of mercerization with different amounts of peroxide, the color was slightly clearer for the higher peroxide concentrations, (B) after neutralization, the slight color variation disappeared and all three had a clear / off-white color, and (C) the final concentrated products were comparable for the three hydrogen peroxide ratios.

[0413] The results show that different peroxide ratios can be used to achieve similar end products. Reducing the peroxide concentration from 1.15% to 0.3% did not affect the bleaching of the end product after neutralization. [Example 6]

[0414] Mass fraction of structural cells in aerogels and foams This example describes a study of the mass fraction of structural cells in aerogels and foams as described herein, such as those in Examples 1 and 2. As described herein, in certain embodiments, an aerogel or foam may contain about 10-50% m / m (or more) single structural cells, groups of structural cells, or both when the aerogel or foam is in a hydrated form.

[0415] As will be appreciated, the mass of the aerogel and foam, when dry, will differ significantly from the mass of the rehydrated (or wet) aerogel and foam. In some experimentally measured examples, the dry mass of the prepared aerogel was about 5.18% of the wet mass of the same aerogel.

[0416] It will be further understood that the structural cells of the aerogels and foams described herein can have a wide range of sizes, and can be substantially uniform or a mixture of different sizes. In certain embodiments, the structural cells can have a size ranging from about 20 μm to about 1000 μm. It is contemplated that larger particles can be obtained, if desired, for example, by reducing the mercerization time or by modifying the source material to have plant cells of a different size range. Typically, for apple decellularized tissue, the structural cells provide an average particle size of about 200 μm, although it will be understood that other sizes are contemplated.

[0417] Figure 106 shows fluorescence microscopy images of three different AA:NaOH ratio conditions (i.e., mercerization conditions): (A) -1:5, (B) -1:2, and (C) -1:1. Images were acquired at 2.5x magnification with an Olympus SZX16 microscope using a BV filter and Congo red staining.

[0418] Particle size analysis: Images were thresholded and segmented using Fiji ImageJ. After the images were converted to binary, a watershed was applied. Feret's diameter was calculated using the Analyze Particles plugin. The particle size histograms were very similar for each case (Figure 107). Figure 107 shows the histograms of particle size distribution from mercerization of different ratios of decellularized AA with 1 M NaOH.

[0419] To further investigate particle size, an ANOVA was performed with Tukey's post-hoc analysis at a significance level of 0.05. The data are summarized in Tables 8 and 9.

[0420] [Table 9]

[0421] [Table 10]

[0422] These results also show that different ratios of decellularized apple to NaOH can result in similar end products. This flexibility in the production process allows for practical adjustments during scale-up, for example. [Example 7]

[0423] Protocol for Mechanical Testing of Aerogels and Foams This example describes the protocol used for mechanical testing of aerogels and foams as described herein, such as those in Examples 1 and 2. In certain embodiments, an aerogel or foam as described herein can have a bulk modulus, as determined by the protocol described in this example, in the range of about 0.1 to about 500 kPa, e.g., about 1 to about 200 kPa.

[0424] Sample preparation 1. Prepare a sample from an aerogel foam, such as that shown in Figure 108 2. Use a biopsy punch of the desired size to cut out a disc of the specimen (e.g., a 10 mm biopsy punch) 3. The sample is kept dry (Figure 109, left) or cross-linked using calcium chloride (Figure 109, right). 4. The sample is then placed on a mechanical tester and compressed to the desired size or % of the sample size.

[0425] Mechanical Test Procedures 1. Prepare the specimen for mechanical testing and measure all dimensions 2. Place the sample on the platons 3. Move the actuator to a specified size directly above the sample before making contact. 4. The load cell is zeroed at the start of every test to ensure accurate force measurements. 5. Place the sample as flat as possible to ensure good contact with the plate. 6. After the required number of compressions, the test is initiated and completed. Depending on the desired mechanical properties, the specimen can be compressed to 5-100% of its original thickness at a user-specified rate (typically <0.1 mm / s to >10 mm / s). During compression, force data is measured using a load cell with an appropriate maximum force (typically 0.1-100 N). 7. When complete, discard the sample. 8. Collect the data and estimate the bulk modulus in the initial elastic region of the curve.

[0426] Bulk modulus extraction For the calculation of bulk modulus, the raw data is provided as a force-elongation curve and converted to a stress-strain plot based on the measured specimen dimensions. The linear portion of the compression curve is evaluated and the slope is determined in kPa. [Example 8]

[0427] Hydrogel crosslinking in aerogels and foams This example describes an approach for crosslinking aerogels and foams as described herein, e.g., hydrogels in Examples 1 and 2 and elsewhere herein. In certain embodiments, at least a portion of the cellulose and / or cellulose derivative(s) of the aerogel or foam may be crosslinked by: physical cross-linking (e.g., using glycine), or chemical cross-linking (e.g., using citric acid in the presence of heat), or At least a portion of the cellulose and / or cellulose derivative(s) of the aerogel or foam is functionalized with a linker (e.g., succinic acid) optionally having attached thereto one or more functional moieties (e.g., amine-containing groups to which crosslinking may be further achieved using one or more protein crosslinking agents, e.g., formalin, formaldehyde, glutaraldehyde, and / or transglutaminase); Or any combination thereof.

[0428] Cellulose-based materials can be cross-linked in a variety of ways. Briefly, the cross-linking can be by physical cross-linking or chemical cross-linking or both.

[0429] Physical crosslinking: An example of physical cross-linking is the use of glycine, which, as an illustrative example, can be carried out as follows:

[0430] Gel formulation The gelation process may involve dissolving methylcellulose in 10 mL of 2 M NaOH for 1 hour with stirring on ice. A glycine solution was also prepared by dissolving glycine in 2 M NaOH. After 1 hour, 5 mL of glycine solution was added, and the mixture was stirred on ice for an additional hour. The mercerized apple structural cells were introduced in one of two different stages. One method of introduction involved mixing the mercerized apple with the viscous solution after the second hour of glycine treatment. This particular mixing method involved using a syringe connected with a F / F Luer-Lock system. It should be noted that for higher methylcellulose concentrations (1 g), mixing using a syringe was very difficult. As a result, a second preparation method was developed. In this approach, the mercerized apple was added directly to the 2 M NaOH solution along with the methylcellulose at the start of the reaction. Mixing was achieved using magnetic stirring. See Table 7 for the formulations tested. It was observed that the viscosity of the mixture increased when glycine was added. The gel was allowed to crosslink overnight at room temperature.

[0431] Such physical cross-linking using glycine has already been described in detail in Example 3 above with reference to Table 7 and Figures 84-90.

[0432] chemical crosslinking One example of chemical cross-linking is the use of citric acid and heat, where the carboxylic acid groups can react with the carboxymethyl cellulose to form a chemically cross-linked matrix, which, as an illustrative example, can be carried out as follows:

[0433] Preparation of carboxymethylcellulose gel cross-linked with citric acid combined with mercerized apple material (e.g., structural cells): CMC preparation · 2% CMC aqueous solution (w / w) 20% citric acid (based on polymer weight) For combination with mercerized materials, an equivalent weight was added to the CMC. Stir at room temperature until clear Heat at 80℃ for 5.8 and 16 hours

[0434] result After 5 hours, small gels began to form, but the majority of the mixture was still liquid. After 8 hours, a moderate amount of gel had formed. The CMC control was transparent, while the CMC with mercerized material was translucent and had a white tint. These gels had the consistency of low-concentration collagen gels commonly used in cell culture experiments.

[0435] Figure 110 shows the results where CMC cross-linked with citric acid was presented. The CMC control was a clear gel, while the CMC with mercerized material (structural cells) was a translucent white gel.

[0436] After 16 hours, a hard "glass or epoxy" like material was obtained, which rehydrated to form a membrane material.

[0437] Figure 111 shows the results of CMC cross-linking with citric acid films. The CMC control (left) was a clear film, while the CMC with mercerized material (structural cells) was a more rigid—translucent white film with the texture of a shrimp shell.

[0438] To further elaborate on chemical cross-linking, it is also contemplated herein that the cellulose structure can be functionalized with a linker molecule, which can then be used to add specific portions of the cellulose chain for cross-linking purposes (among other purposes). For example, it is contemplated that succinic acid can be used to add carboxylic acid groups to the cellulose structure. Succinylated materials can be used to add amine groups. It is contemplated that the amine groups can then be cross-linked with available protein cross-linking agents, such as formalin, formaldehyde, glutaraldehyde, and / or transglutaminase.

[0439] Illustrative example of a succinylation protocol: a) Solvent and sample preparation Solvent Dimethylacetamide (DMA) was dried in a fume hood to remove water. Temperature: 115℃ Duration: 45 minutes LiCl The LiCl was kept in the oven the entire time to prevent hydration. Temperature: 210℃ Sample Decellularized apple-solvent exchange Step 1. Apple pieces were kept in ethanol or acetone in an ultrasonic bath for 20 minutes. Three cycles of solvent exchange with ethanol were performed. Step 2: The apple pieces were immersed in DMA in an ultrasonic bath for 20 minutes. Three cycles of solvent exchange were performed using DMA.

[0440] b) Succinylation of cellulose using DMA and LiCl Scaffold: mass of lycocellulose (after solvent exchange) = 360 mg Chemicals and reagents: DMA=30mL LiCl=271mg AS (succinic anhydride) = 3.1g · Conditions Temperature: 80℃ Duration: 6 hours (under rotary agitation)

[0441] After solvent preparation (DMA and LiCl), cellulose pieces are immersed in DMA. LiCl is then added. The mixture is stirred for 30 minutes. After 30 minutes, succinic anhydride (AS) is added. The mixture is placed in an oven at 80°C for 6 hours. After this process, the solvent is removed and the cellulose is washed vigorously with water until the scaffold is clear and free of visible residue. The image in Figure 112 shows the cellulose immediately after the reaction and excessive washing.

[0442] c) Result The cellulose after the reaction is complete is shown in Figure 112. The cellulose after extensive washing with water is complete is shown in Figure 113.

[0443] FTIR analysis: To confirm that chemical crosslinking had been achieved, Fourier transform infrared spectroscopy was used. The spectral shift indicated that succinic anhydride had been successfully chemically bonded to the scaffold. This linker molecule can be used to bond to other molecules, such as collagen. FTIR spectra are shown in Figure 114, which shows the FTIR spectra of the decellularized scaffold (2AP-DECEL) and the chemically bonded composite of succinylated plant-derived cellulose (5AP-AS).

[0444] Examples of Chemical Modification and Functionalization Processes First step - acylation of cellulose Methodology: By homogeneous succinylation using succinic anhydride Method 1: The cellulose suspended in DMAc / LiCl was stirred in the presence of CO2 (2-5 bar) to obtain a clear solution. Succinic anhydride was then added to the clear cellulose solution and stirred at room temperature. The resulting reaction mixture was poured into vigorously stirred water (200 mL). The water was then made slightly acidic with dilute (0.05 M) hydrochloric acid solution to obtain a white precipitate. The crude product was collected, dissolved in DMAc / LiCl, and reprecipitated with water (200 mL). The white product was further washed with water (200 × 3 mL) to remove the DMAc / LiCl. The pure white product was dried under vacuum at 70 °C for further esterification process.

[0445] Method 2: Cellulose succinylation using succinic anhydride and pyridine in dichloromethane in a static system. The reaction is carried out under reflux. After the reaction period, the reaction is quenched by adding MeOH. The material is then washed several times to remove the pyridine.

[0446] Second Step - Esterification Process Chemical modification of cellulose, such as esterification, etherification, and grafting (from or onto) are the most common techniques. Such derivatization can be achieved by heterogeneous or homogeneous approaches. Heterogeneous modification at the surface of cellulose fibers has been more common due to cellulose solubility challenges. On the other hand, homogeneous modification of cellulose is desirable because the latter may allow control of the DS by adjusting the reaction conditions. Table 10 shows an example of an esterification process.

[0447] [Table 11]

[0448] methodology Esterification can involve high temperatures and cross-linking agents. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), citric acid, and fumaric acid are commonly used in esterification reactions to form hydrogels.

[0449] EDC promotes crosslinking between carboxyl groups and hydroxyl or amine groups, forming non-toxic, water-soluble urea derivatives. EDC is preferred for crosslinking reactions due to its high conversion efficiency, mild reaction conditions, non-toxic and easily separable by-products, and compatibility with materials. Also, an intermediate anhydride is formed during the esterification of cellulose and citric acid.

[0450] Therefore, before the application of transglutaminase, cellulose can be subjected to chemical modification using succinylation (acylation) followed by the preparation of activated NHS-esters and their reaction with nucleophilic amino acid residues present in proteins.

[0451] Transglutaminase Protocol: The following procedure outlines an illustrative example of the general use of MooGloo (i.e., a transglutaminase enzyme) in food applications, for example, for bonding and adhering AA aerogel and other biomaterials.

[0452] Important Chemicals and Solutions 1. MooGloo RM Transglutaminase Formula (Modernist Pantry) 2. MooGloo TI Transglutaminase Formula (Modernist Pantry) 3. MooGloo GS Transglutaminase Formula (Modernist Pantry) 4. Distilled water

[0453] Procedure - RM Formula 1. Open the vacuum-sealed package containing the transglutaminase powder. 2. Make a solution of transglutaminase powder and distilled water in a 1:4 ratio (weight / volume, w / v) (i.e., 5 g of dry powder mixed with 20 mL of distilled water) and mix thoroughly. 3. Pour the slurry onto the designated area of ​​the biomaterial to be adhered and spread evenly. a. If the biomaterial is a gel / liquid solution, transglutaminase powder can also be mixed directly into the solution at 0.5-1.0% w / v concentration to thicken or bind the biomaterial into a uniform form. 4. After mixing or adhering the biomaterial, wrap tightly in parafilm or store in an airtight container. 5. To allow the mixture to bind, transfer the mixture to the refrigerator and store at approximately 4°C for 6 to 24 hours. 6. Store any remaining transglutaminase powder in the freezer for up to 6 months.

[0454] Procedure - TI Formula 1. Open the vacuum-sealed package containing the transglutaminase powder. 2. Make a solution of transglutaminase powder and distilled water in a 1:4 ratio (weight / volume, w / v) (i.e., 5 g of dry powder mixed with 20 mL of distilled water) and mix thoroughly. 3. Pour the slurry onto the designated area of ​​the biomaterial to be adhered and spread evenly. a. If the biomaterial is a gel / liquid solution, transglutaminase powder can also be mixed directly into the solution at 0.5-1.0% w / v concentration to thicken or bind the biomaterial into a uniform form. 4. After mixing or adhering the biomaterial, wrap tightly in parafilm or store in an airtight container. 5. To allow the mixture to bind, transfer the mixture to the refrigerator and store at approximately 4°C for 6 to 24 hours. 6. Store any remaining transglutaminase powder in the freezer for up to 6 months.

[0455] Procedure - GS Formula 1. Open the vacuum-sealed package containing the transglutaminase powder. 2. Make a solution of transglutaminase powder and distilled water in a 1:4 ratio (weight / volume, w / v) (i.e., 5 g of dry powder mixed with 20 mL of distilled water) and mix thoroughly. 3. Pour the slurry onto the designated area of ​​the biomaterial to be adhered and spread evenly. a. Note: The GS formulation cannot be used as a dry powder; if the biomaterial is a gel / liquid solution, mix the slurry directly into the solution at 0.75-1% v / v concentration. 4. After mixing or adhering the biomaterial, wrap tightly in parafilm or store in an airtight container. 5. To allow the mixture to bind, transfer the mixture to the refrigerator and store at approximately 4°C for 6 to 24 hours. 6. Store any remaining transglutaminase powder in the freezer for up to 6 months. [Example 9]

[0456] Cell-based and plant-based meat products and meat imitation foods In certain embodiments, aerogels and / or foam materials as described herein can be used to prepare cell-based and / or plant-based meat products, meat mimetics, cell-cultured meat, cell-based meat, other food applications, cellular agriculture applications, and the like. Mercerized materials as described herein (e.g., structural cells) can be combined with several different hydrogels (as described above), such as alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, dissolved and regenerated cellulose, and the like. The mixture can then generally be placed in any suitable sized container, frozen, and then lyophilized to remove all water. Once fully dehydrated, the material can be crosslinked using (e.g.,) calcium chloride or another crosslinking agent. This step can be performed before or after lyophilization and can result in the material in the desired format. This example demonstrates the use of aerogels for the production of plant-based meat products.

[0457] In certain embodiments, aerogels can be used to create plant-based meat products by customizing their preparation, e.g., the container in which they are prepared. As an example, to create tuna sashimi pieces, mercerized material was molded into a 100 mm dish and then frozen at -20°C for 24 hours. The frozen material was then freeze-dried for 48 hours and then cross-linked using calcium chloride. In one embodiment, once cross-linked, the material can then be dyed, colored, or cut into any desired shape, such as for sashimi pieces. The material was dyed using food coloring by adding several drops (2-6 drops, or the desired amount for the desired color) to a container with water so that the water completely covered the material (e.g., for material used to form a 100 mm dish, 10-20 mL of colored water or food dye). Once dyed, the material was cut into rectangular shapes using a scalpel, knife, or another sharp blade. Vertical slices can be cut across the entire section to mimic the white lines found on tuna or salmon. A food-grade adhesive, such as agar, agar-agar, gelatin, or similar agents, can be used to fill the lines cut by the blade. In one embodiment, 1-5% agar can be used to glue small pieces of material together or to fill the lines cut by the material approximately halfway to three-quarters of the way through. Agar can also be combined with food-grade titanium dioxide (Pan Tai, PTR-630) (0.1-1 g per 100 mL of agar) to color the lines white.

[0458] Figure 117 shows a "tuna" sushi imitation (colored red) created by layering and gluing small pieces of aerogel (cross-linked 50% alginate) scaffold together with more alginate. The construct was then cut into 3 x 2 cm pieces (approximately) and stained with red food dye to mimic real tuna. Small diagonal sections were cut along its length to mimic the boundaries between muscle layers.

[0459] Figure 118 shows a "tuna" sushi imitation (colored red) created by layering and adhering small pieces of pre-dyed aerogel (cross-linked 50% alginate) with an agar "glue" that was colored with titanium dioxide (TiO2), a common white food coloring. This construct allowed for a more convincing imitation of the fascia that exists between the distinct layers of muscle tissue in real tuna.

[0460] Figure 119 shows "tuna" (dyed red) created by layering and gluing small pieces of pre-dyed aerogel (cross-linked 50% alginate) with agar "glue" that has been colored using titanium dioxide (TiO2), a common white food coloring. The agar glue can be placed between layers or in thin grooves cut along the surface of the aerogel to create the linear pattern of fascia that exists between muscle layers.

[0461] Cooking method: Once the resulting biomaterial has been cut, stained, and prepared for the desired appearance and texture, it can be cooked. The material can be pan-fried, baked, or otherwise prepared (e.g., under vacuum, sous vide), or left uncooked. In one embodiment, the material can be pan-fried with a small amount (1 / 4 tsp) of butter in a cast iron skillet heated to 200°C for approximately 1-10 minutes per side (see Figures 9-12). The material is fried until golden brown (approximately 3 minutes for 10mm-100mm diameter material), and then removed from the pan onto a plate.

[0462] Post-cooking mechanical testing: Once cooked, the material can be mechanically tested to determine the bulk compression modulus. In one embodiment, the material was cut into 1 cm x 1 cm pieces, which were then placed on top of a platen on a mechanical tester (e.g., Univert, manufactured by CellScale). Among other features, the speed (compression force per second or size), maximum load (depending on the load cell), and compression displacement (5% to 95% of its size) can be customized. In one embodiment, circular samples approximately 10 mm in diameter and 5 mm thick were mechanically tested by both axial and radial compression. The biomaterial was cut to the specified size and placed on the mechanical tester. The size measurements were then recorded, and the material was compressed to 50% of its size three times.

[0463] The measured bulk moduli from 10 cm of cooked and uncooked biomaterial are as follows:

[0464] [Table 12]

[0465] The present data demonstrate that mercerized aerogels can be used to generate plant-based scaffolds for the development of meat-free substitutes for food products. The resulting material can be customized; its size, shape, appearance, texture, and / or mechanical properties can all be adjusted to produce desired materials, such as pieces of fish (e.g., salmon or tuna) or pieces of steak or chicken. Furthermore, the data support that cooking can result in an increase in the bulk modulus or rigidification of the material. This may be a desirable property, as cell-based meats can also rigidify from cooking. These results are promising for the development of various plant-based foods. Finally, because aerogels are compatible with cell culture (see Figure 41), they can be readily utilized as scaffolds for cell-based meat, cell-cultured meat, and cultivated meat in cellular agriculture applications, for example. [Example 10]

[0466] Dermal Filler Products In another embodiment, the mercerized material, structural cells, aerogels, foams, dissolved cellulose, and / or other such materials described herein can be used for dermal filler applications. For example, the mercerized material can be used by itself as a dermal filler hydrogel, or it can be combined with other carrier gels and / or fluids, such as saline, collagen, hyaluronic acid, methylcellulose, and / or dissolved plant-derived decellularized cellulose. Such formulations can be combined with, for example, lidocaine or another such agent relevant to dermal filler applications. This example provides data for the use of mercerized decellularized apple structural cells as particles for dermal fillers.

[0467] merAA (mercerized apple) needle occlusion test: Size analysis of the mercerized material demonstrated that the process (as previously described in detail herein) was capable of separating the scaffold into single structural cells. These apple cell walls have a size comparable to the HA particle size used in dermal fillers. Therefore, the mercerized material was selected as a candidate for dermal filler applications. It can be used as a material on its own or in combination with other gels / formulations, as discussed below. The first test was a blockage test using a 27G needle. The needle was found not to be blocked, except for large clumps that were filtered out. This is a significant result, as HA fillers typically use 27-30G needles, while BellaFill uses a 26G needle.

[0468] Figure 120 shows a needle occlusion test using mercerized AA. In (A), a 27G needle and syringe are shown. (B) shows the extrusion of mercerized AA. (C) shows an example of, for example, 3D printing or controlled injection / extrusion.

[0469] The mixture was made in a 5 ml syringe and transferred to a 1 cc syringe for a volume of 0.3 ml. With the use of an interlock connector on the 5 ml syringe, we were able to thoroughly mix the mercerized AA with the saline solution by mixing 30 times.

[0470] The formulation is as follows:

[0471] [Table 13]

[0472] Figures 121, 122, and 123 show force-elongation curves. Figure 121 shows the force-displacement curve for N=10 extrusion of water from a 1 cc syringe. Figure 122 shows the force-displacement curve for N=10 extrusion of 20% mercerized AA in a saline mixture from a 1 cc syringe. Figure 123 shows the force-displacement curve for N=10 extrusion of undiluted mercerized AA from a 1 cc syringe.

[0473] Maximum force: The maximum extrusion force was used to compare the three formulations. Descriptive statistics are shown below and compared visually in Figure 124, which shows the maximum extrusion force of water alone, a 20% mercerized AA solution diluted with 0.9% saline, and the undiluted mercerized material.

[0474] Descriptive statistics for maximum extrusion force from a 1cc syringe:

[0475] [Table 14]

[0476] The data show that the undiluted mercerized material had a significantly greater extrusion force than the diluted mercerized material and the water control. Furthermore, the results show that there was no significant difference between the diluted mercerized material and the water control. This provides insight into the sensitivity of the measurement. The viscosity of the diluted material is different from distilled water, but this slight difference could not be discerned using the current method.

[0477] Dermal Filler Application - Rat Model Injection and Size Measurement: Because the occlusion test was successful, the material was intended for use as a dermal filler in a pilot rat study. The injection volume was 600 μL, with four injections per animal. All formulations contained 0.3% lidocaine. While lidocaine was used in this case, several other anesthetics are possible. Typical anesthetics include, for example, 2% lidocaine gel and triple anesthetic gel (BLTgel) composed of 20% benzocaine, 6% lidocaine, and 4% tetracaine. To anesthetize the upper and lower lips and perioral area prior to injection, a dental block using 3% porocaine was administered with a 30G needle. Alternatively, a mixture of 2% lidocaine with epinephrine can be used.

[0478] The first formulation was mercerized AA alone. The second filler was mercerized material diluted with 0.9% saline to yield a final concentration of 20% mercerized material by volume. Similarly, the third formulation contained 20% mercerized material and a 3.5% collagen mixture. Finally, the fourth filler was a 20% mercerized material and regenerated cellulose mixture. The regenerated cellulose was derived from decellularized apple tissue and dissolved using DMAc and LiCl according to the method previously described above. The formulations were coded MER, MER20SAL80, MER20COL80, and MER20REG80, respectively.

[0479] The dermal filler formulation components were as follows:

[0480] [Table 15]

[0481] Figure 125 shows generation II dermal fillers. (A) shows MER, (B) shows MER20SAL80, (C) shows MER20COL80, and (D) shows MER20REG80. The injections contained 0.3% lidocaine and were prepared as 600 μL injections in 1 cc syringes.

[0482] Figure 126 shows the results of a generation II dermal filler used as a dermal filler in a rat model. (A) shows before injection, and (B) shows after injection. The implantation site was tracked weekly using a black outline. The bumps under the skin were measured. The bump size was measured using a vernier caliper. An ellipsoid estimate was used to estimate the area and volume of the injection.

[0483] Figure 127 shows the dermal filler size measurement results for a rat model injection. (A) shows the normalized height, (B) shows the normalized ellipse area, and (C) shows the normalized ellipse volume. [Example 11]

[0484] Crosslinking with citric acid Cellulose is a polymer that presents a large number of hydroxyl groups and can be used to prepare hydrogels with attractive structures and properties. Based on the crosslinking method, hydrogels can be divided into chemical gels and physical gels. Physical gels are formed by molecular self-assembly through ionic or hydrogen bonds, while chemical gels are formed by covalent bonds.

[0485] Cellulose and cellulose derivatives have a wide range of applications, and cellulose esters and cellulose ethers are two major groups of cellulose derivatives with different physicochemical and mechanical properties. Cellulose esters are water-insoluble polymers with good film-forming properties and find a variety of applications.

[0486] Crosslinked cellulose chains are produced by the attachment of multifunctional carboxylic acids via esterification with cellulose-derived hydroxyl groups and their subsequent esterification with other cellulose-derived hydroxyl groups. The attachment of a carboxylic acid moiety to a cellulose hydroxyl group via an esterification reaction of a first cyclic anhydride exposes a new carboxylic acid unit in the carboxylic acid, which has the appropriate chemical connectivity to form a new intermolecular anhydride moiety with an adjacent carboxylic acid unit.

[0487] Citric acid (CA) is considered a non-toxic and relatively inexpensive cross-linking agent that has been used to modify polysaccharides such as cellulose.

[0488] A suggested mechanism for the cross-linking process of cellulose using citric acid relative to conventional cross-linking of cellulose using citric acid in the presence of an acid catalyst is shown below:

[0489] [ka]

[0490] Aerogels produced from cellulose cross-linked with citric acid In this example, various characteristics of aerogels produced from cellulose cross-linked with citric acid, such as pore size and alignment, were evaluated along with aerogel stability. Aerogels were prepared from regenerated cellulose cross-linked with citric acid, or from mercerized cellulose to compare the effects of the two forms of cellulose in aerogel preparation for downstream applications. The goal was to produce aerogels that could be used as scaffolds for bone repair and / or spinal cord regeneration. The first aerogel was produced from a mixture of 1) regenerated cellulose cross-linked with citric acid (AD1CLS) and 2) succinylated cellulose produced by unidirectional freezing. The second aerogel was produced from a mixture of 1) mercerized cellulose cross-linked with citric acid (Merc. AA) (S4) and 2) succinylated cellulose produced by unidirectional freezing. The stability of the two aerogels was then compared.

[0491] methodology Crosslinking with citric acid Four different samples were prepared by mixing mercerized cellulose (Merc. AA) (0.1 g / mL) and succinylated cellulose (0.1 g / mL) in various ratios according to the table below, and then mixed with 2% citric acid to evaluate whether 2% citric acid was sufficient to produce stable aerogels in PBS. Briefly, the polymer was suspended in 50 mL of water to form a gel, after which citric acid was added and maintained under vigorous stirring with a glass rod for 15 minutes. The reaction was carried out on a hotplate shaker at 100 °C for 20 minutes to remove all surface moisture. The material was removed from the oven and kept at room temperature overnight. The next day, the material was incubated in the oven at 105 °C for 2 hours. The reaction product was then slurried in water (60 mL) for 30 minutes, adjusted to pH 7, and washed three times by centrifugation at 4500 rpm for 10 minutes to remove unreacted components.

[0492] Name of cross-linked sample, cellulose and citric acid concentration used.

[0493] [Table 16]

[0494] Aerogel generation Agarose (1%) was liquefied in warm water (70°C) and mixed with 40% hydroxyapatite (HP). Cross-linked Mer.AA (20 g) and succinylated cellulose were loaded into a syringe along with 12 mL of liquefied agarose and HP. The polymers were mixed using two 60 mL syringes equipped with Luer-Lok connectors. The amount of succinylated cellulose was adjusted according to the ratios listed in Table 1.

[0495] The resulting material was placed in a 60 mm TC dish and incubated at -20°C for at least 2 hours to completely freeze the material, which was then freeze-dried for 24 hours.

[0496] As shown in Figure 129, the freeze-dried aerogels were then punched out using a 5 mm biopsy punch (A) and then removed using a fine wire (B) to assess the short-term stability of the aerogels in PBS.

[0497] Aerogels were prepared using regenerated cellulose to compare their porosity with other aerogels prepared from Mer.AACL.

[0498] Aerogel particle size was evaluated by comparing aerogels produced from cross-linked regenerated cellulose (D1CL) and cross-linked mercerized cellulose (S4), both blended with succinylated mercerized cellulose. These materials were evaluated with the goal of obtaining a more homogeneous suspension and more aligned porosity formation under directional freezing. Samples were prepared as described in Table 2 below.

[0499] Composition and name of aerogel samples.

[0500] [Table 17]

[0501] Aerogels were prepared as previously described above. Briefly, two 50 mL syringes connected with a f / f Luer lock connector were used to mix the polymers in the amounts shown in the table above. The previously prepared sample (S4 - cross-linked mercerized cellulose) was mixed with water (4 mL) and inserted into the syringe along with the succinylated cellulose, and the polymers were mixed at least 30 times. The same procedure was performed for cross-linked regenerated cellulose (D1). The sample was placed in a steel tube on a directional freezer for 2 hours.

[0502] After directional freezing, the material was transferred to a -20°C freezer and maintained for 24 hours, followed by freeze-drying for at least 24 hours.

[0503] result Figure 130 shows aerogels produced using cross-linked regenerated cellulose (D1) and succinylated cellulose.

[0504] Figure 131 shows aerogels produced using cross-linked mercerized cellulose (AS4) and succinylated cellulose.

[0505] The aerogel prepared from cross-linked regenerated cellulose (D1), designated "AD1CLS," exhibited two layers. Previous results indicated that aligned pores typically formed only in the bottom portion. Consequently, microscopic imaging was performed on the bottom portion (the portion in direct contact with the copper plate used for directional freezing) of the ADS1 aerogel, as shown by the circled areas in Figures 132-133, and on the top surface of the bottom layer for analysis. For the aerogel prepared from cross-linked mercerized cellulose (AS4), which was subjected to directional freezing and subsequently destroyed after freeze-drying, other regions were examined, as shown in Figures 134-135.

[0506] Figure 132 shows a bright field microscope image of the circled bottom surface of the bottom layer of an aerogel prepared from cross-linked regenerated cellulose (AD1CLS).

[0507] FIG. 133 shows a bright field microscope image of the circled top surface of the bottom layer of the aerogel in FIG.

[0508] Figure 134 shows a bright field microscope image of the circled bottom surface of the top layer of an aerogel prepared from cross-linked mercerized cellulose (AS4).

[0509] FIG. 135 shows a bright field microscope image of the circled top surface of the bottom layer of the aerogel in FIG.

[0510] The results demonstrate that sample S4 produced a more porous, organized structure with regions of aligned porosity. However, the sample was highly unstable in water when stability was assessed. Therefore, further optimization of the cross-linking process was performed. [Example 12]

[0511] Optimizing citric acid concentration for cross-linking The density (or porosity) of the final material varies depending on the initial mass of mercerized cellulose. As such, the cellulose mass was increased to evaluate the effect of citric acid concentration on the aerogels during the cross-linking process. Mercerized cellulose was selected to prepare these samples.

[0512] methodology Mercerized cellulose (Merc. AA) was prepared in water as described above. Various concentrations of citric acid were dissolved in a minimum amount of water (3 mL) in a beaker. The citric acid was then added to the Merc. AA gel and mixed vigorously. The cross-linking process was carried out as described above. The various concentrations of citric acid used to prepare samples S6–S10 are shown in the table below.

[0513] Name of cross-linked samples according to citric acid concentration

[0514] [Table 18]

[0515] The reaction product was slurried with water and the pH was adjusted to pH 7. The cellulose citrate product was air-dried.

[0516] Hydrogels were then produced by mixing S6, S9, and S10 with succinylated mercerized cellulose. Because gels produced using S7 and S8 were relatively unstable, these samples were discarded and not used in subsequent experiments. Succinylated mercerized cellulose was chosen because it has more hydrophilic characteristics, allowing for the production of more homogeneous, uniform hydrogels that can improve pore alignment under directional freezing.

[0517] Polymers were prepared as described above. Briefly, two polymers (crosslinked Merc. AA + succinylated mercerized cellulose) were mixed using two 50 mL syringes connected with a f / f Luer-lock connector. The crosslinked mercerized cellulose (S6, S9, or S10) was mixed with water, after which the succinylated cellulose was added and inserted into the syringe, and the polymers were mixed. The samples were placed in a directional freezer. Aerogels were prepared and named according to the table below.

[0518] Polymer concentration in each aerogel

[0519] [Table 19]

[0520] result FIG. 136 shows aerogels AS6, AS9 and AS10 prepared from crosslinked mercerized cellulose mixed with succinylated mercerized cellulose (samples S6, S9 and S10).

[0521] Figure 137 shows a microscope image of the bottom surface of the bottom layer of each of the aerogels AS6, AS9 and AS10.

[0522] As shown in Figure 136, these formulations resulted in a hard, brittle characteristic of the aerogel, with all samples exhibiting two layers (bottom and top) after directional freezing and freeze-drying.

[0523] Figure 137 shows a microscopic image of the bottom surface of the bottom layer of each aerogel AS6, AS9, and AS10. The bottom surface of the bottom layer is the layer in direct contact with the directional freezing plate. The image shows pores of different sizes, but not aligned.

[0524] The stability of each aerogel in PBS was then evaluated. Figure 138 shows the stability of each aerogel, AS6, AS9, and AS10, after 45 minutes in PBS, compared to the aerogel at t=0. The images demonstrate that increasing the citric acid concentration increased the stability of the aerogels. Indeed, Figure 138 shows that a...

Claims

1. An aerogel or foam, a single structural cell, a group of structural cells, or both derived from a plant or fungal tissue, the single structural cell or the group of structural cells having a decellularized three-dimensional structure devoid of cellular material and nucleic acids of the plant or fungal tissue; The single structural cell, the group of structural cells, or both are dispersed within a carrier derived from a dehydrated, lyophilized, or freeze-dried hydrogel. The aerogel or foam.

2. The aerogel or foam is rehydrated, Preferably, the plant or fungal tissue from which the single structural cell or group of structural cells is derived comprises a decellularized plant or fungal tissue, Preferably, the plant or fungal tissue has been decellularized using SDS and optionally CaCl 2 .

2. The aerogel or foam of claim 1.

3. A method for producing a method of producing a method for ... Preferably, the mercerization comprises treatment of the plant or fungal tissue with sodium hydroxide and hydrogen peroxide, or sodium bicarbonate and hydrogen peroxide, together with heating.

3. The aerogel or foam of claim 1 or 2.

4. The aerogel or foam of any one of claims 1 to 3, having a particle size distribution of monostructural cells having an average Feret's diameter in the range of about 1 μm to about 1000 μm, e.g., about 100 to about 500 μm, e.g., about 100 to about 300 μm.

5. The hydrogel is selected from the group consisting of alginate, pectin, gelatin, methylcellulose, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylmethylcellulose, agar, pluronic acid, triblock PEO-PPO-PEO copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), dissolved or regenerated plant cellulose, dissolved cellulose-based hydrogels, hyaluronic acid, vegetable proteins (e.g., pea protein), food colorants (e.g., beetroot), extracellular matrix proteins (e.g., collagen), collagen glycerides, ...

5. The aerogel or foam of any of claims 1 to 4, comprising a hydrogel having a molecular weight of 1000 to 2000, optionally ...

6. The aerogel or foam of any of claims 1-5, comprising templated or aligned microchannels created by directional freezing; by non-directional freezing; by molding using a mold having microscale and / or macroscale features (e.g., channels); by punching, pressing, stamping, or forming (e.g., using needles) geometric patterns, depressions, holes, channels, grooves, ridges, wells or other structural features in and / or on at least one surface; or by any combination thereof.

7. The method according to claim 1, wherein the plant tissue comprises apple tissue, pear tissue, or heart of palm tissue, Preferably, the hydrogel comprises alginate, pectin or both, and the aerogel or foam is rehydrated with a CaCl2 solution which provides cross-linking. The aerogel or foam according to any one of claims 1 to 6. [0010] Claim 8: When the aerogel or foam is in a hydrated form, it contains about 5% to about 95% m / m, e.g., about 10-50% m / m (or more) of single structural cells, groups of structural cells, or both; Preferably, the aerogel or foam comprises one or more animal cells and has a bulk modulus in the range of about 0.1 to about 500 kPa, e.g., about 1 to about 200 kPa. The aerogel or foam according to any one of claims 1 to 7.

9. The aerogel or foam of any of claims 1 to 8, wherein at least a portion of the cellulose and / or cellulose derivatives of the aerogel or foam are crosslinked by physical crosslinking (e.g., using glycine) and / or chemical crosslinking (e.g., using citric acid in the presence of heat); at least a portion of the cellulose and / or cellulose derivatives of the aerogel or foam are functionalized with a linker (e.g., succinic acid) optionally having one or more functional moieties attached thereto (e.g., amine-containing groups to which crosslinking may further optionally be achieved using one or more protein crosslinkers, e.g., formalin, formaldehyde, glutaraldehyde and / or transglutaminase); or any combination thereof.

10. An aerogel or foam according to any of claims 1 to 9, comprising a single structural cell, a group of structural cells, or both, obtained from a plant or fungal tissue that has been decellularized by mercerization of the decellularized plant or fungal tissue, wherein the single structural cell or group of structural cells has a decellularized three-dimensional structure that lacks cellular material and nucleic acids of the plant or fungal tissue and that lacks one or more base-soluble lignin components of the plant or fungal tissue.

11. An aerogel or foam as described in any one of claims 1 to 10 for use in promoting the growth or repair of bone tissue in a subject in need thereof, wherein the aerogel or foam is for transplantation to an affected site in the subject in need thereof.

12. An aerogel or foam as described in any of claims 1 to 10 for use in repairing spinal cord injury in a subject in need thereof, wherein the aerogel or foam is for transplantation to an affected site in the subject in need thereof and comprises templated or aligned microchannels, such that the aerogel or foam promotes spinal cord repair by aligning the growth of neural cells along the templated or aligned microchannels.

13. A food product comprising the aerogel or foam described in any one of claims 1 to 10.

14. Further comprising a dye or colorant, Preferably, the adhesive comprises two or more aerogel or foam subunits bonded together, More preferably, the adhesive comprises agar; More preferably, the aerogel or foam comprises templated or aligned microchannels, optionally formed by directional or non-directional freezing, and the aerogel or foam comprises muscle cells, fibroblasts, myofibroblasts, neurons, dorsal root ganglion cells, neuronal structures such as axons, neural precursor cells, neural stem cells, glial cells, endogenous stem cells, neutrophils, mesenchymal stem cells, satellite cells, myoblasts, myotubes, muscle precursor cells, adipocytes, preadipocytes, chondrocytes, osteoblasts, osteoclasts, preosteoblasts, tendon precursor cells, tenocytes, periodontal ligament stem cells or endothelial cells, or any combination thereof, aligned along the templated or aligned microchannels, preferably, the aerogel or foam comprises templated or aligned microchannels, optionally formed by directional or non-directional freezing, and the aerogel or foam comprises muscle cells, adipocytes, connective tissue cells (e.g. fibroblasts), cartilage, bone, epithelial or endothelial cells, or any combination thereof, aligned along the templated or aligned microchannels. The food product of claim 13.

15. A cellulose-based hydrogel comprising cellulose derived from plant or fungal tissue that has been decellularized by dissolution with dimethylacetamide and lithium chloride, followed by regeneration with ethanol.

16. A cellulose-based hydrogel comprising cellulose derived from plant or fungal tissue that has been decellularized by dissolution using dimethylacetamide and lithium chloride, LiClO4, xanthogenic acid, EDA / KSCN, H3PO4, NaOH / urea, ZnCl2, TBAF / DMSO, NMMO, an ionic liquid (IL) or any combination thereof.

17. The cellulose-based hydrogel of claim 16, wherein the ionic liquid is 1-butylpyridinium chloride and aluminum chloride, or an alkylimidazolium with a nitrate.

18. A cellulose-based hydrogel as described in claim 16 or 17, wherein the ionic liquid is at room temperature.

19. An aerogel or foam according to any one of claims 1 to 10, or an aerogel or foam for use according to claim 11 or 12, wherein the hydrogel comprises a cellulose-based hydrogel according to claim 15 or 16.

20. A meat imitation comprising a plurality of lines providing the appearance of fatty white lines found in tuna, salmon or other fish meat; Preferably it is an imitation of tuna, salmon or another fish meat; More preferably, it contains one or more dyes or colorants that provide the color of the tuna, salmon or other fish meat, More preferably, the plurality of lines are formed in cuts or channels formed in an aerogel or foam; Preferably, the wires comprise titanium dioxide or beetroot, optionally in combination with agar-agar or sodium alginate as a binder; More preferably, titanium dioxide, optionally combined with agar or sodium alginate as a binder, is applied into the cuts or channels formed in the aerogel or foam to provide the appearance of fatty white lines seen in tuna, salmon or other fish meat. A food product comprising the aerogel or foam according to any one of claims 1 to 12 and 19.

21. A non-absorbable dermal filler comprising an aerogel or foam according to any one of claims 1 to 12 and 19, or a cellulose-based hydrogel according to any one of claims 15 to 18; or any combination thereof.

22. A dermal filler comprising a single structural cell, a group of structural cells, or both, derived from plant or fungal tissue, wherein the single structural cell or the group of structural cells has a decellularized three-dimensional structure devoid of cellular material and nucleic acids of plant or fungal tissue, and the single structural cell, the group of structural cells, or both, are obtained from the plant or fungal tissue by mercerization.

23. The composition according to claim 22, further comprising a carrier fluid or gel, Preferably, the carrier fluid or gel comprises water, an aqueous solution such as a saline solution, or a hydrogel such as collagen, hyaluronic acid, methylcellulose and / or dissolved plant-derived decellularized cellulose-based hydrogels; Preferably, the composition further comprises an anesthetic agent such as lidocaine, benzocaine, tetracaine, polocaine, epinephrine, or any combination thereof; Preferably, the material comprises PBS (physiological saline), hyaluronic acid (cross-linked or non-cross-linked), alginate, collagen, pluronic acid (e.g. Pluronic® F127), agar, agarose or fibrin, calcium hydroxylapatite, poly-L-lactic acid, autologous fat, silicone, dextran, methylcellulose or any combination thereof; More preferably, the anesthetic comprises at least one of: 2% lidocaine gel; a triple anesthetic gel containing 20% ​​benzocaine, 6% lidocaine and 4% tetracaine (BLTgel); 3% porocaine; or a mixture of 2% lidocaine with epinephrine.

23. The dermal filler of claim 22.

24. The structural cells have a size, diameter or Feret diameter distribution in the range of about 20 μm to about 1000 μm, and an average projected particle area in the range of about 30,000 to about 75,000 μm2; Preferably, the structural cells have a particle size, diameter or Feret's diameter distribution with a peak of about 200-300 μm, or an average particle size, diameter or Feret's diameter within the range of about 200 μm to about 300 μm; 24. The dermal filler according to claim 22 or 23.

25. Sterile, Preferably, the sterilization is by gamma sterilization, autoclaving or treatment with ethanol; Preferably, the composition is formulated for subdermal injection, deep dermal injection, subcutaneous injection (e.g., subcutaneous fat injection), or any combination thereof, and provided in a syringe or injection device; The dermal filler according to any of claims 22 to 24.